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As current diagnostic indicators for dry eye syndrome (DES) lack both sensitivity and 
specificity, a pressing concern exists to develop activity markers that align closely 
with the principal axes of DES progression. Deciphering pathological alterations in 
single tear components therefore marks the future of human tear research. In my 
thesis, I report the development of a comprehensive quantitative approach for 
analyzing the lipid profiles of human tears and meibum, the predominant lipid source 
for tears, based largely on the principles of high-pressure liquid-chromatography 
coupled to mass spectrometry (HPLC-MS). Particular emphasis was placed on 
deriving the quantitative composition of the tear lipidome, as the precise homeostasis 
of tear components is instrumental in ensuring the structural integrity of tear film 
lipid layer for maintaining good quality vision. The lipidomic approaches developed 
were subsequently applied onto separate clinical cohorts in two separate case/control 
studies and a longitudinal study, respectively, to unravel the lipid perturbations in 
DES.  
Comprehensive lipid anomalies associated with various aspects of DES, 
including disease pathogenesis and treatment response, were reported. Notably, it was 
found that meibum O-acyl--hydroxy fatty acids (OAHFA) were consistently 
decreased with increasing severity of DES. In addition, in another separate 
longitudinal study monitoring the treatment response of meibomian gland dysfunction 
(MGD) patients to routine eyelid warming, the levels of OAHFA in tears were 
significantly increased at the end of the treatment period, with concomitant 
alleviation of ocular discomfort. Our findings therefore indicated that OAHFA could 
serve appropriate indicators of DES progression and treatment response/outcome. In 
addition, we found that low molecular mass wax esters (WE), as well as medium to 
high molecular mass WE containing saturated fatty acyl moieties, were specifically 
reduced in DES patients, suggesting that such species might function biophysically in 
vi 
 
the stabilization of tear film structure. Importantly, these WE species were also 
significantly correlated with both DES signs and symptoms, and therefore could 
potentially serve as objective, “unifying” indicators of DES onset and pathogenesis 
without compromising patients’ symptoms. Interestingly, it was observed that eyelid 
warming resulted in drastic reductions in various classes of lysophospholipids in the 
tear samples of MGD patients, implying a diminished level of phospholipase A2 
(PLA2) activity at the ocular surface following the relief of meibomian gland 
obstruction via heat treatment.  
Besides, our comprehensive lipidomic analyses of human tear and meibum 
also have important implications for the structure of existent tear film model, 
especially with regard to composition of the amphiphilic lipid sublayer. We had 
shown that the tear fluid is appreciably enriched in phospholipids and sphingolipids 
relative to the meibum, and demonstrated that a surplus of phospholipids and 
sphingolipids is available in tears to constitute the amphiphilic lipid sublayer. We had 
also put forth cholesteryl sulfate as a novel candidate for this interfacial lipid 
sublayer. In addition, associations between specific tear lipids with physiological 
processes such as aging and lacrimal reflex were reported. In conclusion, this work 
confers hypothesis-generating new insights pertaining to the functions of lipids in 
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Chapter 1. Introduction  
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1.1 Evolutionary significance of tears 
Tear production dates back to approximately 360 million years ago when 
crossopterygian fish first left water, subsequently giving rise to the amphibians. 
Lubrication became an urgent necessity for these organisms to survive in the dry 
aerial environment, driving the concomitant development of the aqueo-serous 
lacrimal glands that create a lacrimal film for protecting the delicate cornea. During 
the course of evolution, basal lacrimal secretion perpetuated from amphibians to 
reptiles, birds, and eventually mammals (Murube, 2009). The initial development of 
tears was probably designated for maintaining the nutritional homeostasis of the 
cornea and in providing a smooth optical surface covering the constantly 
desquamating corneal epithelium to ensure the proper refraction of light. As an 
evolutionary adaptation to non-aquatic living, humans developed a structurally and 
biochemically complex preocular tear film stabilized by precise compositional and 
hydrodynamic factors (Pflugfelder et al, 1998). 
 
1.2 Tear film model – physiological and biophysical roles of individual sublayers 
 
Figure 1.1. Hypothetical tear film model. Figure is not drawn to scale. Modified from Butovich, 2009b. 
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The tear film constitutes the interface between the ocular surface and its immediate 
external environment, and is thus of critical importance in protecting the eye from a 
myriad of environmental stresses. The tear film is composed of three basic layers – 
the carbohydrate-rich glycocalyx layer where the apical microvilli of the superficial 
corneal epithelial cells resides; an intermediate aqueous-mucin gel layer that 
constitutes the bulk of the tear film; as well as the most superficial lipid layer in 
immediate contact with the external environment (Figure 1.1) (McCulley et al, 2004).  
 The inner mucous (i.e. glycocalyx) layer is produced by conjunctival goblet 
cells as well as conjunctival and corneal epithelial cells (Chao et al, 1980), and are 
products of the family of MUC genes (Tiffany, 2008). Two major types of mucins are 
found in the tear film, namely the secreted or soluble mucins, of which the most 
critical in the eye is represented by MUC5AC. The transmembrane mucin functions 
to facilitate tear film spreading over the cornea and in ensuring corneal wettability by 
rendering the originally hydrophobic corneal epithelium hydrophilic (Rolando et al, 
2001), thus facilitating the anchorage of the gelatinous layer of soluble mucins and 
other aqueous components (Tiffany, 2008). On the other hand, the aqueous layer is 
produced by the main and accessory lacrimal glands, which, together with the soluble 
mucins secreted by the conjunctival goblet cells, constitute the aqueous-mucin layer 
that forms the bulk of the tear film. The aqueous-mucin layer is critical for 
maintaining the homeostatic health of the corneal epithelium by bringing in essential 
nutrients and oxygen, while removing epithelial debris, foreign contaminants and 
carbon dioxide via nasolacrimal drainage (Rolando et al, 2001). In particular, the 
aqueous-mucin gel layer had been shown to entrap and immobilize invading microbes 
and foreign particles (Kirkeby et al, 2011), which were later extruded from the ocular 




The tear film lipid layer (TFLL) comprises the outer, superficial sublayer 
consisting predominantly of non-polar lipids and an inner, amphiphilic layer which 
serves as a boundary between the non-polar lipid sublayer and the polar aqueous layer 
underneath, facilitating the interaction between the two layers and the even spreading 
of the non-polar lipid sublayer during each blink of the eye (McCulley et al, 2004; 
Joffre et al, 2008; Butovich, 2009b; Green-Church et al, 2011). The TFLL plays a 
major role in the pathogenesis of evaporative dry eye due to its chief function in 
retarding evaporation from the underlying aqueous layer (McCulley et al, 2004). In 
addition, the forward flow of the meibum at the lid margin also serves to keep the 
sebum of skin or lash follicle away from the tear film to prevent the mixing of lipids 
that could substantially compromise tear film structural integrity. The presence of a 
hydrophobic barrier of nonpolar lipids at the outermost region of the tear film helps to 
limit the spillage of tears under normal conditions (i.e. in the absence of reflex 
tearing), thus preventing the maceration of skin region adjacent to the lid margin 
(Bron et al, 2004).   
The lipid constituents of tears, regardless of their sources of origin in the 
lacrimal or meibomian glands, collectively serve to reduce the surface tension of tears 
(Bron et al, 2004). It was previously shown that the extraction of lipids from aqueous 
tears obtained from normal individuals resulted in an appreciable increase in surface 
tension, reaching values comparable to that in tear samples collected from dry eye 
patients (Nagyová et al, 1999). It was thought that dry eye syndrome (DES)-
associated tear film instability could be partly attributed to the elevation in surface 
tension typically observed in the tear samples of dry eye patients (Nagyová et al, 
1999). The structural integrity and stability of the tear film is intricately linked to the 
development and progression of DES. Therefore, an analytical examination of the 
compositional changes of the TFLL is of paramount importance to the understanding 
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of DES pathogenesis and also in facilitating the development of better diagnostic 
tools and treatment strategies. 
The tear film is essentially separated from the rest of the lacrimal system in 
an open eye, and can be considered as “perched” on the ocular surface, as it is spread 
over the exposed ocular surface but remains independent of the ocular adnexa. In 
addition, tear film osmolarity is, to a large extent, determined by the electrolyte 
concentration, since even the major proteins are found in considerably lower amounts 
than the electrolytes (Tiffany, 2008).  
 
1.3 Tear lipids 
1.3.1 Sources of tear lipids 
 
Figure 1.2. Meibomian glands topography within the upper and lower tarsus. The drawing 
illustrates a posterior view of the eyelids with the anterior part removed, and the connective tissues were 
made translucent to expose the glands embedded within. Reproduced from Sobotta D. Atlas der 
Anatomie des Menschen with the kind permission of Elsevier. 
 
The tear film lipids are composed chiefly of meibomian lipids that are deposited onto 
the marginal reservoirs of the lids via secretion from the meibomian glands. Other 
minor sources of tear lipids include contribution from the lacrimal glands as well as 
aged corneal epithelial cells that are being constantly sloughed off as part of the 
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physiological process of corneal epithelial shedding (Bron et al, 2004). The 
meibomian glands are modified sebaceous glands found the inner eyelids, numbering 
approximately 25-40 in the upper tarsus and 20-30 in the lower tarsus (Figure 1.2). 
These tubuloacinar glands are embedded vertically in the dense connective tissues in 
the inner tarsal plates, opening onto the eyelid margin just anterior to the 
mucocutaneous junction (Blackie et al, 2010). Each gland comprises several clusters 
of secretory acini that drain into an elongated central duct via short, lateral connecting 
ductules. The terminal region of the central duct is lined by an ingrowth of the 
epidermis covering the free lid margin, forming a short excretory duct that opens as 
an orifice just anteriorly to the mucocutaneous junction in the posterior lid margin 
(Knop et al, 2011). 
 
1.3.2 Production, secretion, and excretion of tear lipids 
The secretory acini of the meibomian glands follow a holocrine mode of secretion as 
evident in their structures. Each secretory acinus is completely filled with secretory 
cells termed meibocytes. The basal cells that line the periphery of the acinus are 
smaller and darker in morphological appearance, which serves as the proliferating 
progenitor cell population responsible for ensuring the continual production of new 
meibocytes. As the meibocytes mature, they display progressive accumulation of 
lipids and move towards the centre of the acinus, that explains their increasingly 
foamy and pale appearance in conventional histology of paraffin-embedded sections. 
At maturation, central cells undergo shrinkage, compaction, nuclear disintegration, 
and the eventual disintegration of the cell membranes occur as the cells transit from 
the acinus to ductule, releasing the whole cell contents as the oily secretory product 
termed meibum (Knop et al, 2011). 
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  Due to the length of the meibomian gland central duct, an appreciable 
distance exists between the points of physiological secretion at individual acinus to 
the actual delivery of the secreted meibum via the glandular orifice onto the marginal 
lid reservoir, where the meibum elicits its chief function in constituting the TFLL. 
The continuous process of meibocyte regeneration, maturation and lipid production in 
the secretory acinar clusters generate a consistent driving force that moves the 
meibomian oils within the glandular ductal system towards the orifice at the lid 
margin. In addition, the mechanical action of the lid muscles located on the external 
region of the tarsal plate also facilitates the delivery of the meibum onto the lid 
margin via the glandular orifices. During a blink, the orbicularis muscles compress 
onto the meibomian glands enclosed within the tarsal tissues, thereby releasing 
glandular secretions in a manner likened to a “milking action”; while the Riolan’s 
muscles are thought to exert compression on the terminal regions of the ductal system 
that further pushes the meibum out via of the glandular orifices, as supported by the 
observation that meibum is released onto the lid reservoir in the form of jets of liquid 
(Knop et al, 2009). While it was speculated that instead of providing a reinforcing 
push that facilitates to convey meibum out onto the lid margins, the Riolan’s muscle 
might function antagonistically to the orbicularis muscles to control the outflow of 
meibum, no evidence is currently available to support this stance. It had also been 
suggested that the enclosure of meibomian glands within dense connective tissues 
helps to create a homogenous distribution of forces onto individual glands during 
muscular compression (Knop et al, 2009). 
 The meibomian glands also display considerable functional redundancy. 
Previous investigation via the staining of delivered lipids at the meibomian gland 
orifices has demonstrated that active delivery only occurs in 45% of the glandular 
openings at any one point in time (Norn, 1985). In addition, glandular function also 
decreases appreciably with age, with a reduction in active glands by 50% from the 
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age of 20 years to the age of 80 years, consistent with the morphological observation 
of gland dropout (disappearance of gland tissues) with aging using meibography 
(Arita et al, 2008). Furthermore, it was noted that glandular activity also depends on 
the location of individual glands along the lid margin, with a decreasing gradient of 
secretion from the nasal to the temporal region of the eyelid, and a recovery time of 
approximately two hours after a full expression (Blackie et al, 2009).  
 Contrary to other sebaceous glands of the skin that are mainly regulated via 
hormonal factors, electron microscopy and histochemistry has revealed that the 
meibomian glands possess a dense meshwork of unmyelinated nerve fibres around 
the acini (Perra et al, 1996). The nerve endings are found proximal to the acini but 
remain outside the basement membrane, constituting synapses en passant that lack a 
direct postsynaptic structure in the target cell. It has been shown in rats that the 
parasympathetic fibers for the meibomian glands share a common origin to that of the 
lacrimal glands in the superior salivatory nucleus (LeDoux et al, 2001). This pattern 
of innervation offers the attractive notion that a common regulatory mechanism exists 
to precisely control the various ocular surface glands that contribute to the different 
components of the tear film in order to maintain an optimal tear film composition 
(Knop et al, 2011). The precise details pertaining to how the meibomian gland is 
integrated into the complex neural feedback loops innervating the lacrimal glands, 
however, remains to be determined.  
 The exact route for meibomian excretion is not known.  It has been 
speculated that meibomian lipids simply flow outward over the lid skin with 
individual blinks, as with lid closure, the down-phase of a blink would compress the 
tear film lipids onto the lid reservoir, the excess of which could only possibly spill 
forward as surface tensional forces dictate that lipids could not flow backwards 
behind the lid tissues under such circumstances (Holly, 1973). Excretion by bulk flow 
over the lid margin onto surrounding lid skin and lashes therefore represents the most 
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direct means of lipid removal (Bron et al, 2004). Diffusion of lipids from the tear film 
lipid layer into the aqueous layer represents another possible excretory route for 
meibomian lipids. Nonetheless, this pathway is restricted to polar lipids that can 
efficiently transit the aqueous phase of the tear film, which are found in considerably 
lower abundance compared to nonpolar lipids in tears. In addition, this pathway is 
unlikely a significant pathway for tear lipid excretion considering the comparably 
small amounts of lipids in the tear film to that found in the marginal lid reservoirs. 
Lipids arriving at the aqueous phase of the tear film would subsequently be removed 
via nasolacrimal drainage along with other aqueous components (Bron et al, 2004).
  
1.4 Epidemiology and pathophysiology of dry eye syndrome 
DES is a prevalent ophthalmic condition adversely affecting up to 80% of the 
population over the age of 80, with potential debilitating effects on specific segments 
of the population such as contact lens wearers, people who have undergone refractive 
surgeries, post-menopausal women and patients suffering from a variety of 
autoimmune disorders (Aquavella, 2012). Symptoms relating to DES represent some 
of the leading causes for patient visits to ophthalmologists and optometrists, and the 
disease affects 14% to 33% of the general population worldwide (Schein et al, 1997; 
Lin et al, 2003), depending on the varying criteria used for its classification in 
different regions of the world.  
Delicate hormonal and neuronal regulatory networks that precisely 
coordinate the functions of various ocular components including the cornea, lacrimal 
glands, mucous cells and the meibomian glands are required to ensure tear film 
homeostasis. The causes of DES are often multifactorial and could be associated with 
deficiencies in any one or more of the ocular surface components as aforementioned. 
Regardless of the initiating causes, chronic dryness and the resultant tear film 
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hyperosmolarity leads to inflammation that jeopardizes the structural and functional 
integrity of the lacrimal gland, meibomian gland, as well as corneal and conjunctival 
epithelial tissues. The gradual destruction of these tissues that are major contributors 
of various tear film components further aggravates tear film homeostasis and results 
in a vicious cycle of inflammatory events that represents the major pathologic 
mechanism driving sustained ocular surface injuries in DES (Baudouin, 2001) (Figure 
1.3).  
Inflammatory insults to the ocular tissues can take different facets.  For 
instance, the secretory acinar epithelial cells in the lacrimal glands of Sjögren’s 
syndrome (SS) patients displayed enhanced expression of apoptotic markers after 
being targeted by lymphocytes, despite possessing apparently normal morphology 
(Fujihara et al, 1999). Apart from direct insults by immune cells, inflammatory 
mediators could also deprive glandular tissues of the essential trophic stimulation 
necessary for their physiological maintenance (e.g. via inhibition of neuronal signals 
to the glands), leading to chronic destruction of the glandular tissues (Zoukhri et al, 





Figure 1.3. Schematic diagram illustrating the core mechanism driving the pathogenesis of dry eye 
syndrome. In essence, the desiccation stress imposed on corneal and conjunctival tissues can trigger a 
cascade of inflammatory reactions at the ocular surface that further damages the meibomian and/or 
lacrimal gland tissues, thus aggravating the disease in a vicious cycle of inflammatory assaults.   
 
The development of DES results in culminating epithelial lesions that, 
beyond a critical threshold of cellular degeneration, trigger local inflammatory 
reactions. It has been surmised that exogenous factors such as bad air quality, 
infection, and allergies could further exacerbate inherent, but subclinical, hormonal or 
autoimmune perturbations that eventually lead to a cascade of cellular aberrations 
signified by excessive apoptotic cell death and inflammatory responses (Baudouin, 
2001). Such adverse perturbations to ocular homeostasis could result in degradation 
of ocular surface protective mechanisms, profound changes in tear film layers, neural 
dysfunction and continual atrophies of conjunctival and corneal epithelia. Thus, once 
the onset of DES is triggered, inflammation represents the key mechanism driving 
sustained ocular surface injuries as both the cause and consequence of cellular 
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damages, and patients become entrapped in a downhill spiral of ocular inflammatory 
assaults (Baudouin, 2001) (Figure 1.3). 
DES can be broadly classified into aqueous-deficient or lipid-deficient (i.e. 
evaporative dry eye) subtypes (Figure 1.4) (DEWS, 2007a). It has been noted that 
while dry eye can be triggered by any of these subtypes, disease subtypes are not 
mutually exclusive entities, and one disease subtype could coexist with or even give 
rise to events that further aggravate the disease via another major mechanistic 
pathway (DEWS, 2007a). 
 
Figure 1.4. Simplified classification of dry eye syndrome. Modified from Bron, 1997.  
 
1.4.1 Lacrimal dysfunction 
The volume of tear fluid at the anterior eye is a precise balance between inflow and 
outflow. Sources of tear inputs include the inflow from the main and accessory 
lacrimal glands and the permeation of water through the corneal epithelial tissues via 
aquaporin-regulated channels, while the loss of tears from the ocular surface can be 
attributed mainly to the drainage through the lacrimal puncta following blinking as 
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well as evaporation from the open eye (Tiffany, 2008). The lacrimal apparatus 
represents the predominant source of aqueous tears for the tear film, and a failure in 
lacrimal secretion is therefore regarded as the chief contributor to aqueous-deficient 
dry eye (DEWS, 2007a). 
During normal life, tear film breakup is a rather uncommon event, as blinking 
is a rapid and almost automatic response to ocular desiccation (Tiffany, 2008).  
Breakup occurs when the tear film breakup time falls short of the inter-blink time, 
which could occur as a result of compromised corneal sensation and/or tear film 
instability. Tear film instability, a hallmark of dry eye, occurs when the synergy 
between stabilizing components of tear film is disrupted due to reduced tear secretion, 
delayed clearance and altered tear composition. Reflex tearing usually ensues as an 
initial compensatory mechanism to alleviate ocular irritation. Over time, however, 
inflammatory events together with progressive secretory exhaustion and reduction in 
corneal sensation eventually obliterate this reflex response, leading to aggravated tear 
film instability (DEWS, 2007a). It has been speculated that excessive reflex 
stimulation of the lacrimal gland may trigger a neurogenic inflammatory cytokine 
response within the lacrimal gland per se, which may induce autoantigen presentation, 
immune cell targeting and the release of proinflammatory mediators that culminate in 
tissue damage, and possibly constituting the molecular basis of  “lacrimal exhaustion” 
(DEWS, 2007a). 
Apart from serving as a compensatory response to mitigate ocular irritation, 
the production of reflex tears is also crucial in supplying essential factors such as 
vitamin A, epidermal growth factors (EGF), hepatocyte growth factors (HGF) and 
transforming growth factors beta (TGF-β) that would be distributed across the ocular 
surface via blinking action, a deficiency of which may lead to squamous metaplasia 
(Tsubota, 1998). Vitamin A is needed for the differentiation and maintenance of 
mucosal epithelium, while EGF and HGF facilitate cellular proliferation (Li et al, 
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1996). The shear forces during blinking are also critical in facilitating the even 
distribution of mucous secretion from conjunctival goblet cells across the eye, while 
displacing contaminated mucus threads along with entrapped cell debris into the 
lacrimal puncta (Holly et al, 1984). 
 It is important to recognise that apart from an adequate production of aqueous 
tears to maintain tear film structural integrity and prevent ocular desiccation, a 
continual supply of fresh tears from the lacrimal functional unit is equally 
indispensable for maintaining ocular homeostasis and health. It has been shown that 
approximately 10% of total tear volume is lost via evaporation, while the remaining 
90% drains through the lacrimal punctum (Mishima et al, 1966). A continual supply 
of fresh tears is thus essential for bringing in oxygen and other essential trophic 
factors to ensure the health of the avascular cornea, while the removal of resident 
tears at regular intervals is important in preventing the excessive accumulation of 
inflammatory cytokines and other cellular waste products that can build up in the 
conjunctival sacs.  
Lacrimal dysfunction can arise primarily due to autoimmune disorders, as in 
SS, or as a result of acinar atrophy or ductal obstruction that constitute a natural 
process of aging (Figure 1.4) (Holly et al, 1984). With advancing age, the increased 
occurrence of ductal pathology such as periductal fibrosis, interacinar fibrosis, loss of 
paraductal blood vessels and acinar degeneration could jeopardize proper lacrimal 
function (DEWS, 2007a). In both cases, the resultant lacrimal hypofunction leads to 
ocular desiccation. It is nonetheless important to consider that the severe ocular 
aberrations in SS could not be solely attributed to cellular stress imposed by the 
overall hyperosmolarity, but also due to an accompanying lack of trophic factors 





1.4.2 Meibomian gland dysfunction  
Meibomian gland dysfunction (MGD) represents a major cause of dry eye and ocular 
discomfort (Baudouin, 2001). MGD is a common condition with particularly high 
prevalence throughout Asia, afflicting 57.8 %-62.5 % of the elderly above 65 years 
old in Taiwan, and up to 50% in Thailand (Lekhanont et al, 2006; Lin et al, 2003). 
Shimazaki and colleagues found that amongst 82 patients experiencing symptoms of 
ocular discomfort, 65 % of the eyes had varying degrees of MGD, while tear 
deficiency was diagnosed only in 36 % of the eyes. In addition, scores of fluorescein 
and Rose Bengal staining are also significantly higher in eyes with MGD than that 
without (Shimazaki et al, 1995).  
 
Figure 1.5. An illustration explaining the pathological process of meibomian gland dysfunction 
leading to evaporative dry eye syndrome.  
 
 Obstructive MGD represents the predominant form of MGD, with 
hyperkeratinization and elevated viscosity of the meibum as core mechanisms that 
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precipitate in ductal obstruction (Figure 1.5) (Knop et al, 2011). Hyperkeratinization 
of the excretory ductal epithelium leads to the plugging of meibomian gland orifices, 
which might be mediated by endogenous factors such as age (Norn, 1987), sex and 
hormonal perturbations (Cermak et al, 2003), as well as exogenous factors including 
topical medication (Jester et al, 1982) and contact lens wear (Arita et al, 2009). The 
onset of hyperkeratinization could involve the release of a developmental blockade 
that normally inhibits the progression to full keratinization of the ductal epithelium 
(i.e. cornification) (Knop et al, 2011). On the other hand, compositional alterations in 
meibomian lipids could substantially enhance the viscosity and consistency of the 
secreted meibum, which also contribute appreciably to the obstructive process. 
Compositional changes in meibum lipids could arise due to intrinsic factors such as 
hormonal perturbations (Cermak et al, 2003; Sullivan et al, 2002), or due to 
enzymatic modifications by commensal or foreign bacteria (Dougherty et al, 1986; 
McCulley et al, 1986). 
Ductal obstruction leads to an immediate hyposecretion of meibomian oils 
onto the lid margin reservoirs, as well as a subclinical, internal stasis of meibum 
within glandular ducts. Inspissation of stagnant secretion triggers a degenerative 
atrophic process that progressively damages the lid and embedded glandular tissues 
via mechanical traumatization (Gutgesell et al, 1982; Straatsma, 1959; Obata, 2002). 
With obstructed orifices, the continual secretion of meibum from meibocytes gives 
rise to elevated intraglandular pressure resulting in ductal dilatation. The presence of 
rigid tarsal connective tissues surrounding the meibomian gland tissues, however, 
restricts the dilatation of glandular ducts, thereby exerting considerable back pressure 
onto glandular tissues that eventually leads to acinar atrophy. The pressure-driven 
atrophic process might be associated with inflammatory assaults due to the 
downstream release of chemokines and cytokines following cellular stress triggers. 
The resultant acinar degeneration gives rise to a secondary hyposecretion that further 
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compromises meibomian lipid secretion (Knop et al, 2011). The inadequate delivery 
of meibomian oils onto the eyelid margins is thought to significantly compromise tear 
film structural integrity and stability, therefore giving rise to symptoms of ocular 
discomfort in lipid-deficient DES. On the other hand, the inspissation of meibum 
within glandular ducts also encourages the proliferation of commensal bacteria 
normally resident on the ocular surface and probably also within the glandular ducts 
(Dougherty et al, 1984). These bacteria can produce lipid-degrading enzymes that 
release toxic lipid breakdown products (e.g. free fatty acids, lyso-phospholipids) 
(Dougherty et al, 1986), and possibly trigger a subclinical inflammatory cascade 
producing various cytokines that further irritates the ocular epithelia and induces 
more keratinization (Dougherty et al, 1986). In addition, bacteria-mediated chemical 
modifications of meibomian lipids could also result in elevated meibum viscosity 
(Dougherty et al, 1986; McCulley et al, 1986) that aggravates the obstructive process.  
On a separate note, the degeneration of meibomian acini in the absence of 
ductal dilatation has also been observed in humans (Obata et al, 1994), suggesting 
that a primary acinar atrophy with accompanying reduction in meibomian gland 
secretions may constitute a natural phenomenon of aging.  
 
1.5 Motivations and aims 
DES represents an escalating problem in view of the aging populations in 
different parts of the world, and the financial burden incurred by DES-associated 
morbidities is expected to grow. In spite of its pervasiveness, the development of 
improved diagnostic and therapeutic modalities has not been keeping in pace, which 
might be attributed to the relatively small number of affected individuals eventually 
developing severe blinding pathology (Aquavella, 2012). As a highly prevalent but 
yet frequently under-diagnosed disease, DES represents an often neglected condition 
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that can substantially affect the quality of life. While seldom a life-threatening disease 
on its own, if left untreated, DES can result in chronic eye pain and elevated risk of 
other ocular conditions that can considerably threaten vision. Demographic changes 
and modern lifestyle also indicate the emerging importance of DES, as the patient 
population is expected to expand significantly in the near future (Asbell, 2006).  
Despite this, the current diagnostic platform for DES lacks both sensitivity 
and specificity, and none of the clinical tests are sufficiently predictive of 
symptomatology to qualify as leading indicators of the disease. The current paucity in 
the objective association between subject symptoms and ocular surface functional 
indicators calls for the development of new diagnostic modalities that could confer 
better correlates between ocular symptoms and signs (Aquavella, 2012). Such indices 
could potentially offer better coherency between the actual ocular health status and 
patient-reported symptoms, which allows for more objective monitoring of disease 
severity and treatment outcome without compromising patients’ symptoms.  
Secretion from the meibomian glands, or the meibum, constitutes the cardinal 
source of lipids for the TFLL in humans (McCulley et al, 2004; Butovich, 2009b). 
Numerous studies in the past decades have shown that the human meibum is made up 
of a highly complex mixture of lipids from various classes (Butovich, 2009b; Joffre et 
al, 2008; Wojtowicz et al, 2009; Tiffany, 1978; Nicolaides et al, 1981; McCulley et al, 
1997; Mathers et al, 1998), which has posed a considerable amount of challenges in 
the elucidation of its composition. The limiting quantity of sample (typically in the 
range of a few milligrams) that can be obtained from donors further exacerbated the 
progress in the compositional evaluation of human meibum. The analytical challenges 
are further intensified in the lipidomic analysis of the human tear fluid, which is of a 
predominantly aqueous nature. Detection of fine perturbations in tear composition is 
also obscured by the limited amounts of tear samples (typically 5 to 10 µL in volume) 
that could be obtained from individual subjects (Tsubota, 1998). Nevertheless, the 
elucidation of single lipid components in meibum or tears that are specifically altered 
19 
 
in DES may confer new insights pertaining to the molecular pathogenesis of the 
disease. Even minor aberrations in tear components can adversely affect the structural 
integrity and physiological properties of the tear film protecting the delicate cornea, 
and may be manifested in various ocular conditions including DES. Hence, the 
development of comprehensive lipidomic platforms designated for the qualitative and 
quantitative analyses of human meibum and tears denotes a fundamental goal of this 
project (Chapters 2 and 3).  
The precise lipid composition of human tears has for long remained an 
intriguing topic for the field of ocular research, largely due to the critical biochemical 
and biophysical functions elicited by the tear film in maintaining healthy vision. In 
particular, the composition of the amphiphilic lipid sublayer of human tear film has 
been a matter of contention (Lam et al, 2011). A comprehensive elucidation of human 
tear lipidome, in comparison with the meibum lipidome, could therefore pave the way 
for enhancing current understanding of the existent tear film model (Chapter 3). 
While conventionally perceived as major components of cellular membranes 
and lipid droplets with largely structural roles, lipids have now emerged as key 
players serving distinct biochemical functions in a wide range of biological processes 
such as signalling events, trafficking, and compartmentalization of macromolecules 
(Wenk, 2005). Similarly, lipid species that are critically involved in DES 
pathogenesis can either serve structural roles in maintaining the structural integrity of 
TFLL or function as mediators in various biochemical pathways implicated in the 
disease, or both. Inflammation and oxidative stress are two primary events that 
underlie the a number of disease pathologies, and are often associated with lipid 
peroxidation that leads to the formation of various bioactive lipids, including oxidized 
phospholipids, short chain reactive aldehydes, platelet activating factors, oxidized 
cholesteryl esters, oxidized free fatty acids, lysophospholipids and oxysterols (Ashraf 
et al, 2009). Since inflammation is also considered a major mechanism that fuels the 
vicious cycle of ocular desiccation and damages once DES onset has been triggered 
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(Section 1.4), it would also be physiologically meaningful to investigate if lipid 
species known to be associated with cellular inflammatory events were specifically 
altered in DES. In addition, lipid correlates with DES-associated physiological 
processes and conventional DES clinical indicators would also be investigated in an 
attempt to search for novel molecular diagnostics and potential lipid biomarkers that 
could better signify disease onset and clearly delineate DES pathogenesis and 
progression. This was achieved via investigating lipid changes in the meibum and tear 
samples from individual clinical cohorts in two separate cross-sectional, 
observational studies, as well as another longitudinal study (Chapters 2, 4 and 5), 
using the global lipidomic platforms I have earlier developed (Chapters 2-3) for the 
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The recent decades have witnessed an emerging number of studies pertaining to 
meibomian and tear lipids (Butovich, 2011), which is partly attributed to the 
technological advancements in the area of mass spectrometry (Shine et al, 2003; 
Sullivan et al, 2006; Nichols et al, 2007; Butovich et al, 2007a; Butovich et al, 2007b; 
Butovich, 2009a; Joffre et al, 2008; Butovich, 2008; Butovich, 2009b; Butovich et al, 
2009; Chen et al, 2010; Butovich, 2011; Rantamäki et al, 2011). While these studies 
have contributed to constructing a more comprehensive view of human meibum 
composition, most of these studies were, however, circumscribed by a relatively 
small sample size, or a lack of clinical and demographic information pertaining to the 
individuals from which lipid samples were collected (Butovich et al, 2007a; Butovich 
et al, 2007b; Butovich, 2009a; Butovich et al, 2009b). Moreover, few of the works 
published in the recent decade have analyzed and compared the meibum lipid 
compositions between normal volunteers and individuals suffering from DES, except 
for a study reported by Joffre and coworkers (Joffre et al, 2008) that has primarily 
focused on the comparison of fatty acid composition in the meibum between normal 
individuals and those suffering from meibomian gland dysfunction (MGD). 
Furthermore, all of the published studies aforementioned have emphasized on the 
analyses of meibum lipids collected from non-Asian populations, and very limited 
data currently exist on the potential effect of race or ethnicity on dry eye prevalence. 
Data from the Women’s Health Study have, however, suggested that the prevalence 
of severe symptoms and/or clinical diagnosis of dry eye might be greater in Hispanic 
and Asian as compared to Caucasian individuals (DEWS, 2007b). 
It must be noted that the complexities in the manifestations of DES per se 
and its highly multifactorial nature have presented a considerable amount of 
challenges in the clinical classification and diagnosis of the disease. The difficulties 
in DES diagnosis have, to a large extent, hindered the development of new 
pharmacological therapies due to a lack of objective tests for response outcomes 
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(Schein et al, 1997; Ousler et al, 2005), and may also be an explanation for the 
relative scarcity of case-control studies (see above). Nevertheless, one must recognise 
that it is this very lack of definite clinical markers that necessitates the search for 
novel biomarker(s) that can provide greater sensitivity and specificity to facilitate 
disease diagnosis and treatment monitoring. Recently, Sullivan and coworkers (2010) 
have evaluated the different clinical indicators commonly used to categorize varying 
degrees of DES, and a comprehensive scheme encompassing the myriad of clinical 
markers has been consolidated. The group has generated a composite index of disease 
severity, which serves to standardize clinical definitions of DES disease severity by 
providing the corresponding threshold values for each clinical marker that distinctly 
define and mark out each severity level. 
This chapter presents the first comprehensive report on the lipid profiles of 
meibum obtained from individuals of an Asian origin, mainly Chinese in ethnicity. 
We present a comprehensive lipidome of the human meibum comprising a total of 
256 lipid species from 12 major lipid classes investigated. Comparisons have also 
been made on the quantitative and qualitative differences in lipid profiles of meibum 
between normal volunteers and patients, as well as amongst patients suffering from 
varying degrees of DES stratified based on the thresholds for OSDI as defined by 
Sullivan and colleagues (2010) (See Section 2.2.3, Figure 2.1), in an attempt to 
elucidate potential lipid marker(s) that can possibly confer new insights into the 
diagnosis, monitoring as well as pathogenesis of DES. 
 
2.2 Materials and Methods 
2.2.1 Chemicals and lipid standards 
Chloroform and methanol were purchased from Merck (Merck Pte. Ltd., Singapore). 
Ammonium hydroxide (28% in H2O) and palmityl palmitate were purchased from 
Sigma-Aldrich (St. Louis, MO, USA). Deionized water was obtained from a MilliQ 
purification system (Millipore, Bedford, MA, USA). 1,2-Dimyristoyl-sn-Glycero-3-
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Phosphocholine (DMPC), 1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine 
(DMPE), 1,2-dimyristoyl-sn-glycero-3-phosphoglycerol (DMPG), 1,2-dimyristoyl-
sn-glycero-3-phospho-L-serine (DMPS), N-heptadecanoyl-D-erythro-sphingosine 
(C17-Cer), D-glucosyl-β-1,1’ N-octanoyl-D-erythro-sphingosine (C8-GluCer) and N-
(dodecanoyl)-sphing-4-enine-1-phosphocholine (C12-SM) were obtained from 
Avanti Polar Lipids (Alabaster, AL, USA). Dioctanoyl phosphatidylinositol PI-
8:0/8:0 was purchased from Echelon (Echelon Biosciences, Inc., Salt Lake City, UT, 
USA). OAHFA 18:1/16:0 was synthesized as previously described (Butovich et al, 
2009) and used as an internal standard for quantitation of OAHFA species.  
Cholesteryl stearate-26,26,26,27,27,27(d6) and TAG48:0(d5) were purchased from 
CDN Isotopes Inc. (Quebec, Canada).  
 
2.2.2 Meibum collection and lipid extraction 
Human meibum was collected using by the soft expressing procedure. The eyelids of 
subjects were softly squeezed and the meibum released immediately solidified at 
room temperature. The expressed meibum was collected using a metal spatula. 
Meibum lipids collected were eluted into an eppendorf tube by washing the metal 
spatula thoroughly with 900 µL of chloroform: methanol (1:1). The lipid extracts 
were dried using SpeedVac (Thermo Savant, milford, USA) and stored at -80oC until 
further analysis. The dried meibum lipid samples were reconstituted in chloroform: 
methanol (1:1) prior to analysis by high-pressure liquid chromatography coupled with 
mass spectrometry (HPLC/MS). 
 
2.2.3 Clinical cohort and study design 
In total, 42 patients and 13 control subjects were recruited for this study (Figure 2.1). 
The 42 patients were diagnosed with dry eye syndrome at Singapore National Eye 
Center. The patient samples were further reduced to 27 (24 females and 3 males; 
average age of 59.4, range 28-75) by including only patients with OSDI >21. Control 
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subjects (7 females and 3 males; average age of 29.4; range 22-45) were defined as 
healthy volunteers with OSDI <12.9 (Sullivan et al, 2010) (Figure 2.1 and 
Supplementary Material 2.2). Informed consent was obtained from all participating 
subjects and the procedure was approved by the Institutional Review Board of the 
Singapore Eye Research Institute (R594/15/2008).  Clinical examinations included 
subjective symptoms, Schirmer’s test type I (without anaesthesia), tear breakup time 
(TBuT) and corneal fluorescein staining. Clinical microscopic features of MGD such 
as loss of expressibility of meibomian glands, alteration in the viscosity of the 
meibum expressed, irregularity of meibomian gland orifices, and eyelid notching or 
telangiectasia were recorded if present. 
 




Tear Breakup Time. For the TBuT, a drop of normal saline was instilled on 
the fluorescein strip (Fluorets) then shaken off so that no visible drop remained. The 
subject was asked to look up before the introduction of the fluoret to the inferior 
conjunctival fornix on the right then left eye. The participant was then asked to blink 
a few times and close the eyes for a few seconds without blinking. Participant was 
then asked to open the eyes, look ahead at the observer’s forehead and not blink for as 
long as possible. The TBuT was defined as the time between the lid opening and the 
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first appearance of any dry spot on the cornea. The subject was then requested to 
close his eyes for a few seconds and the procedure repeated for left eye.  
Schirmer’s I test. The Schirmer’s test I (Schir I) was done with the standard 
strips® currently used (5 mm wide with a notch for folding) (Bausch & Lomb Sno 
strips, New York, USA). No prior anaesthetic was used before the test and the strips 
were positioned over the inferior temporal half of the lower lid margin in both eyes at 
the same time. Subjects were asked to close their eyes for a total duration of 5 
minutes with the strips rested on their lid margins, and the wetted length (i.e. 
Schirmer’s I score) was measured to the nearest 0.5 mm.  
Corneal Fluorescent Staining. Corneal fluorescein staining was evaluated in 
each subject after the TBuT determination, since the instillation of fluorescein had 
been done. The documentation of staining spots was performed under slit lamp 
biomicroscopy and documented in the 5 zones of the cornea (central, superior, 
inferior, nasal and temporal) as reported in the CLEK study (Barr et al, 1999).  
In the current study, dry eye patients were classified predominantly based on 
a scale of symptom severity. A modified form of the Ocular Surface Disease Index 
(OSDI) symptom questionnaire was used for symptom assessment (Schiffman et al, 
2000) (Supplementary Material 2.1). Compared to other standard clinical tests, 
diagnosis of dry eye based on symptom severity might possibly confer better 
indication of early-stage ocular surface distress, and symptomatic evaluation of the 
disease nonetheless represents the best way to monitor disease progression and 
treatment effectiveness as far as the quality of life of any given patient is concerned 
(Dogru et al, 2005). While there is no general consensus over which dry eye 
questionnaire is most comprehensive in terms of symptom coverage, or which 
symptom is best correlated to disease pathogenesis and progression, symptomatic 
classification of patients can nevertheless represent a good way for preliminary 
analysis of the possible lipid biomarker(s) that correlate with the observed symptom, 
and which may therefore play a role in disease pathogenesis. In the current study, the 
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OSDI cut-offs reported by Sullivan and colleagues (2010) were used as a reference to 
stratify patients into different groups with different severity levels (i.e. mild, 
moderate, severe) (Supplementary Material 2.3), and also as a crucial criterion for 
selection of DES patients and normal controls in a more stringent manner apart from 
other commonly used clinical indicators (Figure 2.1). As Sullivan and colleagues 
established the OSDI cut-offs based on a combination of DES clinical parameters 
such as tear osmolarity and TBuT, using these cut-offs as thresholds in our study 
would ensure the clinical significance of the individual subgroups being studied. 
 
2.2.4 High-performance liquid chromatography-electrospray ionization mass 
spectrometric (HPLC/MS) profiling of diverse lipids 
Mass spectrometric profiles of lipid extracts were obtained using an Agilent 1100 
HPLC system and a 3200 Q-Trap mass spectrometer (Applied Biosystems, Foster 
City, CA). The HPLC system consisted of an Agilent 1100 binary pump, an Agilent 
1100 thermo sampler and an Agilent 1100 column oven. Briefly, separation of lipids 
was carried out on a Phenomenex Kinetex 2.6µ-C18 column (i.d. 4.6x100 mm) using 
an isocratic mobile phase chloroform:methanol:0.1M ammonium acetate (100:100:4) 
at a flow rate of 150 µL/min for 22 min; injection volume: 10 L. Mass spectrometry 
profiles were recorded under both positive and negative electrospray ionization (ESI) 
modes with enhanced mass scan, and ESI conditions are: Turbo spray source voltage, 
were 5000 and -4500 volts for positive and negative ion modes, respectively; source 
temperature, 250 °C; scan rate:1000 amu/sec; Ion Source Gas 1 (GS1): 40.00, Ion 
Source Gas (GS2): 30.00, curtain gas: 25; scan range, 300-1100 da.  
Single stage mass spectrometry profiles of lipid extracts were also carried out 
using an Accela HPLC system coupled with an LTQ Orbitrap XL hybrid Fourier 
Transform Mass Spectrometer (Thermo Fisher Scientific, Waltham, MA) using both 
reverse phase HPLC/MS as aforementioned, as well as normal phase HPLC/MS 
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approach. In the case of reverse-phase LCMS, 5 µL of each extract was injected into 
a Phenomenex Kinetex 2.6µ-C18 column (i.d. 4.6x100 mm) with the mobile phase as 
aforementioned at a flow rate of 120 µL/min for a total duration of 30 min. In normal 
phase LCMS, separation of individual lipid classes of polar lipids by normal phase 
HPLC was carried out using a Phenomenex Luna 3μ-silica column (i.d. 150x2.0 mm) 
with the following conditions: mobile phase A (chloroform:methanol:ammonium 
hydroxide, 89.5:10:0.5), mobile phase B (chloroform:methanol:ammonium 
hydroxide:water, 55:39:0.5:5.5). Mass spectrometry profiles were recorded under 
both positive and negative modes in separate runs, and mass accuracy of less than 2 
ppm were obtained throughout the analytical runs. 
 
2.2.5 Quantitative analysis of lipids using high-performance liquid 
chromatography coupled to mass spectrometry (HPLC/MS) 
Lipid profiles were analyzed using the 3200 and 4000 Q-trap HPLC/MS/MS systems. 
Neutral lipids were analyzed using a sensitive HPLC/MS method in the electrospray 
ionization (ESI) mode (Shui et al, 2010; Shui et al, 2011b). Briefly, separation of 
triglycerides (TAG) from polar lipids was carried out on an Agilent Zorbax Eclipse 
XDB 5μ-C18 column (i.d. 4.6x150mm), with chloroform:methanol:0.1 M ammonium 
acetate (100:100:4) as mobile phase at a flow rate of 0.25 ml.min-1. Selective ion 
monitoring (SIM) was used to record cholesteryl esters (CE), wax esters (WE) and 
TAG species. TAG were calculated as relative contents to the spiked d5-TAG 48:0 
internal standard, while CE and WE were normalized to cholesteryl stearate-
26,26,26,27,27,27(d6) and palmityl palmitate spiked into the samples, respectively.  
An Agilent HPLC system coupled with an Applied Biosystem Triple 
Quadrupole/Ion Trap mass spectrometer (4000 Q-trap) was used for quantification of 
individual polar lipids including various phospholipids, sphingolipids and O-acyl--
hydroxy-fatty acids (OAHFAs). The HPLC system contained an Agilent 1200 binary 
pump, an Agilent 1200 thermo sampler, and an Agilent 1200 column oven. HPLC 
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conditions: Luna 3µ-silica column (i.d. 150×2.0 mm); mobile phase A 
(chloroform:methanol:ammonium hydroxide, 89.5:10:0.5), B 
(chloroform:methanol:ammonium hydroxide:water, 55:39:0.5:5.5); flow rate 300 
µl/min; 5% B for 3 min, then linearly switched to 30% B at 24 min and maintained 
for 5 min, and then linearly changed to 70% B at 5 min and maintained for 7 min. 
Then, the composition of the mobile phase was returned to the original ratio over 5 
min and maintained for 6 min before the next sample was analyzed. Mass 
spectrometric profiles were recorded under both positive and negative ESI modes, 
and ESI conditions are: Turbo Spray source voltage, 5000 and −4500 volts for 
positive and negative, respectively; source temperature, 300°C; GS1: 40.00, GS2: 
40.00, curtain gas: 25 (Shui et al, 2011b). Based on product ion and precursor ion 
analysis of head groups, multiple reaction monitoring (MRM) transitions were set up 
for quantitative analysis of polar lipid species (Fei et al, 2008). Levels of individual 
lipid were quantified using spiked internal standards including dimyristoyl 
phosphatidylcholine (28:0-PC), dimyristoyl phosphatidylethanolamine (28:0-PE), 
dimyristoyl C14-phosphatidylserine (28:0-PS), dimyristoyl phosphatidyglycerol 
(28:0-PG), dimyristoyl phosphatidic acid (28:0-PA), and dioctanoyl 
phosphatidylinositol (16:0-PI). OAHFA 18:1/16:0 was synthesized in-house and used 
as an internal standard for quantification of OAHFA species.  Molar concentration 
(µmolml-1) was calculated by normalizing the raw intensity of individual lipid species 
to that of corresponding internal standards of known concentrations. Molar fractions 
were then calculated as the ratios of concentrations of individual species to the total 
concentrations of all lipids detected.  
 
2.2.6 Statistical Analysis 
Quantitative comparisons were made between 27 patients and 10 control subjects for 
all 256 lipid species analysed using the Student’s t test to identify lipid species that 
were significantly different between patients and control subjects (p<0.05 was 
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considered to be statistically significant). In order to account for age as a confounding 
factor in the analysis of lipid profiles between patients and control subjects, patients 
were stratified into three groups (i.e. mild, moderate and severe) based on OSDI score 
which offers a measure of symptom severity (Supplementary Material 2.1). The lipid 
levels in patients from the three categories were compared using one-way ANOVA 
with post-hoc TukeyHSD test (p<0.05 was considered to be statistically significant) 
to correlate changes in lipid levels with DES progression. There was no significant 
age differences between the 3 groups by ANOVA (p>0.05).  
 
2.3 Results 
2.3.1 Lipid distribution of meibum lipidome 
Table 2.1. Historical overview on the distribution of major lipid classes in human meibum.  




















SE 8-34 29.50 16 39.4 30 13 66.83 
WE 13-23 34.96 68 51.1 - 28 25.21* 
TAG 11-43 4.00 6 3.1 - 0.05 4.03 
DE - 8.37 - 2.3 - - - 
FFA 0-24 2.14 1 2.8 - 3 - 
PL‡ 0-5 16.04b 
(polar lipids) 





SL† - 1.5c - - 0.10 
OAHFA - - - - - - 3.46 
SE, sterol ester; WE, wax ester; TAG, triacylglycerides; DE, diesters; FFA, free fatty acid;  PL,  
phospholipid; SL, sphingolipid; OAHFA, o-acyl-　-hydroxy-fatty acid. ‡ PL refers to sum total of PC, 
phophatidylcholine; PE, phosphatidylethanolamine; PI, phosphatidylinositol; PG, phosphatidylglycerol. † 
SL refers to sum total of SM, sphingomyelin; CER, ceramides; GluCer, glucosylceramide; DihexCer, 
dihexosylceramide.  
* The quantity of WE is subjected to the use of palmityl palmitate as an internal standard. 
a Analyses were conducted on pooled samples. 
b Estimate was given for total polar lipids excluding free fatty acids 







Figure 2.2. Preliminary single-stage mass spectrometric scan of the human meibum. Single-stage 
MS profile of human meibum revealed that (A) CE, WE and TAG represent the predominant species  in 
the positive ion mode, while (B) OAHFA are the major species in the negative ion mode. Various 
isobaric species of OAHFA were present in the human meibum.  
 
Single-stage mass spectrometric profile in the positive ion mode revealed that the 
non-polar lipid classes of CE, WE and TAG comprise the bulk of human meibum 
lipids (Figure 2.2A), constituting approximately 90% of the total lipids present (Table 
2.1). On the other hand, the class of OAHFA constitutes the majority of the polar 
lipid fraction detected in the negative ion mode (Figure 2.2B), making up 
approximately 3.5% of the total meibum lipids, followed by various subclasses of 
phospholipids (phosphatidylcholines, PC; phosphatidylethanolamines, PE; 
phosphatidylinositols, PI; phosphatidylglycerols, PG) and sphingolipids 
(sphingomyeloins, SM; ceramides, Cer; glucosylceramides, GluCer; 
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dihexosylceramides, DihexCer) that collectively comprise less than 1% of the total 
meibum lipids (Table 2.1).  
 
2.3.1.1 Distribution of non-polar lipids  
The non-polar lipid fraction of the meibum was largely represented by CE, WE and 
TAG (Table 2.1). CE represents a major component of the non-polar lipid fraction 
and comprised approximately 65% of the entire lipid pool in current analysis (Table 
2.1). With reverse-phase column, individual species of CE was separated on the basis 
of increasing hydrophobicity due to increasing lengths of the aliphatic fatty acid 
chains (Figure 2.3). At least 20 different species of CE were observed, with 
essentially long chain and very long chain fatty acid residues (LCFA and VLCFA) 
ranging from C16 to C34. Saturated and monounsaturated fatty acids were the most 
prominent compounds of the CE pool. The seven most abundant compounds of the 
CE family were CE18:1, CE20:0, CE24:1, CE24:0, CE25:0, CE26:0 and CE30:1 
(Figure 2.4A). WE constituted around 25% of the total lipid pool in the meibum 
(Table 2.1), with total carbon number ranging from C35 to C48. Saturated and 
monounsaturated fatty alcohol moieties also predominated this class of lipids, with 
the four most abundant species represented by C42H80O2 (C18:1C24:1), C42H82O2 
(C18:1C24:0), C44H84O2 (C18:1C26:1), C44H86O2 (C18:1C26:0) (Figure 2.4B). Up to 
40 different TAG species were detected, with triolein (TAG/54:3) being the most 
abundant species; other abundant species include TAG/49:2, TAG/50:2, TAG/52:3, 
TAG/52:2 and TAG/54:2 (Figure 2.4C). It was estimated that TAG comprised 
approximately 4% of the lipids detected in human meibum (Table 2.1). Notably, a 
number of polyunsaturated TAG species (number of double bonds > 3) were also 
detected in the current study, and their identities have been further confirmed by 






Figure 2.3. Representative extraction ion chromatogram (EIC) of selected CE species eluted in the 






Figure 2.4. Distribution of non-polar lipid species in human meibum of normal subjects (n=10) and 
patients (n=27). (A) CE, cholesteryl esters; (B) WE, wax esters; (C) Triacylglycerides, TAG. Mean 






Figure 2.5. Single-stage mass scan of human meibum using LTQ-Orbitrap operating in the 
positive ion mode. Various PUFA-containing TAG (number of double bonds > 3) species were 
unambiguously identified in the human meibum. PUFA: Polyunsaturated fatty acids; TAG: 
Triacylglycerides.  
 
2.3.1.2 Distribution of polar lipids 
 
Figure 2.6. Distribution of OAHFA species in human meibum of normal subjects (n=10) and 
patients (n=27).  Mean values were plotted, and error bars represent standard errors of the mean. 
#p<0.10, *p<0.05, **p<0.01. OAHFA: O-acyl--hydroxy-fatty acids.  
 
The class of OAHFA constitutes the bulk of the polar lipid fraction and consists of 28 
distinct species, with C18:1/32:1, C18:1/30:1, C16:1/32:1 as the three species found 
in highest abundance (Figure 2.6). A number of isobaric species were found (Figure 
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2.2) and their identities were confirmed using precursor ion scans in the negative ion 
mode as well as fatty acyl-based MRM approach (Table 2.2). To our knowledge, this 
is the first attempt at the quantification of OAHFA species using HPLC-MRM 
approach, which can provide more specific identification and therefore more accurate 
quantification of individual OAHFA species compared to shotgun lipidomic 
precursor ion scan analysis (Chen et al, 2010). For instance, the OAHFA 
compositions of 46:2, 48:3, 48:2, 49:2, 50:3, 50:2 and 52:3 were each composed of 
more than one distinct species, which can be distinguished from one another via the 
use of MRM. In concordance with previous studies (Butovich et al, 2009; Chen et al, 
2010), oleic acid (C18:1) represents the predominant fatty acid found in this class of 
lipids, followed by C16:1, C18:2 and a small amount of C18:0  (Figure 2.6).  
Table 2.2. Summary of multiple reaction monitoring (MRM) transitions for individual OAHFA 
species. 
Lipid Species MRM 
transition 
Lipid Species MRM 
transition 
Lipid Species MRM 
transition 
18:1/24:1 645.7/281.2 18:2/30:1 727.7/279.2 18:1/32:2 755.7/281.2 
18:1/24:0 647.7/281.2 18:1/30:2 727.7/281.2 16:1/34:2 755.8/253.2 
18:1/25:0 661.7/281.2 16:1/32:1 729.7/253.2 16:1/34:1 757.7/253.2 
18:1/26:1 673.7/281.2 18:1/30:1 729.7/281.2 18:1/32:1 757.7/281.2 
18:1/26:0 675.7/281.2 18:1/31:1 743.7/281.2 18:2/33:1 769.8/279.2 
18:0/27:2 687.7/283.2 16:1/33:1 743.8/253.2 18:1/33:1 771.8/281.2 
16:1/30:1 701.7/253.2 18:1/31:0 745.7/281.2 18:2/34:1 783.7/279.2 
18:1/28:1 701.7/281.2 18:2/32:2 753.7/279.2 18:1/34:2 783.8/281.2 
18:1/28:0 703.7/281.2 18:2/32:1 755.7/279.2 18:1/34:1 785.7/281.2 
16:1/32:2 727.7/253.2     
 
PC represents the predominant class of phospholipids found in the human 
meibum, constituting approximately 0.2% of the total lipids present in the meibum of 
normal controls (Table 2.3). More than 40 different PC species were detected, with 
PC34:2, PC34:1 and PC36:4e/36:3p as the three most abundant ions (Figure 2.7A). 
Up to 10 species of lysophosphatidylcholines (LPC) that have not been previously 
reported in the meibum were also detected, with LPC18:0e and LPC18:2 being 
present in appreciably greater quantities than other LPC as well as PC species (Figure 
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2.7A). For the first time, comprehensive lipid profiles for the classes of PE and PI 
were reported (Figure 2.7B-C).  
 
 
Figure 2.7. Distribution of phospholipid species in human meibum of normal subjects (n=10) and 
patients (n=27). (A) PC, phosphatidylcholines; Insert, PC species that significantly differed between 
normal subjects and patients; (B) PE, phosphatidylethanolamines; (C) PI, phosphatidylinositols; (D) PG, 
phosphatidylglycerols. Mean values were plotted, and error bars represent standard errors of the mean. 





Figure 2.8. Distribution of sphingolipid species in human meibum of normal subjects (n=10) and 
patients (n=27). (A) SM, sphingomyelins; (B) Cer, ceramides; (C) GluCer, glucosylceramides; (D) 
dihexCer, dihexosylceramides. Mean values were plotted, and error bars represent standard errors of the 





Notably, lysophospholipids were present in greater abundance than their 
diacyl counterparts within each phospholipid class analyzed (Figure 2.7). For instance, 
LPE18:0p/18:1e and LPE18:0 represent the two most abundant lipid species within 
the class of PE (Figure 2.7B); while LPI18:0 and LPG18:0 were found in highest 
quantity within the lipid classes of PI and PG respectively (Figure 2.7C-D). In 
addition, a number of sphingolipids from the classes of SM, Cer, GluCer and 
DihexCer were also detected, making up approximately 0.10% of the total meibum 
lipids (Table 2.1, Figure 2.8).  
 
Table 2.3. Comparison on the distribution of major lipid classes in the human meibum between 
normal subjects (n=10) and DES patients (n=27). 
                     LIPID CLASS  Percent Total Lipids (%)  
 Normal  Patient  
Cholesteryl  esters (CE)  66.834+3.413  67.755+1.924  
Wax esters (WE)  25.214+2.564  23.877+1.733  
Triacylglycerides (TAG)  4.031+0.519  4.549+0.314  
Phosphatidylcholines (PC)  0.190+0.050  0.612+0.238  
Phosphatidylethanolamines (PE)  0.154+0.044  0.136+0.017  
Phosphatidylglycerols (PG)  0.002+0.001  0.002+0.000  
Phosphatidylinositols (PI)  0.023+0.005  0.025+0.003  
Sphingomyelins (SM)  0.032+0.005  0.061+0.014  
Ceramides (CER)  0.031+0.005  0.040+0.008  
Glucosylceramides (GluCer)  0.020+0.006  0.024+0.002  
Dihexosylceramides (DihexCer)  0.013+0.004  0.011+0.001  





2.3.2 DES-associated clinical parameters in various clinical subgroups 
The TBuT and Schir I of patients were significantly lower compared to the controls 
(p<0.05), indicating compromised tear film stability and reduced lacrimal function in 
DES patients. In addition, patients were symptomatic and exhibited appreciably 
elevated OSDI (p<0.05) compared to control subjects that were essentially symptom-
free (Table 2.4). Despite the discernible differences between patients and control 
subjects in terms of DES-associated clinical signs and symptoms, the age of the 
patient group was significantly higher than that of the controls (p<0.05), which 
represents a confounding factor in our current analyses. On the other hand, there was 
no significant difference in age, TBuT and Schir I of the patients in each level of 
disease severity (Table 2.4). Similarly, there was no difference in the viscosity of the 
meibum or regularity of the gland orifices by clinical examination between these 
groups. There was also no appreciable difference in the extent of eyelid notching or 
telangiectasia in these patients. The absence of appreciable differences in DES-
associated clinical signs amongst the various severity subgroups was not surprising 
considering the known lack of correlation between clinical signs and symptoms 
pertaining to the disease (DEWS, 2007c). 
Table 2.4. Summary of the age and other DES clinical parameters (Schirmer’s I, Tear Breakup 
Time, Ocular Surface Disease Index) of DES patients (n=27), normal subjects (n=10), and patients 
from the mild (n=12), moderate (n=12) and severe (n=11) categories.  
Group Age Schir I (mm) TBuT (secs) OSDI 
Normal 29.40+2.22 21.00+2.85 5.70+1.31 3.54+1.20 
Patient 59.41+2.23 8.33+1.52 2.93+0.22 47.76+3.52 
Milda 60.58+2.86 8.25+1.91 3.91+0.76 12.15+1.93 
Moderateb 63.50+3.12 11.50+2.98 3.08+0.31 32.47+2.14 
Severec 57.00+2.71 5.91+1.43 2.82+0.33 62.69+3.99 
Tear breakup time, TBuT; Schirmer’s test 1, Schir I; OSDI, ocular surface disease index. Values were 
presented as means + standard errors. aMild: OSDI < 21.0; bModerate: 21.0 < OSDI < 41.2; cSevere: 
OSDI > 41.2. OSDI cut-offs for mild, moderate and severe categories of patients were adopted from 







2.3.3 Lipid aberrations in patients compared to normal controls 
The molar fraction of individual lipid classes in DES patients and normal controls 
was shown in Figure 2.9. No appreciable difference was observed in the overall lipid 
distribution between meibum obtained from patients and normal controls (Figure 
2.9A). Similar to the trend observed in normal controls, the non-polar lipid classes of 
CE, WE and TAG constitute the bulk of the lipids in the meibum, with CE being 
present in proportionately higher levels than both WE and TAG; and the class of 
OAHFA forms the majority of the polar lipid fraction in both groups (Figure 2.9A). 
While both groups of individuals displayed similar general lipid profiles, detailed 
analysis of the polar lipid fraction revealed that the levels of PC (p=0.093) and SM 
(p=0.064) were higher in patients than in normal controls with marginal significance 
(Figure 2.9B, insert). Notably, the total fraction of PC in patients was approximately 
threefold of that in normal controls (Figure 2.9B, insert).  
The levels of individual lipid species in normal controls and patients were 
quantified and the differences were illustrated by the heat plots in Figure 2.10. 
Notably, a number of highly unsaturated TAG species, including TAG/54:7, 
TAG/54:5, TAG/56:7 and TAG/56:6 were significantly higher (p<0.05) in patients 
than control subjects (Figure 2.10A). On the other hand, numerous polar lipid species 
displayed strikingly different profiles between the two groups. A number of PC 
species was found in significantly higher levels in patients compared to normal 
controls, and these species were predominantly LPC or those containing double 
bond(s) within their structures (i.e. ether/plasmalogen PCs or unsaturated PCs), with 
the exception of PC32:0 (Figure 2.10B). A similar trend was observed for unsaturated 
PI species (Figure 2.10C). Also noteworthy is that GluCer d18:0/16:0 (p<0.01), 
GluCer d18:0/18:0 (p<0.01); as well as GluCer d18:0/24:0 (p<0.05) were 






Figure 2.9. Changes in meibum lipid profiles with DES. (A) Overall distribution of major lipid classes 
in human meibum in normal subjects (n=10) and DES patients (n=27). (B) Comparison of the changes in 
major lipid classes between normal subjects (n=10) and patients (n=27).  Insert, phospholipids (PC, PE, 
PG, PI) and sphingolipids (SM, Cer, GluCer, DihexCer). Mean values were plotted, and error bars 





Figure 2.10. Fold changes in individual species of selected lipid classes with DES. Heatplots illustrate 
individual (A) TAG, Triacylglycerides; (B) PC, Phosphatidylcholines; (C) PI, Phosphatidylinositols; and 
(D) GluCer, Glucosylceramides species that differed significantly between normal subjects (n=10) and 
patients (n=27). Values were plotted as fold changes in DES (i.e. ratios of molar fraction in patients to 
molar fractions in controls). #p<0.10,*p<0.05, **p<0.01.  
 
 
2.3.4 Lipid aberrations with increasing disease severity 
There were no major differences in the overall distribution of lipids between the 
different categories of patients (Figure 2.11A). Similar to the general trend observed 
in meibum from normal controls, the non-polar lipid classes of CE, WE and TAG 
constitute the bulk of the meibum, and species of OAHFA form the majority of the 
polar lipid fraction. Interestingly, the total fraction of TAG was significantly different 
between patients for the three severity levels (p<0.05), with the total TAG fraction 
being significantly higher (p<0.05) in the mild category compared to the moderate 
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category of patients. The total level of TAG increased slightly in the severe category 
compared to the moderate category albeit not reaching statistical significance. 
Individual species of non-polar lipids that displayed statistically significant 
(p<0.05) and marginally significant (p<0.10) changes in quantities were shown in 
Figure 2.11B-C. It is noteworthy that most of the differences in individual non-polar 
lipid species were observed between patients from the mild and moderate categories. 
For instance, the levels of a number of CE species, including CE18:0, CE20:0 and 
CE21:0, were found in significantly higher levels (p<0.05) in the moderate than the 
mild category of patients (Figure 2.11B). Individual TAG species, on the other hand, 
displayed the opposite trend (Figure 2.11C). Consistent with the general trend 
observed for total TAG level, the levels of several TAG species, including TAG/46:1, 
TAG/46:0, TAG/48:2, TAG/48:1, TAG/48:0, TAG/50:2, TAG/51:2, TAG/51:1, 
TAG/52:4 and TAG/52:1, were significantly lower (p<0.05) in the moderate than the 
mild category of patients. The levels of majority of these TAG species increased 
slightly in the severe group compared to the moderate group, but were not of 
statistical significance.  
Individual species of polar lipid species that showed statistically significant 
(p<0.05) and marginally significant (p<0.10) changes in quantities were shown in 
Figure 2.11D-F. In contrast to the changes observed in non-polar lipid species, most 
of the appreciable changes in phospholipid and sphingolipid species were found 
between the moderate and severe categories (Figure 2.11D-E). A number of LPC, and 
other PC species containing double-bond(s) inherent in their structures (i.e. 
ether/plasmalogen PCs or unsaturated PCs), were found in lower levels in the severe 
compared to the moderate category of patients with marginal significance (p<0.10). 
Interestingly, the level of Cer d18:1/19:0 was significantly different (p<0.01) between 
the three categories of patients (Figure 2.11E); with a significantly higher level 
(p<0.05) observed in the moderate group than the mild group, and its level dropped 





Figure 2.11. Quantitative comparison of lipid profiles between mild (n=12), moderate (n=12) and 
severe (n=11) categories of DES patients. (A) Comparison between total lipid classes. Insert, 
phospholipids (PC, PE, PG, PI) and sphingolipids (SM, Cer, GluCer, DihexCer). Summary of individual 
lipid species that showed significant differences in selected lipid classes of (B) CE and WE, cholesteryl 
esters and wax esters; (C) TAG, triacylglycerides; (D) Phospholipids; (E) Sphingolipids; (F) OAHFA, 
(O-acyl)--hydroxy-fatty acids. Mean values were plotted, and error bars represent standard errors of the 




A number of OAHFA species, including OAHFA 16:1/32:2, OAHFA 
16:1/33:1, OAHFA 18:2/32:2 and OAHFA 16:1/34:2 were observed to be 
significantly different (p<0.05) between the three categories of patients (Figure 
2.11F). Notably, all these OAHFA species displayed a consistently decreasing trend 
as the severity level increases, although the levels between moderate and severe 
categories of patients were not statistically significant. Remarkably, the levels of 
OAHFA 16:1/32:2 and OAHFA 16:1/34:2 were significantly higher (p<0.05) in the 




2.4.1 Lipidome of the human meibum 
2.4.1.1 CE were found in greater abundance than WE. 
In concordance with previous studies (Chen et al, 2010; Harvey et al, 1987), 
cholesterol represents the dominant sterol in the sterol ester pool of the meibum 
(Figure 2.2A), therefore, subsequent analysis using SIM was focused on the detection 
and quantification of cholesterol-based ester species. The CE species detected with 
highest abundance included CE24:0, CE25:0 and CE26:0, which is in agreement 
previous studies (Chen et al, 2010; Nicolaides et al, 1981). Other abundant species 
included CE18:1, CE20:0, CE24:1 and CE30:1. Consistent with prior study (Butovich, 
2009a), a group of highly hydrophobic compounds that eluted after the VLCFA-CE 
reported above, with retention time at approximately 18-19 min according to the 
current gradient program, was detected, which could possibly represent CE species 
with chain lengths greater than C-32 (Figure 2.3), but their quantification was not 
attempted in the current study. As preliminary single-stage MS profile in the positive 
ion mode (Figure 2.2A) and previous literature (Butovich et al, 2009; Butovich, 2011) 
have indicated that oleic acid (C18:1)-based WEs are the major WE species within 
the human meibum, we therefore focused subsequent analysis on the quantification of 
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C18:1-based WE species in the human meibum. In concordance with Butovich et al 
(2009a), the major fatty alcohols (FAl) found in WEs were of a saturated nature and 
ranged from C17 to C30, although considerable amounts of their monounsaturated 
counterparts were also present (see Section 3.3.1.3).  
Figure 2.12. Representative ion chromatogram of meibum WE and internal standard (i.e. 
palmitoyl palmitate). As palmitoyl palmitate did not elute together with major WE species due to its 
shorter chain length, current quantification of WE is possibly affected by matrix effects. WE: wax esters. 
Also notable was the observation that equimolar amounts of WE containing saturated fatty acids ionize 
preferentially compared to species containing unsaturated fatty acids. These limitations in WE 
quantification were resolved in Section 3.3.1.3.  
 
Contrary to earlier reported studies (Chen et al, 2010; Mathers et al, 1998; 
McCulley et al, 1997), the most abundant class of non-polar lipids detected was CEs 
instead of WEs, which comprises more than half (approximately 67%) of the total 
lipids in the human meibum. This stark difference in the levels of CEs may be due to 
different methods of analysis used in estimating the quantity of individual lipid 
species in the meibum compared to earlier studies, such as alterations in the 
approaches employed for separation and ionization of the individual lipid classes 
present in the meibum. Moreover, in the current study, a single standard (cholesteryl 
stearate-26,26,26,27,27,27(d6) and palmityl palmitate) was used for quantification of 
the entire class of CE and WE species, respectively. This could also lead to errors in 
the quantitative estimation of individual CE, and especially WE species in this study. 
Most WE species detected in meibum were unsaturated in nature and are oleic acid 
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(C18:1)-based. To our knowledge, there is no commercially available standard 
suitable, such as deuterated or 13C-labelled WE species, for use in the accurate 
quantification of meibum WE species. While palmityl palmitate (C16:0C16:0) is not 
present endogenously in the human meibum, it is considerably shorter than most 
endogenous WE species (Figure 2.12). Due to its shorter chain length and thus faster 
elution in LC than other WE species, the quantification of WE in the current study 
might be influenced by the matrix effects. In order to achieve absolute quantification, 
isotopically labelled standards with structures identical to each individual CE or WE 
species would be needed to minimize the effect of ion suppression on the 
quantification of individual lipid species. These issues will be addressed further in 
Section 3.3.1.3. 
Moreover, the quantity of CE detected in the study group (27 patients and 10 
normal controls) ranged from 38.7% to 82.6% (Figure 2.13A), while that for WEs 
ranged from 11.1% to 49.5% (Figure 2.13B). This indicated that the altered ratio of 
CEs to WE observed between different studies could be partly due to minor variations 
in sampling techniques, e.g. the force applied onto eyelids to express the meibum, or 
natural variations inherent in the populations.  
 
Figure 2.13. Scatter plots illustrating individual percentages of (A) CE, cholesteryl esters; and (B) 




2.4.1.2 Both phospholipids and OAHFA represent possible candidates for the 
amphiphilic layer. 
The occurrence of phospholipids in human meibum has been a matter of contention, 
as numerous phospholipid species that have been reported earlier (Tiffany, 1978; 
Shine et al, 2003; McCulley et al, 1997) using chromatography were not robustly 
detected in later studies (Butovich et al, 2007a; Chen et al, 2010) targeted at 
elucidating the meibum lipidome. Earlier report has estimated that the amount of 
phospholipids typically present made up less than 0.05% of the total meibum lipids 
(Butovich, 2009b), while total phospholipids in this current study was estimated to 
constitute approximately 0.40% of total lipids.  
Phospholipid species present in the meibum, such as PC34:2 and PC34:1, 
were consistently detected in all samples tested, which is in contrast to earlier report 
stating that phospholipids were not detected at all in many of the samples tested 
(Butovich, 2009b). The definitive identification of phospholipids in this current study 
is supported by the recent findings (Saville et al, 2011), in which the presence of 
several phospholipid species belonging to the classes of SM and PC in both the 
human meibum and tears were reported. The consistent detection of phospholipids in 
all samples tested in the current study, despite in relatively low abundance, suggests 
that this class of lipids might be inherently present in the meibum. Moreover, since 
the meibomian glands are holocrine glands and the individual acinar cells are 
excreted in toto (McCulley et al, 2004), it is thus not surprising that phospholipids 
originating from the cell membranes constitute a natural source of polar lipids in the 
meibum. Nevertheless, it cannot be ruled out that the controversial presence of 
phospholipids in meibum samples could have been due to differences in sampling 
techniques. For instance, varying amounts of force applied onto the eyelids to express 
the secretion from the glands would have resulted in different amounts of cell debris 
in the meibum collected. Further investigation is needed to confirm the presence and 
origin of phospholipids in the human meibum. 
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The presence and origin of phospholipids in the human meibum have 
remained intriguing topics, because phospholipids have been proposed as possible 
candidates for the amphiphilic layer of TFLL on the basis of their amphiphilic nature 
(McCulley et al, 1997; McCulley et al, 2004; Shine et al, 2003). The amphiphilic 
component of the TFLL is critical for maintaining the structural integrity of the tear 
film as a whole, and has been proposed as a crucial intermediate player in ensuring 
the even spreading of the non-polar lipid layer together with the aqueous layer during 
each blink of the eye (McCulley et al, 2004). While current findings suggest that 
phospholipids remain likely candidates for the amphiphilic layer, it is also important 
to consider the physiological roles of OAHFA, a relatively new class of amphiphilic 
compounds first confirmed in the human meibum by Butovich et al (2009). It was 
stated that on a structural basis, the estimated ratio of 1 amphiphilic molecule per 20 
non-polar ones is essential for maintaining the bulk of non-polar molecules in TFLL 
(Butovich, 2009b). In this study, the amount of OAHFA in the meibum was estimated 
to be approximately 3.5% of the total meibomian lipids, which seemed to fit the 
required ratio relatively well. It is also possible that species of phospholipids and 
OAHFA, as well as other polar lipids detected such as the sphingolipids, function 
synergistically as the amphiphilic layer to maintain the structural stability of TFLL. 
 
2.4.2 Changes in lipid profiles in relation to DES progression and disease onset 
In order to circumvent the limitation imposed by the age difference between patients 
and control subjects, patients of similar ages were categorized into three severity 
levels based on OSDI (Supplementary Material 2.3). Furthermore, it is of substantial 
clinical importance to distinguish between different severity levels of DES (i.e. mild, 
moderate and severe) for effective diagnostic and prognostic purposes on a clinical 
basis (Zhou et al, 2009). Comparison in the changes of lipid profiles between DES 
patients and normal controls were also reported in an attempt to reveal lipid species 
that might be pathologically relevant to DES onset. Nevertheless, further validation 
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using age-matched controls and larger sample size is essential to verify the current 
results reported. 
 
2.4.2.1 Implications of TAG perturbations on DES pathogenesis 
A relatively consistent trend was observed for a number of saturated and unsaturated 
TAG species, which were significantly decreased in the moderate category compared 
to the mild category. In an earlier model of TFLL proposed by McCulley and Shine, 
TAG and WE were suggested as transitional lipids that facilitate the bridging between 
the polar and non-polar lipid phases (McCulley et al, 1997). In their proposed model 
(Figure 2.14), it was stated that TAG unsaturation is critical for maintaining the 
stability of the polar lipid phase as well as in promoting the proper segregation of 
non-polar and polar lipids in the meibum, as interactions between TAG and PC 
depend on the degree of fatty acid unsaturation within TAG at a temperature range of 
35oC-37oC (Jester et al, 1989). As such, the drop in the levels of unsaturated TAG 
species in moderate category of patients compared to the mild patients could possibly 
have an adverse effect on TFLL stability.  
 
Figure 2.14. TAG as the transitional layer between non-polar and polar lipids in the tear film lipid 
layer. McCulley and Shine have previously proposed that mono- and di-unsaturated TAG could serve as 
transitional lipids that facilitate the bridging between polar and non-polar lipids, and the interaction 
between TAG and phospholipids depends on the degree of unsaturation in TAG fatty acid chain 




A notable finding in the current study was the detection and quantification of 
several highly unsaturated TAG species (n>4) with relatively low abundance, which 
has not been previously reported. This indicates a high degree of unsaturation in the 
fatty acid moieties that constitute such TAG species, implying their susceptibility to 
lipid peroxidation. Such TAG species might therefore possibly be of potential 
relevance to inflammatory processes associated with DES pathogenesis (Wakamatsu 
et al, 2008) despite their low abundance in the human meibum. Thus, PUFA-
containing TAG species, which were found to be significantly elevated in DES 
patients compared to controls, can possibly predispose patients to ocular 
inflammatory attacks associated with DES onset due to the higher susceptibility of 





2.4.2.2 Implications of phospholipid changes on DES pathogenesis 
In the current study, we have identified a number of inflammation-associated 
bioactive lipid species, such as various LPC, as well as their unsaturated phospholipid 
precursors that significantly differed in quantity amongst patients of different severity 
levels, as well as between patients and control subjects. This finding was 
corroborated by a previous comprehensive study on protein biomarkers in tear fluid, 
which has identified a correlation between dry eye severity and the levels of proteins 
associated with inflammatory response, including α1-acid glycoprotein 1, S100A8 
and S100A9 (Zhou et al, 2009).  
Increasing knowledge on the role of phospholipase A2 (PLA2) in the 
maintenance of ocular homeostasis and pathology of ocular-related diseases has 
become available in the recent decade (Wang et al, 2010). The expressions of PLA2s 
have been previously detected in both the conjunctiva and corneal epithelial tissues 
adjacent to the tear film, and specifically cleave the acyl ester bond at the sn-2 
position of phospholipids to yield free fatty acids and lysophospholipids (Wang et al, 
2010). A number of studies have indicated increased PLA2 activity in patients with 
ocular diseases such as chronic blepharitis (Song et al, 1999) and non-Sjögren’s 
severe dry eye disease compared to normal controls. The hydrolysis of phospholipids 
can result the release of free fatty acids and lysophospholipids, both of which can 
potentially function as lipid signalling molecules that can exert an array of 
physiological effects including inflammatory reactions (Landreville et al, 2004), 
contributing to the pathogenesis of DES. Thus, we speculate that the observed 
increase in the levels of lysophospholipids found in patients could possibly be 
attributed to increased PLA2 activity and the subsequent hydrolysis of phospholipids. 
Phospholipid-bound polyunsaturated fatty acids (PUFA) are also principal targets for 
events of oxidative attacks (Subbanagounder et al, 2000). Therefore, the increased 
levels of unsaturated and plasmalogen/ether PCs in patients would theoretically 
54 
 
predispose the affected individuals to the disease by increasing the chances of 
oxidized phospholipid formation via oxidative attacks, leading to a series of pro-
inflammatory responses that essentially underlie the advanced stage DES 
pathogenesis.  
While a number of lysophospholipids and ether/plasmalogen phospholipids 
were found in increased levels in patients compared to controls, the opposite trend 
was observed for patients in the severe category. These lipid species aforementioned 
were decreased in the severe category when compared to the moderate category with 
marginal significance. Culminating evidence now suggest that oxidized phospholipids 
can exert both pro- and anti-inflammatory effects depending on the biological context 
(Leitinger, 2003). Thus, changes in the levels of oxidized phospholipids and their 
precursor phospholipids in the meibum of DES patients might be either due to 
inflammatory assaults associated with disease progression, or a result of defensive 
mechanisms of the meibomian gland cells or corneal epithelial cells to elicit anti-
inflammatory responses in an attempt to maintain cellular homeostasis.  
Structurally, it has been suggested that the presence of unsaturated fatty acids 
in phospholipids results in de-mixing or segregation of the polar lipid layer, which 
could potentially destabilize the tear film as a consequence (McCulley et al, 1997). 
In-depth analysis into the precise roles of individual oxidized phospholipids as well 
as their quantification in DES patients versus control subjects is needed to construct a 
more holistic view of the lipid-mediated inflammatory responses associated with DES. 
The complex interplay of inflammatory-associated and structural functions exhibited 
by the various phospholipid species might possibly explain their fluctuating levels as 
disease severity increases. 
 
2.4.2.3 OAHFA might represent suitable indicators of DES progression. 
In contrast to phospholipids, OAHFA displayed a consistently decreasing trend as 
disease severity increases. This supports their putative role in maintaining the 
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structural integrity of TFLL by serving as candidates for the amphiphilic layer to 
facilitate interactions between the polar and non-polar lipids. Their clear and 
discernible trend across different disease severity levels might possibly allow them to 
function as indicators of disease progression. Verification of the observed trends in 
OAHFA species with larger sample size is needed before a conclusive statement can 
be made. 
 
2.4.2.4 Sphingolipids might be critical in maintaining the structural integrity of 
TFLL. 
It was notable that the class of SM lipids was appreciably increased in the meibum of 
patients with marginal significance (p=0.064). McCulley and Shine have suggested 
that sphingolipids, especially cerebrosides, are crucial players in initiating the 
segregation of polar lipids from the more non-polar lipids in the presence of water 
molecules, and a decreased amount of cerebrosides was found in the meibum of 
patients with chronic blepharitis (McCulley et al, 1997). While an opposite trend was 
observed in this current study, it must be noted that overall structural stability of the 
tear film should depend on a delicate homeostatic balance of lipid species, especially 
those that carry out fundamental roles in stabilizing the TFLL. Therefore, 
sphingolipids can be potentially important in promoting the structural integrity of 
TFLL. Also of interest was the observation that a number of GluCer species including 
GluCer d18:0/16:0, GluCer d18:0/18:0 and GluCer d18:0/24:0 were significantly 
increased in patients. Increased levels of Cer have been observed in patients with 
meibomian keratoconjunctivitis (MKC) due to abnormal hyperkeratinization of the 
meibomian gland ducts resulting in their obstruction (Mathers et al, 1998). Liu and 
colleagues (2011) has also recently confirmed that keratinization plays a critical role 
in the pathogenesis of MGD via genome-wide analysis of lid tissues obtained from 
normal controls and MGD patients (Liu et al, 2011). In a recent study, it has been 
found that increasing Cer to meibum ratios in vitro have an appreciable impact on the 
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stability of human meibum films, suggesting that higher than optimal level of Cer 
decreases the stability and elasticity of the TFLL leading to its collapse (Arciniega et 
al, 2010), thereby supporting the structural roles elicited by Cer species in TFLL. 
 
2.4.3 Limitations of the current study design 
There was a lack of age-matched control subjects for unbiased comparison of lipid 
profiles with that of DES patients (Table 2.4), who were of a significantly older age 
than the control subjects largely due to the higher incidence of DES with increasing 
age and therefore the difficulty in recruiting old controls. It has been previously 
reported that aging exerts a significant effect on the lipid profiles of a number of polar 
and neutral lipid species in the human meibum (Sullivan et al, 2006), thus, certain 
changes observed in the current study could possibly be confounded by the effect of 
age. As only m/z values but not the specific identities of the lipid species have been 
reported in the study aforementioned, we were unable to do a comparison with results 
obtained in this study. Gender was also not perfectly matched in the current study, 
although a larger proportion of female subjects were found in both patients and 
control groups (Supplementary Materials 2.1; 2.3). Also, it was more difficult to 
recruit male DES patients due to female individuals having a greater predisposition to 
the disease.  
The multifactorial nature and complicated manifestations of ocular surface 
disease make it almost impossible to rely solely on any single biomarker for disease 
diagnosis and monitoring. This implies that currently there is no single diagnostic test 
that can be used as a proxy for severity level of dry eye or MGD for evaluating lipid 
levels.  On the other hand, a panel of tear biomarkers is probably required to 
rationally classify dry eye and MGD for the purpose of treatment and clinical trials, 
which will be addressed in Chapters 3-4. 
In conclusion, the current study represents the first attempt to provide an 
insight into sieving out the pathologically relevant lipid species for dry eye disease on 
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scale of the entire lipidome, which can undoubtedly facilitate a more comprehensive 
understanding of the disease itself. In essence, more drastic quantitative differences 
were observed in minor lipid species of lower abundance compared to non-polar 
species (CE and WE) that constitute the bulk of the meibum amongst patients of 
different severity levels, as well as between patients and normal controls. Amongst 
the various lipid classes investigated, OAHFA represents the only class of lipids with 
consistently decreasing levels that correlate with increasing disease severity, which 
renders these lipids suitable indicators of dry eye disease progression. Nevertheless, it 
is crucial to recognise that age is a confounding factor in the current experimental 
design that cannot be overlooked, and it is thus essential to recruit age-matched 




Chapter 3. Lipid Profiles of Human Tears: Collection 





The tear fluid covers the anterior surface of the cornea and serves critical functions in 
maintaining the homeostasis of the ocular surface. Tears hydrate and lubricate the 
mucous membranes constituting the ocular surface, supply nourishment to the 
avascular corneal epithelium and provide a smooth optical surface essential for visual 
acuity. The drainage of tears via the lacrimal puncta flushes contaminants and 
irritants out of the eye, thereby functioning as a first line of defense for the anterior 
eye against invading pathogens (Zhou et al, 2012; Rantamäki et al, 2011). The typical 
volume of tears in normal eyes ranges from 3.4 to 10.7 l per eye (Scherz et al, 1974). 
Despite its small volume, tear represents a biological fluid of immense complexities 
with a wide array of proteins/peptides, electrolytes, lipids and small molecule 
metabolites contributed by distinct sources (Zhou et al, 2012) (see Section 1.3.1). The 
precise balance of these various metabolites is crucial in ensuring the proper 
physiological function and maintaining the biophysical integrity of the precorneal tear 
film. Perturbations in this delicate equilibrium may be manifested in various ocular 
conditions such as the DES and blepharitis (Zhou et al, 2012; Zhou et al, 2009; Tong 
et al, 2011).   
Recent decades have witnessed tremendous progress in the systematic 
profiling of proteins (Zhou et al, 2012; Zhou et al, 2012; Green-Church et al, 2008; de 
Souza et al, 2006) as well as small molecule metabolites (Chen et al, 2011) present in 
tears. Furthermore, with technological advancements in mass spectrometry and 
nuclear magnetic resonance spectroscopy, the lipid composition of the human 
meibomian gland secretions, the predominant source of lipids for the precorneal tear 
film, has been elucidated with great compositional and structural details (see Chapter 
2) (Lam et al, 2011; Borchman et al, 2012b; Saville et al, 2011; Butovich, 2008; 
Butovich, 2009a; Butovich et al, 2007b; Borchman et al, 2010c; Butovich et al, 2009; 
Chen et al, 2010; Butovich et al, 2012). A comprehensive lipidomic analysis of the 
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tear fluid per se, however, has lingered behind. The appreciably lower lipid 
concentration in human tears, which is largely aqueous compared to the meibum, as 
well as the limiting amount of unstimulated tears that could be obtained from 
individual subjects, present a new level of challenge for the field of lipidomics. In 
spite of these analytical challenges, a comprehensive elucidation of the tear lipidome 
is imperative to unravel the biophysical properties of the tear film. As a proximal 
fluid to the anterior eye, the tear is a dynamic reflection of metabolites present at the 
ocular surface and therefore represents a rich source for the discovery of ocular 
disease-related biomarkers.  
Apart from the analytical challenges posed by the limited abundance but yet 
great complexities of lipid species in tears, the biochemical analysis of tears has also 
been plagued by the problem of specimen collection. For instance, while the use of 
the Schirmer’s strips to collect tears is a common practice in dry eye clinics, this 
procedure is relatively invasive compared to capillary tube collection. Furthermore, 
the physical presence of the strip might lead to mechanical stimulation of the corneal 
and conjunctival epithelia (Zhou et al, 2012; Markoulli et al, 2011). The Schirmer’s 
method is therefore known to collect both cellular and secreted proteins (Markoulli et 
al, 2011). Capillary collection is generally less invasive than Schirmer’s strips, but the 
process can be slow due to the paucity of flow. It is also technically challenging to 
avoid contact with the lids or ocular surface during the prolonged process in ensuring 
the collection of only basal but not reflex tears (Markoulli et al, 2011). An adaptation 
to the capillary method involves the use of a fixed volume of saline to flush the ocular 
surface before collection, which serves to increase the subsequent flow rate at the 
expense of sample dilution and potential induction of reflex tearing. Therefore, a 
global lipidomic platform and systematic comparison of tear collection techniques 
will be of immense practical value for the ocular community in facilitating the 
standardization of collection procedures. This will also aid future clinical designs to 
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use human tears as a proximal fluid for biomarker discovery pertaining to both ocular 
and systemic diseases, which would be of immense importance to the field of ocular 
research and beyond.  
Compared to tears, meibum-derived lipid markers indicative of DES reported 
in Chapter 2 are circumvented by the assumption that meibomian lipids are fully 
incorporated into the tear film lipid layer without proportional alterations of the 
various lipid classes. Moreover, manually expressed meibum might not provide 
accurate reflections of the physiological compositions normally secreted onto the lid 
margin and subsequently incorporated into tears. Tear lipid biomarkers can thus 
potentially offer a closer reflection of disease pathophysiology and display better 
correlation to clinical tests routinely used for dry eye diagnosis, such as the 
Schirmer’s test and the tear film breakup time. In addition, a comprehensive tear 
lipidome would also facilitate pharmaceutical development of artificial tears for 
alleviating DES and other ocular diseases. 
A preliminary analysis of human tears using mass spectrometry has 
concluded that meibum represents the prominent source of lipids for the tear film 
(Butovich, 2008). The presence of PC, SM, WE and free cholesterols (Cho) in tears 
has been demonstrated using infrared spectroscopy (Borchman et al, 2007b). Saville 
and colleagues (2010) subsequently provided the relative abundances of individual 
species of PC and SM in human tears. The polar lipid composition has further been 
expanded by two other groups, who have reported a predominance of LPC 
(Rantamäki et al, 2011; Dean et al, 2012). In addition to PC and SM, Rantamäki et al 
(2011) also reported the presence of TAG, Cer and PE in tears. As most of these 
studies only focused on selected lipid groups in tears, a comprehensive lipidome with 
sufficient details to encompass the sheer complexities of the various classes of lipids 
in tears is therefore still lacking.  
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WE are structurally simple lipids composed of long-chain fatty alcohols 
esterified to fatty acids, and is a major lipid class of the meibomian gland secretions, 
collectively known as meibum. A preliminary analysis of human tears using mass 
spectrometry concluded that meibum represents the prominent source of lipids for the 
tear film (Butovich, 2008). The most widely-used methods for analysis of WE are gas 
chromatography coupled with various detectors such as flame ion detection and mass 
spectrometry, which usually require steps of hydrolysis and derivatisation (Harvey et 
al, 1987; Joffre et al, 2008). Direct detection of WE as [M + NH4]+, [M + H]+ or 
[M + Li]+ adducts by MS without chromatographic separation of individual molecular 
species has also been previously reported (Fitzgerald et al, 2007; Butovich et al, 
2007b), which unavoidably resulted in ion suppression due to the simultaneous 
ionization of all analytes present. More recently, Vrkoslav et al (2010) and Butovich 
et al (2012) have employed HPLC/APCI/MS and gas-liquid chromatography-ion trap 
MS, respectively, for analyses of intact WE and henceforth their exact molecular 
structures, albeit highly fragmented daughter ions were observed in both studies that 
could have possibly affected the sensitivity and accuracy of their analytical methods. 
Herein, I demonstrated that WE are predominantly ionized as [M+NH4]+ under 
our chosen mass spectrometric conditions (See Section 3.2.5), and further developed 
specific MRM transitions for sensitive quantitation of 141 species of WEs in human 
tears, which confers information pertaining to the molecular compositions (i.e. both 
fatty acid and fatty alcohol moieties) of individual species. In addition, I report the 
HPLC/MS/MS-based approaches for the comprehensive qualitative and quantitative 
characterization of human tear and meibum lipidomes from individual subjects. The 
meibum lipidome was significantly expanded from that reported in Chapter 2, and 
quantitative corrections were made in order to obtain a more accurate depiction of the 
relative proportions of various lipid classes. My analyses revealed that human tears 
comprise more than 600 individual lipid species from 17 distinct lipid classes in 
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volumes less than 10 L per sample. We also report, for the first time, the presence of 
a novel lipid amphiphile, cholesteryl sulfate (CS), in the human tears and meibum, 
which would have considerable impact on existent tear film model. In addition, 
systematic comparisons of the tear lipidomes collected using different sampling 
techniques were evaluated.  
 
3.2 Materials and Methods 
3.2.1 Study group 
For preliminary analysis and method validation, 45 patients and 15 volunteers were 
recruited to contribute pooled or individual samples of tears and meibum. The 
patients were diagnosed with dry eye syndrome at the Singapore National Eye Center 
(SNEC). Written informed consent was obtained from all participating subjects and 
the procedure for the project was specifically approved by the SingHealth Centralised 
Institutional Review Board (CIRB Reference No: 2008/611/A). We adhered to the 
tenets of the declaration of Helsinki for all human research conducted in this study. 
The detailed clinical procedures have been reported in Section 2.2.3 (Lam et al, 2011).  
 
3.2.2 Human tear and meibum sample collection   
Schirmer’s tears were collected from both eyes of the subjects without anaesthesia 
using the Sno’s strips (Bausch & Lomb Sno strips®, New York, USA) as described in 
Section 2.2.3 (Supplementary Material 3.1). The strips were stored at -80oC in glass 
vials until further analysis. Capillary tears were collected using 5 L glass 
microcapillary tubes (Blaubrand® intraEND, Wertheim, Germany). The collection 
time was limited to a maximum of 5 min with collection volumes between 2 to 10 L. 
The capillary tube rested in the lateral tear meniscus and care was exercised to 
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minimize contact with the bulbar conjunctiva or the lid margin. Reflex tearing was 
observed in some subjects (Supplementary Material 3.2). Flush tears were collected 
by instilling 20 L of non-preserved, unit dose saline (sodium chloride injection 
0.9 %, B Braun, Germany) into the inferior palpebral fold using an Eppendorf pipette. 
Care was taken not to contact the eye with the pipette tip. Participants were then 
instructed to gently close and rotate their eyes. Tears were then immediately collected 
by the capillary tubes as aforementioned. Tears were expelled from the capillary 
tubes into glass vials. Capillary tubes were washed two times with 
chloroform:methanol (2:1) to remove residual lipids and the washings were also 
pooled together with the tear samples and store at -80oC until further analysis. 
Meibum samples were collected as previously described in Section 2.2.2 (Lam et al, 
2011).  
 
3.2.3 Lipid extraction of tear and meibum samples 
3.2.3.1 Capillary tears 
Lipids were extracted at 4 oC for 1h with 200 L ice-cold of chloroform:methanol 
(1:1) at 1200 rpm in a thermomixer. Samples were then centrifuged at 3000 rpm for 
5min at 4oC and 200 L of clear supernatant was transferred to fresh glass vials. 
Second extraction was carried out by repeating the procedures and the extracted 
organic fractions were pooled and dried using speed-valco (Thermo Savant, Milford, 
USA). Dried lipid extracts were stored at -80 oC until mass spectrometric analysis.  
3.2.3.2 Schirmer’s tears 
The first three 5 mm segments of the strips were cut into fine pieces (of 
approximately 2 mm) using micro-scissors pre-washed with methanol between 
samples. Lipids were extracted overnight at 4 oC with 900 L of ice-cold 
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chloroform:methanol (1:2) at 1200 rpm in a thermomixer. 540 L of deionised water 
and 300 L of chloroform were added to form separate phases. Samples were 
vortexed and incubated on ice for 3 min. Samples were then centrifuged at 3000 rpm 
at 4 oC for 5 min and the lower organic phase was removed. The aqueous phase was 
re-extracted with 500 L of chloroform and 50 L of 0.1 M hydrochloric acid. The 
extracted organic fractions were pooled and dried using speed-valco (Thermo Savant, 
Milford, USA). Dried lipid extracts were stored at -80oC until mass spectrometric 
analysis.  
3.2.3.3 Meibum 
Meibum samples were extracted as previously described in Section 2.2.2 (Lam et al, 
2011). 
 
3.2.4 Qualitative single-stage lipid profiling of human tears 






3.2.5 Development of LC-MRM approach for rapid and sensitive profiling of 
tear wax ester species  
3.2.5.1 Synthesis of wax ester standards 
Wax ester molecular species 13C18:1(oleic acid-1,2,3,7,8,9,10-13C7)C26:0, 
C18:1C26:0, 13C18:1(oleic acid-1,2,3,7,8,9,10-13C7)C28:0 and C18:1C28:0 were 
synthesized in-house using oleic acid, oleic acid-1,2,3,7,8,9,10-13C7, fatty alcohols 
26:0 and 28:0 as previously described (Vrkoslav et al, 2010). Briefly, fatty acid was 
stirred in SOCl2 for 20 min before addition of benzene, and the mixture was 
evaporated until dry. The residues were dissolved in CHCl3, followed by addition of 
the respective alcohol and triethyl amine. The mixture was stirred for 60 min. The 
reaction products were washed with 5% H2SO4 in water and water. The organic layer 
was collected and dried over MgSO4. The synthesized WE were purified by 
preparative TLC using hexane/diethyl ether (93:7, v/v) mobile phase (Vrkoslav et al, 
2010).   
 
3.2.5.2 Development and validation of high-performance liquid chromatography 
coupled to multiple reaction monitoring method for analyses of tear wax esters 
Wax ester molecular species were analyzed using an Agilent 1200 HPLC system 
coupled with an Applied Biosystem 3200 Qtrap mass spectrometer.  Briefly, 
separation of lipids was carried out on a Phenomenex Kinetex 2.6µ-C18 column (i.d. 
4.6x100mm) using an isocratic mobile phase chloroform:methanol:0.1M ammonium 
acetate (100:100:4) at a flow rate of 150 µl/min for 22 min. Based on tandem mass 
spectrometry of individual wax ion peaks, MRM transitions were established for 
measurement. Lipid extracts from tear samples of 8 human subjects were pooled and 
used for profiling of wax lipid species. Levels of WEs in tears were quantified using 
two separate internal standards. Palmitoyl palmitate (C16:0C16:0) for WE with 
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saturated fatty acyl heads, while WE containing unsaturated fatty acyl heads were 
quantitated using 13C18:1C26:0. Using this set of standards, individual WE species 
were normalized to the respective internal standards on basis of their chain lengths.  
In-house synthesized WE species including C18:1C26:0, C18:1C28:0, 
13C18:1(oleic acid-1,2,3,7,8,9,10-13C7)C26:0 and 13C18:1(oleic acid-1,2,3,7,8,9,10-
13C7)C28:0, as well as WE species purchased from Sigma-Aldrich (St. Louis, MO, 
USA) such as C18:1C18:0, C18:1C22:0, C22:0C18:0 and C16:0C16:0 were used for 
quantitative method validation. Specifically for human tears, C18:1C18:0, 
C18:1C22:0, C18:1C26:0, C18:1C28:0, and C22:0C18:0 represent WE species found 
endogenously based on our preliminary analyses (Lam et al, 2011), while 
C16:0C16:0 and the deuterated standards represent suitable internal standards due to 
their absence in tear samples.  
Method reproducibility was investigated using a mixture of endogenous species, 
as aforementioned, spiked with palmitoyl palmitate and deuterated WEs as internal 
standards. This preparation was run 9 times (n=9) under the specific MRM transitions 
to obtain the ratios of individual endogenous WE to their corresponding standards. 
The linear range was obtained using serial dilution of endogenous wax species spiked 
with palmitoyl palmitate and deuterated species as internal standards Briefly, 1 ng, 10 
ng, 50 ng, 100 ng, 1 µg, 10 µg, 20 µg, 50 µg, and 100 µg per mL of wax species was 
spiked with C16:0C16:0, 13C18:1(oleic acid-1,2,3,7,8,9,10-13C7)C26:0 and 
13C18:1(oleic acid-1,2,3,7,8,9,10-13C7)C28:0 as the internal standards, and measured 
using the LC-MRM approach. The LC-MRM results were subjected to linear 
regression analysis, and the squared correlation coefficient (r2) was calculated. The 
limit of detection (LOD) was defined as the lowest amount of WE that could be 
reliably identified with ion signal-to-noise ratio (determined by peak height) ≥ 3:1 




3.2.6 Analysis of tear lipidome using high-pressure liquid chromatography 
coupled to mass spectrometry 
3.2.6.1 Normal-phase liquid chromatography coupled with mass spectrometry 
Polar lipids were analyzed using an Agilent 1200 HPLC system coupled with an 
Applied Biosystem Triple Quadrupole/Ion Trap mass spectrometers 3200 Q-trap as 
described previously (Shui et al, 2011b). Separation of individual lipid classes of 
polar lipids by normal phase HPLC was carried out using a Phenomenex Luna 3μ-
silica column (i.d. 150x2.0 mm) with the following conditions: mobile phase A 
(chloroform:methanol:ammonium hydroxide, 89.5:10:0.5), B 
(chloroform:methanol:ammonium hydroxide:water, 55:39:0.5:5.5). MRM transitions 
were set up for quantitative analysis of various polar lipids. Individual lipid species 
were quantified by referencing to spiked internal standards. PC-14:0/14:0, LPC-C20, 
PE-14:0/14:0, LPE-C17, PS-14:0/14:0, LPS-C17, PA-17:0/17:0, LPA-C14, PG-
14:0/14:0, C14-LBPA, C8-GluCer, C17-Cer, C17-S1P and C12-SM were obtained 
from Avanti Polar Lipids (Alabaster, AL, USA). Dioctanoyl phosphatidylinositol (PI, 
16:0-PI) was used for phosphatidylinositol quantitation and obtained from Echelon 
Biosciences, Inc. (Salt Lake City, UT, USA). GM3 species were quantified using 
C17-GM3 as an internal standard.  OAHFA species were quantitated using OAHFA 
18:1/16:0, which was synthesized as previously described (Butovich et al, 2009) .  
 
3.2.6.2 Reverse-phase liquid chromatography coupled with mass spectrometry 
Phospholipids, sphingolipids, cholesterol sulphate, glycerol lipids (DAG, TAG), 
cholesteryl esters were analyzed using a modified version of reverse phase 
HPLC/ESI/MS/MS described previously (Shui et al, 2010). Wax esters were analysed 
using HPLC/ESI/MRM as described in Section 3.2.5. Briefly, separation of lipids 
aforementioned was carried out on a Phenomenex Kinetex 2.6µ-C18 column (i.d. 
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4.6x100mm) using an isocratic mobile phase chloroform:methanol:0.1M ammonium 
acetate (100:100:4) at a flow rate of 150 µl/min for 22 min. Cholesteryl sulphate and 
individual cholesteryl ester species were quantified using d6-cholesterol sulphate 
(Avanti Polar Lipids, Alabaster, AL, USA) and d6-C18 cholesterol ester (CDN 
isotopes) as internal standards, respectively. Using neutral loss-based MS/MS 
techniques, the levels of TAG were calculated as relative contents to the spiked d5-
TAG 48:0 internal standard (CDN isotopes), while DAG species were quantified 
using 4ME 16:0 Diether DG as an internal standard (Avanti Polar Lipids, Alabaster, 
AL, USA). The levels of WE were quantified using three standards, palmitoyl 
palmitate (C16:0C16:0) for WE with saturated fatty acyl heads, while WE containing 
unsaturated fatty acyl heads were quantitated using 13C18:1C26:0 or 13C18:1C28:0 
based on their acyl chain lengths, which were synthesized as in-house using oleic 
acid-1,2,3,7,8,9,10-13C7 (Vrkoslav et al, 2010).  
 
3.2.6.3 Atmospheric pressure chemical ionization  
Free cholesterol and cholesterol esters were further analyzed using 
HPLC/APCI/MS/MS as previously described with corresponding d6-cholesterol and 
d6-C18 cholesterol ester (CDN isotopes) as internal standards (Shui et al, 2011a). 
 
3.2.7 Quantitative correction of meibum and tear lipidomes 
The levels of WE could not been accurately quantified due to the lack of appropriate 
standards as described in our previous work on meibum lipid composition (Lam et al, 
2011). The use of palmitoyl palmitate (C16:0C16:0), a relatively short-chain 
saturated WE not found endogenously, as the only internal standard for the 
quantitation of the entire class of WE led to an underestimation of WE levels (see 
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Section 2.4.1.1). In order to improve WE quantification, we synthesized in-house two 
additional internal standards, namely 13C18:1C26:0 and 13C18:1C28:0, using oleic 
acid-1,2,3,7,8,9,10-13C7 (Vrkoslav et al, 2010). Using this set of standards, 
individual WE species were normalized to the respective internal standards on basis 
of their chain lengths. We also synthesized in-house WE species C18:1C26:0 and 
C18:1C28:0; and purchased C18:1C18:0 from Sigma-Aldrich (St. Louis, MO, USA) 
for quantitative method validation of WE. 
 It has been previously demonstrated that the ionization efficiency of an 
equimolar ratio of CE increased in a virtually linear manner with increasing length of 
their fatty acid moieties in the electrospray ionization (ESI) mode, while the degree of 
unsaturation of the fatty acid moieties has negligible effects on the overall ionization 
efficiency of CE species (Butovich, 2010). The use of deuterated cholesteryl stearate 
(d6-CE-18:0) as the sole internal standard for the quantitation of the entire class of 
meibum CE in the ESI mode (see Section 2.4.1.1), which comprises a predominance 
of long-chain CE species (C20-C36) (Figure 2.3), would have therefore led to an 
overestimation of their abundances (Lam et al, 2011). We have corrected for this 
effect via the use of APCI-MS in our current analysis, as we have previously shown 
that HPLC/APCI/MS allows for a wide dynamic linearity range in measuring the 
levels of CE in plasma samples due to less ion suppression compared to ESI mode 








3.3.1 HPLC/MS and HPLC/MS/MS analyses of wax esters 
In our selected LC-MS system, the in-house synthesized wax ester 13C18:1(oleic acid-
1,2,3,7,8,9,10-13C7)C26:0 ionizes effectively with electrospray ionization and mainly 
forms ammonium adduct ions [M+NH4]+ at m/z 671.7 (Figure 3.1A). Tandem mass 
spectrometry (MS/MS) spectra of parent adduct ions [M+NH4]+ yield fragment ions 
at m/z 272.3 ([oleic acid-1,2,3,7,8,9,10-13C7+H-H2O]+), 290.3 ([oleic acid-
1,2,3,7,8,9,10-13C7+H]+), and 254.3 ([oleic acid-1,2,3,7,8,9,10-13C7+H-2H2O]+) 
(Figure 3.1A, insert). Similar fragmentation patterns were observed for wax ester 
C18:1C22:0 comprising an unsaturated FA (Figure 3.1B). In saturated FA-containing 
WE molecular species such as C16:0C16:0, however, protonated FA (RCOOH2+) 
predominates over all other daughter ions (Figure 3.1C). Fragmentation of 
C16:0C16:0 mainly yields RCOOH2+ (FA16:0) at m/z 257.3 (Figure 3.1C), while the 
main daughter ions of wax ester C22:0C18:1 is represented by m/z 341.4 (RCOOH2+ 




Figure 3.1. Tandem mass spectrometry of wax esters. (A) Formation of ammonium adduct parent 
ions at m/z 671.7 for wax ester standard 13C18:1(oleic acid-1,2,3,7,8,9,10-13C7)C26:0 synthesized in-
house, as well as product ion scan (PIS) of parent ions at m/z 671.7 (insert). (B) PIS scan of parent ions 




Further single-stage LC coupled with high-resolution Orbitrap MS profiling 
of tear lipid extract demonstrated the existence of a diversity of WE molecular 
species in human tear lipidome (Figure 3.2A). Product ion scans of individual wax 
ester parent ions indicated the presence of isobaric wax species containing a variety 
of fatty acid head groups. For instance, molecular ion at m/z 664.6980, which 
corresponds to wax ester C44H86O2, gave product ions of 265(247, 283), 237(219, 
255), 285, 257 and 293 (275, 311), which correspond to fatty acid moieties of 18:1, 
16:1, 18:0, 16:0 and 20:1, respectively (Figure 3.2B). Based on the above 
information, individual MRM transitions for various wax ester species, which include 
compositional information on both fatty acids and fatty alcohols present, were set up 
as a single LC-MRM method.  
In combination with upfront column separation to minimize ion suppression from 
matrix, these MRM transitions enabled the sensitive analysis of individual WE 
species in human tear lipidome. Using isocratic elution condition with 
chloroform:methanol:ammonium acetate as a mobile phase, WE species were 
separated according to their molecular masses (i.e. total carbon number and number 
of total double bonds). The retention time of wax ester species having equal total 
number of double bonds increased with increasing total carbon number under our 
selected chromatography scheme, as illustrated using oleic acid-containing WEs with 
saturated fatty alcohols of increasing chain lengths (Figure 3.3A). Linear regression 
(retention time versus total carbon number) showed good linearity with R2 = 0.997 for 
WE composed of oleic acid and saturated fatty alcohols. Similar patterns of elution 
were obtained for wax species having the composition of oleic acid-monounsaturated 
fatty alcohol, which was eluted around 0.55 min earlier than their saturated 






Figure 3.2. The diversity of wax esters in human tear fluid. (A) High-resolution MS profiling of wax 
esters in human tears using HPLC-Orbitrap mass spectrometry. (B) Product ion scan of parent ions at 







Figure 3.3. Peak chromatograms of oleic acid-containing wax esters in human tears comprising 
different fatty alcohols based on HPLC/MRM. (A) Extracted ion chromatograms of oleic acid-based 





Using C16:0C16:0, 13C18:1(oleic acid-1,2,3,7,8,9,10-13C7)C26:0 and/or 
13C18:1(oleic acid-1,2,3,7,8,9,10-13C7)C28:0 as internal standards for quantitation of 
various wax species having both saturated and unsaturated fatty acid head groups, the 
coefficient of variations (COVs) of individual wax species were found to range from 
4.5-9.0% (n=9) (Figure 3.4), which indicated high reproducibility of the analytical 
method developed. In addition, simple linear regression of standard curve showed 
linearity with R2 > 0.999 for all concentrations (ranging from 0.001 to 100 µg/mL) of 
the various wax species investigated (data not shown). The linearity range of the LC-
MRM detection for WE species was estimated to be at least three orders of 
magnitude. The limit of detections ranged from 65 to 81 nmol/L for the WE species 
tested in this study, which is appreciably lower than those obtained using 
HPLC/APCI/MS (Butovich et al, 2012). Compared to earlier methods (Lam et al, 
2011; Shui et al, 2011), the increased sensitivity for WE analyses herein could be 
mainly attributed to (1) increased specificity using specific MRM scanning and (2) 
high fragmentation of parent ions in previous HPLC/APCI/MS. 
 







3.3.2 Lipid distribution of tear lipidome 
3.3.2.1 Analytical workflow facilitated characterization of polar lipid species 
based on retention times and specific multiple-reaction-monitoring (MRM) 
transitions  
 
Figure 3.5. Schematic summary of analytical workflow employed. Human tear and meibum 
lipidomes were elucidated using high-pressure liquid chromatography (HPLC) coupled to different 
ionization modes (ESI +/-; APCI+) in mass spectrometry. Different lipid classes were analyzed and 
quantitated chiefly using HPLC-MS in the reverse phase (RP) and normal phase (NP). ESI: electrospray 
ionization; APCI: atmospheric pressure chemical ionization; + positive mode; - negative mode. 
 
In the current study, all individual lipid species in human tears were measured in a 
simple analytical workflow, using either normal phase (NP)- or reverse phase (RP)-
HPLC/MS (Figure 3.5). Pooled tear samples from DES patients were first analyzed to 
determine representative baseline values. Our analyses revealed the astonishing 
complexities of the human tear fluid lipidome (Table 3.1), consisting of the non-polar 
lipid classes of CE, WE, TAG, DAG, and free Cho; the glycerophospholipid classes 
such as PC, PE, phosphatidylinositols (PI), phosphatidylglycerols (PG), 
phosphatidylserines (PS), phosphatidic acids (PA) and lyso-biphosphatidic acids 
(LBPA); the sphingolipid classes including SM, Cer, glucosylceramides (GluCer), 
monosialodihexosyl-gangliosides (GM3) and sphingosine-1-phosphate (S1P); CS as 
well as O-acyl--hydroxy fatty acids (OAHFA), a unique class of amphiphilic 
compounds first reported to be present in meibum by Butovich and colleagues (2009). 
The tear (and meibum) lipidomes presented in this study are a significant 
expansion from previous report by our group (Lam et al, 2011) and others (Saville et 
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al, 2010; Rantamäki et al, 2011; Dean et al, 2012) (Table 3.1; Figure 3.6). First, CS, 
LBPA, S1P and GM3 have so far not been reported in tear nor meibum. Second, we 
expanded the list of phospholipid species to include PI, PG and PA from previously 
reported PC, PE and PS (Rantamäki et al, 2011; Dean et al, 2012; Ham et al, 2006). 
While the presence of PA in tears has been suggested by Dean et al based on earlier 
TLC results, no prior mass spectrometric analysis of tears has confirmed the presence 
of PA in tears (Glasgow et al, 1995; Dean et al, 2012). In addition, we detected the 
unambiguous presence of LBPA species in the human tears with LBPA 36:2 as the 
most abundant species (Figure 3.7), which are isobaric compounds of PG with 
PG34:1 as the predominant species; and were distinguishable from the latter via their 
different retention times using HPLC separation.  
 
Figure 3.6. Lipidome of pooled sample of (A) Schirmer’s strip-collected tears (n=8) and (B) 
meibum (n=7) from DES patients. 
 
With regard to sphingolipids, SM represents the major sphingolipid class in 
human tears and meibum (Table 3.1; Figure 3.6; Figure 3.8). The presence of SM in 
tears and meibum has been extensively reported (Borchman et al, 2007b) and 
characterized (Ham et al, 2006; Saville et al, 2010; Saville et al, 2011; Lam et al, 
2011). We expanded the list of 14 individual SM species in human tears from that of 
Saville et al (2010) to include additional species such as SM18:1/16:1, SM18:1/18:1, 






Table 3.1. An overview of major lipid classes in human tears. Values were presented as the percent of 
total lipids measured. Comparisons were made only with selected recent studies on human tear lipidomes 
derived using mass spectrometry. 
















CE +a + - - - 44.82 
WE +a + - - - 35.21 
TAG + + - 5.1 - 2.84 
DAG + + - - - 0.30 
Cho - + - +c - 5.94 
Sphingo-
lipids 
SM + - +b 3.0 + 1.50 
Cer - - - 3.0 - 0.26 
GluCer - - - - - 0.003 
GM3 - - - - - 0.01 
S1P - - - - - 0.0001 
Phospho-
lipids¥ 
PC + - +b 70.6 + 2.96 
PE - - - 17.6 -d 1.99 
PS - - - 0.3 -d 0.57 
PA - - - - - 0.14 
PI - - - - - 0.76 
PG - - - - - 0.008 
LBPA - - - - - 0.03 
Others OAHFA - - - - - 2.52 
 CS - - - - - 0.14 
a: Undetectable using mass spectrometry but presence indicated via thin-layer chromatography. 
b: Amount of total SM approximately equal to total PC detected in tears. 
c: Detected using thin-layer chromatography; estimated to be approximately twice of TAG in abundance. 
d: Below the limit of detection in their study.   
+ Detected but relative abundances were not reported; - Not detected. 
¥ Values presented were sum of diacyl- and lyso-phospholipids. 
 
The lipid composition of tear fluid derived from the pooled patient sample 
has also been validated in individual Schirmer’s samples from a cohort of 28 DES 
patients with a reasonable range in individual DES clinical indicators, including the 
tear breakup time, Schirmer’s type I length, modified ocular surface disease index 
(OSDI) and Baylor score for corneal staining (Supplementary Material 3.3; Figure 
3.7). The lipidomic composition of tear fluids displayed a striking overall consistency 
even for samples with very low wetted lengths (i.e. 0-3 mm), demonstrating the 
sensitivity of our analytical methods and the feasibility of our protocol to be 
translated for use in dry eye clinics for large-scale analysis of tear samples from 
severe DES patients with significantly impaired lacrimal function. More importantly, 
a major merit of our analytical approach lies in fact that all the reported lipids were 
analyzed within a simple analytical workflow that does not necessitate additional 
steps of sample preparation nor lipid enrichment.  
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3.3.2.2 Various classes of lysophospholipids were detected in human tears 
 
Figure 3.7. Single-stage ion spectra for selected classes of polar lipids in tears. Selected polar lipid 
classes including (A) LPC; (B) LPS; (C) LPA; (D) LPE; (E) PE; (F) PC and (G) LBPA were illustrated. 
Accurate masses of major species from each lipid class were shown. Ion spectra were obtained using the 
LTQ Orbitrap XL with normal phase LC-separation. 
 
Of particular relevance to tear film structural integrity, a diverse range of amphiphilic 
lipid compounds was detected, including various classes of phospholipids and their 
lyso-forms. In accordance with Rantamäki et al and Dean et al, lysophospholipids 
formed a major proportion of the phospholipid pool (Figures 3.6-3.7). Nevertheless, 
our results showed that the diacyl-forms of most phospholipid subclasses were found 
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in higher levels than their lyso-forms, with the exceptions of the subclasses of PS and 
PE (Figure 3.6; Table 3.2).  
 
Figure 3.8. Single-stage ion spectra obtained using the Orbitrap. The ion spectra were obtained using 
single-stage scan with normal phase LC-separation for (A) CS, (B) OAHFA and (C) SM. Accurate 




Figure 3.9. Heatmap illustrating the lipid profiles of all lipid species analyzed in 28 individual 
human tear samples from dry eye patients. Values were plotted as log10 of mole fraction of 
individual lipid species. It was observable that the lipid profiles were generally reproducible even in 
samples with very low Schirmer’s score (<5mm). One anomalous sample of relatively high Schirmer’s 
length displayed unusually low levels of polar lipids that might be related to disease pathology. The 
overall consistency in lipid profiles validated the sensitivity and reproducibility of our analytical 
approach even for samples with very low amount of tears.  
 
 
Our analysis of the human tears, however, indicated that lyso-PE, instead of 
lyso-PC as reported by Rantamäki et al and Dean et al, dominated the polar lipid 
fraction (Figure 3.6). Furthermore, lyso-PS were found in comparable quantities to 
lyso-PC (Figure 3.6; Table 3.2), which consisted predominantly of three distinct 
species, namely LPS16:0, LPS18:0 and LPS18:1 (Figure 3.7), which were different 
from the unusual species (LPS19:3; LPS20:2) earlier reported (Rantamäki et al, 2011). 
This is also in contrast to earlier studies which reported that serine-containing 
phospholipids were of negligible quantities (Rantamäki et al, 2011; Dean et al, 2012). 
This apparent disparity might possibly be due to the usage of only ESI positive mode 
in the analysis of tears by Rantamäki et al, as PS species ionize preferentially in the 
negative mode. On the other hand, while Dean et al have employed neutral loss scan 
(NLS) in the negative mode for analysis of PS, they did not detect appreciable 
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amount of PS in tears, which was possibly due to insensitive methodology (Limit Of 
Detection, 12 ng/µL). The lack of column separation in the method used by Dean et 
al (2012), coupled with the complex pool of phospholipids inherent in tear samples 
might have also significantly suppressed the ionization of PS species. Indeed, Ham et 
al (2006) found significant quantities of PS in dry eye rabbit tears but not in normal 
tears using matrix-assisted laser desorption ionization (MALDI)-TOF-MS (Ham et al, 
2006). In our study, however, serine-containing phospholipids, in particular lyso-PS, 
constitute a considerable proportion of the lysophospholipid pool in the tears of both 
dry eye patients and normal subjects.  
Consistent with Rantamäki et al and Dean et al, LPC16:0 represents the most 
abundant lyso-PC species in human tears (Figure 3.7; Figure 3.10), other major PC 
species include PC34:1, PC34:2 and PC36:2. Also in agreement with Rantamäki et al, 
we detected appreciable quantity of PE and lyso-PE in human tears collected using 
the Schirmer’s strips in both pooled (Figure 3.6) and individual samples (Figure 3.9). 
This is in contrast with that reported by Saville et al (2010) and Dean et al (2012) 
who reported PE to be lower than the limit of detection in their analyses. We 
postulate that in addition to the limiting concentration of PE in tears, the use of 









Table 3.2. The relative abundance of individual classes of lipids in the human tears and meibum. 
Values were present as percentage molar fraction (normalized to total lipids). The lipid profiles were 
obtained using pooled samples of Schirmer’s tears and meibum collected from dry eye patients.   
 Percent (%) Tear Meibum 
Neutral Lipids TOTAL CE 44.8175 49.2656 
TOTAL WE 35.2106 43.0449 
TOTAL FREE CHO 5.9397 1.5566 
TOTAL CS 0.1400 0.2778 
TOTAL TAG 2.8387 2.3849 
TOTAL DAG 0.2978 0.0317 
 TOTAL OAHFA 2.5170 2.8754 
Lyso-
glycerophospholipids 
TOTAL LPC 0.4937 0.0242 
TOTAL LPS 0.4632 0.0162 
TOTAL LPA 0.0655 0.0012 
TOTAL LPI 0.0453 0.0037 
TOTAL LPE 1.2935 0.0412 
Glycerophospholipids TOTAL PC 2.4687 0.2004 
TOTAL PS 0.1104 0.0104 
TOTAL PA 0.0771 0.0071 
TOTAL PI 0.7165 0.0439 
TOTAL PE 0.6974 0.1341 
TOTAL PG 0.0079 0.0013 
TOTAL LBPA 0.0291 0.0024 
Sphingolipids TOTAL SM 1.4967 0.0594 
TOTAL CER 0.2582 0.0162 
TOTAL GLUCER 0.0032 0.0003 
TOTAL GM3 0.0123 0.0011 





Figure 3.10. Comparison of polar lipid profiles between tears and meibum. Lipid profiles were 
obtained from pooled samples of Schirmer’s tears (n=8) and meibum (n=7), respectively. Values were 
plotted as log
10
 of the mol fraction of individual species, and a value of -9 indicates undetectable in the 
respective samples. The tear fluid is significantly enriched in phospholipids and sphingolipids compared 




Figure 3.11. Comparison of non-polar lipid profiles between tears and meibum. Lipid profiles were 
obtained from pooled samples of Schirmer’s tears (n=8) and meibum,(n=7) respectively. Values were 
plotted as log
10
 of the mol fraction of individual species, and a value of -9 indicates undetectable in the 
respective samples. The lipid profiles of (A) CE, CS, free Cho; (B) WE; (C) TAG; were largely similar, 






3.3.2.3 Quantitative corrections of major neutral lipid classes in tears and 
meibum  
Consistent with previous reports (Borchman et al, 2007b; Butovich, 2008), CE and 
WE were unambiguously detected in human tears as the predominant non-polar lipid 
classes in our study. This is in stark contrast to the tear lipidome earlier reported 
(Rantamäki et al, 2011), which showed a complete absence of CE and WE despite a 
noticeable band corresponding to CE in TLC. A notable analytical advancement in 
our current study is the quantitative corrections of the proportions of WE and CE in 
the human tears and meibum (See Section 3.2.7). Using our improved approach 
incorporating in-house synthesized 13C-labelled WE as internal standards, we found 
that WE constitute approximately 43% of the total lipids in the human meibum (Table 
3.2), which is in excellent agreement with a recent value (40+10% (wt/wt)) 
determined by GC/MS (Butovich et al, 2012). Furthermore, we have detected and 
characterized the comprehensive profile of DAG species in human tears (Figure 3.11), 
which were in appreciably higher levels than that in human meibum (Table 3.2). This 
class of compounds corresponded to an earlier preliminary observation stating that 
the human tears contained a new range of compounds with higher polarity than the 
non-polar components of meibum that co-eluted with authentic DAG (Butovich, 
2008). On the other hand, Ham et al (2004) have also previously reported the 
presence of a few DAG species, such as DAG16:0/16:0 and DAG 16:0/18:0, in the 
human tears (Ham et al, 2004).  
 
3.3.3 Validation of Schirmer’s strip method of tear collection  
In order to ensure that tears collected using Schirmer’s strips represent an accurate 
reflection of the dynamic lipid microenvironment at the ocular surface we considered 
a few key issues: (1) What is the lipid background in the paper strip per se? (2) To 
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what extent does the strip act as a chromatographic system? (3) Does the portion of 
tears captured by the strip represent a true reflection of the concentrations of lipid 
metabolites in the tear reservoir?  Collectively, we found that the first three 5-mm 
segments of the wetted strip area (regardless of total wetted length) were sufficient to 
provide a tear lipidome that was reflective of the actual lipid compositions in the tear 
reservoir with negligible background interferences). The Schirmer’s strip method of 
tear collection is thus suitable for use in lipid analysis (see below).  
 
3.3.3.1 Lipid distribution and background noise along the wetted length of the 
Schirmer’s strip 
The wetted portions of the Schirmer’s strips were cut into 5 mm segments using 
micro-scissors pre-washed with methanol to remove any residual contaminating lipids. 





Figure 3.12. Schematic diagram illustrating the procedures for validating and comparing different 
tear collection techniques. Schirmer’s tears collected from four volunteers on two separate occasions 
were used to validate the gradient of lipid metabolites along the wetted length of the strips. Briefly, the 
wetted portion of each strip was cut into 5mm segments and lipid extractions were carried out on 
individual segments. The segment before the notch of the Schirmer’s strip, which was not taken into 
account during the measurement of the Schirmer’s length, was denoted the -5-0mm segment. The 
representative lipidome of Schirmer’s strip-collected tears from normal volunteers was compared with 




Table 3.3. Summary of the percentages of the major classes of tear lipids detected in the first three 
segments of the strips relative to the amounts along the entire length of the wetted portions. 
 Segment  -5-0 Segment 0-5 Segment 5-10 Percent of Total in 
first 3 segments 
TOTAL CE 57.07 33.13 4.09 94.29 
TOTAL WE 52.93 30.33 5.21 88.47 
TOTAL 
OAHFA 
53.12 32.58 5.78 91.48 
TOTAL PC 66.11 8.14 6.57 80.82 
TOTAL CER 62.68 9.39 7.32 79.39 
TOTAL SM 74.60 8.58 4.67 87.85 
TOTAL PS 65.50 8.35 7.87 81.72 
TOTAL PI 73.47 5.44 5.47 84.38 
 
It was found that lipids were concentrated in the first two segments of the 
strip, with the -5-0 mm segment, which is in direct contact with the conjunctiva 
during the collection process, having the highest abundance of all lipid classes (Table 
3.3). The blank Schirmer’s strips gave rise to relatively low background noise in the 
mass spectrometric analysis of the individual lipid classes (Figure 3.13), and did not 
produce appreciable peak shapes in the mass spectra. This indicates that the strip 
materials did not contain the endogenous tear lipids and the Schirmer’s strips are 
suitable for collecting tears intended for lipid analysis. Therefore, in order to 
maximize the accuracy of our analytical results, we have chosen to extract and 
analyze lipids only from the first three segments (i.e. -5-10mm, Schirmer’s 
length=10mm) of the strips regardless of the actual length of the entire wetted portion, 
as it is apparent from our preliminary analyses that lipids, especially the non-polar 
lipids such as CE and WE, do not travel along the strips as efficiently as the aqueous 
portion of the tears. This approach could minimize the level of background noise 
presented by the strip materials without significantly compromising the extraction 
efficiency of the endogenous tear lipids, as the first three strip segments contained at 
least 80% of all lipids along the entire wetted area (Table 3.3). Furthermore, lipid 
extraction from a fixed length of the strip could standardize the background noise in 
individual samples for unbiased comparison of endogenous lipid levels between 
samples. Also, the region of Schirmer’s strips furthest away from the notch of the 
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papers might have unavoidably contacted with facial skin during the collection 
process, especially for subjects with longer Schirmer’s lengths. Thus, possible 
contamination with skin lipids could also be minimized by considering only the first 
three 5 mm segments of the strips.  
 
 
Figure 3.13. The distribution of major classes of non-polar and polar lipids along the entire length 





3.3.3.2 Uniform (non-selective) capture of different lipid classes by Schirmer’s 
strip 
In order to investigate if the Schirmer’s strips captured lipids in a manner that reflects 
the actual concentrations of lipids from the respective classes in the tear reservoir, a 
lipid cocktail consisting of different lipid standards with concentrations that 
approximate the relative abundances of individual lipid classes in the human tears 
was dried under pure nitrogen gas. The dried samples were then reconstituted in 
phosphate buffered saline and diluted to create different concentrations of “artificial 
tear lipids”. Schirmer’s strips were placed in glass vials containing varying 
concentrations of the artificial tear lipids for five minutes and lipid extraction and 
mass spectrometric analyses were subsequently carried out on the first three 5 mm 




Figure 3.14. Plots of raw intensities detected in the first three 5-mm segments of the strips against 
the relative concentrations of lipid standards used. 
 
An approximately linear relationship was observed between the raw 
intensities of individual lipid standards and their relative concentrations in the 
reconstituted lipid mixture (Figure 3.14), implying that Schirmer’s strip-collected 






3.3.4 Comparisons of tear lipidomes obtained using different collection 
techniques  
As it has been documented that conflicting reports on the clinical biochemistry of 
tears could be attributed to differences in specimen collection (e.g. Schirmer’s strips 
or capillary tubes) (Van Haeringen, 1981), we next investigated the quantitative and 
qualitative differences in tear  lipids collected using different techniques. Thus far, 
only preliminary statements have been made on the generally similar lipid profiles 
between tears collected using Schirmer’s strips and capillary tubes, but no detailed 
comparison has been conducted (Butovich, 2008). We systematically compared the 
different clinical techniques for tear collection based on the quantity and composition 
of lipids captured (Figure 3.12). The Schirmer’s method of tear collection generally 
captures the highest absolute amounts of lipids (Figure 3.11). CE and WE were found 
to be the predominant non-polar lipid classes and PC was the major polar lipid 
fraction in all three collection procedures (Figures 3.16-3.17). Higher levels of all 
lipid classes (except GM3) in tears collected using Schirmer’s strips could be 
attributed to overall greater amount of tears collected with this method. The enhanced 
detection of specific lipid classes under an overall limiting absolute concentration of 
total lipids in capillary-collected tears could be attributed to the different limits of 
detection using MRM for the various lipid classes. We found no appreciable 
differences in lipid composition of tears collected using capillary without saline flush 
from that with saline flush (apart from the lower absolute amounts of lipids in the 
latter), which is in good agreement with a previous study that reported an essentially 
similar tear proteome using the two methods (Markoulli et al, 2011). 
On the basis of the similar tear lipid profiles collected using the three 
methods, we adopted the Schirmer’s method for subsequent tear analysis in our 
clinical cohort primarily due to the overall greater absolute amounts of tear lipids that 
this method could capture. Furthermore, the Schirmer’s method is a routine clinical 
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procedure in dry eye clinics and could be performed with relative ease. Aside from 
providing tear samples for analysis, the Schirmer’s method of tear collection also 
confers additional clinical information pertaining to the ocular health status of 
subjects compared to the capillary method. (i.e. lower Schir I implies impaired tear 
secretion). 
 
Figure 3.15. The molar concentrations of lipids collected in each sampling technique. Molar 
concentrations of (A) total lipids and major classes of non-polar lipids such as (B) CE; (C) WE and (D) 
free Cho; and major classes of polar lipids such as (E) LPS and (F) PC were all found in significantly 
higher levels in tear samples collected using the Schirmer’s strips (n=10) than that collected using 
capillary tubes with (n=5) or without (n=5) saline flush. The Schirmer’s strip method of tear collection is 
thus most desirable in capturing the greatest amounts of lipids from individual eye for comprehensive 
lipidomic characterization and subsequent biomarker derivation. Mean values were plotted. Error bars 
indicate standard errors of the means. ST: Schirmer’s tears; CT: capillary tears; CT saline: capillary tears 








Figure 3.16. Heatmaps illustrating the levels of individual polar lipids species in different types of 
tear samples. CST: Combined Schirmer’s Tears (n=8); CM: Combined Meibum (n=7); ST: Schirmer’s 
Tears (mean of n=10); M: Meibum (mean of n=5); CT: Capillary Tears (mean of n=5); CT saline: 
Capillary Tears with saline flush (mean of n=5). Values were presented as log10 absolute (molar) 







Figure 3.17. Heatmaps illustrating the levels of individual species of non-polar lipids in different 
types of tear samples. CST: Combined Schirmer’s Tears (pool of n=8); CM: Combined Meibum (pool 
of n=7); ST: Schirmer’s Tears (mean of n=10); CT: Capillary Tears (mean of n=5); CT saline: Capillary 
Tears with saline flush (mean of n=5). Values were presented as log10 of absolute (molar) concentration 




3.3.5 Enrichment of polar lipids in tears compared to meibum 
Our current analysis of the tear lipidome revealed that phospholipids comprise a 
substantial amount (approximately 6%) of the total tear lipids. On the other hand, the 
detection of considerable amount of CS in the tear fluid (approximately 0.14%) has 
introduced a novel, hitherto unknown amphiphile to the tear film (Figure 3.18). 
Furthermore, CS (p<0.001) and OAHFA (p<0.05) represent the only lipid classes that 
were positively correlated with TBuT, which is a proximal measure of tear film 
stability after blinking (See Section 4.3.1: Figure 4.4). 
Figure 3.18. Tear -film model. The tear film lipid layer comprises the superficial sublayer consisting 
predominantly of non-polar lipids and an inner, amphiphilic sublayer, which facilitates the interaction 
between the polar and non-polar components of tears. The composition of the amphiphilic lipid sublayer 
has remained a matter of contention (Dilly, 1994; Butovich, 2009b). Our global lipidomic analysis 
has introduced cholesteryl sulfate as a novel candidate for the amphiphilic sublayer. Other possible 
amphiphilic lipid candidates were also listed. Percent abundances of respective lipid classes were 
presented in parentheses. Figure is not drawn to scale. CE: cholesteryl esters; WE: wax esters; TAG: 
triacylglycerides; DAG: diacylglycerides; free cholesterols (Free Cho); O-acyl--hydroxy-fatty acids 






3.3.6 Quantitative profiling of wax esters in human tear fluid 
The developed LC-MRM method for WE was applied for analysing human tear 
samples. I have previously reported human meibum WE composition using HPLC-
SIM-MS method (See Chapter 2) (Lam et al, 2011). While it is well-established that 
the predominant source of WE in human tears is the meibum (Lam et al, 2011), the 
precise composition of tear WE is not yet known. In this study, for the first time, I 
have applied sensitive HPLC-MRM approaches developed for direct measurement of 
WE molecular species inherent in human tears. MRM transitions of a total of 141 WE 
molecular species were established based on tear WE profiles (Figure 3.19). 
Quantitative analysis indicated that oleic acid-containing (FA18:1) WE are most 
abundant, which account for 47.7 % of total WE present, while WE comprising 
palmitic acid (FA16:1), FA18:2 and FA17:1 account for 24.03 %, 10.47 % and 10.10 % 
of total WE amount, respectively (Figure 3.19). In addition, other minor species 
include FA 16:2 (3.53 %) and FA20:1 (1.91 %) (Figure 3.19). While fatty alcohol in 
the WE of human tears ranged from 17 carbons to 32 carbons, C24, C25 and C26 
fatty alcohols represent the predominant species. These observations are consistent 
with previous findings of WE molecular compositions in meibum (Chen et al, 2010; 
Lam et al, 2011; Butovich et al, 2009). Our comprehensive analysis of WE molecular 
species demonstrated that the human tear lipidome comprises a myriad of WE 
molecular species with distinct combinations of fatty acids (C15-C20) and fatty 
alcohols (C15-C32), as well as varying degree of unsaturation. The structural 
diversity of WE, the predominant lipid class in the human tear lipidome, would be 
crucial in ensuring the proper physiological function and maintaining biophysical 
integrity of the tear film. A comprehensive elucidation of the tear lipidome, in 
particular WE, is thus imperative to unravel the complex biophysical properties of the 






Figure 3.19. Compositional profiles of wax esters in human tear classified according to fatty acid 
groups, including multiple reaction monitoring transitions (MRM) used for the detection and 





3.4.1 Physiological implications of the tear lysophospholipidome 
In considering the possible physiological functions of the novel lipids detected in the 
human tears, it is important to reckon the unique biochemistry at the ocular surface 
and the critical importance of ocular homeostasis in maintaining precise vision. 
Valuable insights can be drawn from the tear fluid proteome, of which bactericidal 
proteins such as lysozyme, lactoferrin and lipocalin form the bulk constituents (Zhou 
et al, 2012). In line with this, lyso-PC has been reported to increase the bactericidal 
activity of neutrophils (Yan et al, 2004), while lyso-PE have been shown to possess 
antifungal and antibacterial activity in housefly (Meylaers et al, 2004). Therefore, the 
physiological significance of the tear lysophospholipidome seems to coincide with 
that of the tear proteome, which comprises a predominance of metabolites with 
microbicidal properties. 
Being constantly exposed to pathogenic insults, the ocular surface epithelium 
also forms a physical barrier and serves as a first line defense against the external 
environment (Ueta, 2008). The delicate visual axis that confers visual acuity is 
extremely vulnerable to the destructive potential of immunogenic inflammation 
(Streilein, 2003), therefore the timely resolution of inflammation to restore tissue 
normalcy after an immunogenic event is critical for protecting the cornea from 
collateral tissue damage in ensuring healthy ocular homeostasis. Our in-depth 
analysis of tear lipidome has demonstrated lyso-PS to be a considerable 
lysophospholipid fraction, with the level of lyso-PS being comparable to that of lyso-
PC. This is rather unusual and unique to the tear lipidome, as lyso-PC have been 
found to be in considerably higher abundance than lyso-PS in both plasma (Makide et 
al, 2009) and rabbit aqueous humor (approximately 50-fold in normal rabbit eyes) 
(Tokumura et al, 2012). Thus, the exceptionally high abundance of lyso-PS in tear 
lipidome suggests active ocular synthesis and enrichment rather than merely being 
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residual artefacts from plasma ultrafiltrate, and it is thus likely that lyso-PS elicit 
physiological functions critical for ocular homeostasis. Of interest to the ocular 
milieu biochemistry, lyso-PS have been suggested to elicit unique signalling 
characteristics crucial in orchestrating resolution of acute inflammatory events 
(Frasch et al, 2012). In particular, LPS18:0 and LPS18:1 have been identified as the 
key modified PS species following neutrophil oxidase activation that facilitated the 
optimal resolution of neutrophilic inflammation (Frasch et al, 2008). Incidentally, 
LPS18:0 is also a predominant lyso-PS species found in our current analysis of the 
tear lipidome, which accounted for more than 90% of the total ion counts for all lyso-
PS species detected. 
 
3.4.2 Biophysical relevance to tear film model 
Our comprehensive and comparative lipidomic profiling of human tears and meibum 
has furthered the current understanding of the existent human tear film model. The 
longstanding perception that phospholipids serve as an amphiphilic layer of the tear 
film lipid layer has been recently challenged due to the ambiguous occurrence of 
phospholipids in human meibum, the predominant source of lipids for tears (Butovich, 
2009b; Lam et al, 2011). Based on the considerably low abundance of phospholipids 
in the human meibum, Butovich (2009b) has proposed that OAHFA, the most 
abundant polar lipid class in the meibum, might comprise the amphiphilic lipid 
sublayer of the tear film instead. The significant enrichment of phospholipids and 
sphingolipids in the human tear fluid compared to the meibum therefore has 
important implications for our understanding of tear film physiology. Our current 
analysis of the tear lipidome revealed that a surplus of phospholipids is available in 
tears (approximately 6% of the total tear lipids) (Figure 3.14) to constitute the tear 
film amphiphilic lipid sublayer, therefore providing new insights pertaining to the 
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tear film composition and biophysical structure especially with regard to the 
components of the amphiphilic sublayer, which has largely remained a matter of 
contention.  
 Nonetheless, it is important to also recognize the critical structural functions 
that OAHFA might elicit at the ocular surface. In particular, OAHFA and CS are the 
only lipid classes that displayed significant positive correlations to tear film stability 
measured by TBuT in our study. OAHFA might therefore exert critical physiological 
functions at the ocular surface despite their relatively lower abundance in tears 
compared to phospholipids. This is also in accordance with our earlier observation 
based on analysis of human meibum that decreasing amounts of OAHFA were 
observed for patients with increasing DES severity (see Chapter 2). 
On the other hand, the detection of an appreciable level of CS in the tear fluid 
has added a novel candidate for the tear film amphiphilic lipid sublayer. CS have 
been shown to interact with phospholipids in a manner akin to cholesterols, inducing 
hydrocarbon ordering in lipid bilayers and stabilizing model membranes (Kitson et al, 
1992). Moreover, under physiological conditions, the sulfate moiety of CS is ionized, 
converting CS from a relatively hydrophobic molecule into a highly amphiphilic 
compound comprising a highly charged headgroup (Bleau et al, 1974). While the 
physiological significance of CS in tears is presently obscure, CS represents a suitable 
candidate for the amphiphilic sublayer of the tear film based on its biophysical 











Chapter 4. Cross-sectional Case/Control Study: Tear Lipid 






























DES represents one of the most frequently encountered ocular morbidities in the 
United States, with nearly five million Americans over 50 years and above being 
affected, and tens of millions more having milder symptoms or episodic 
manifestations of the disease subjecting to external environmental trigger (DEWS, 
2007b). Despite its prevalence, there is presently no universal consensus on the 
diagnostic guidelines for the disease (Savini et al, 2008). Current clinical tests lack 
reproducibility and are not sufficiently predictive of symptomatology to facilitate 
effective disease diagnosis and prognosis (Sullivan et al, 2012). A pressing concern 
exists to develop DES activity markers that closely align with the principal axes of 
disease progression, for replacing current diagnostic indicators lacking in both 
sensitivity and specificity.  
 In essence, DES is a multifactorial disease largely characterized by 
perturbations in the lacrimal functional unit (LFU), which is an integrated system 
comprising the lacrimal glands, ocular surface (cornea, conjunctiva and meibomian 
glands) and the lids, as well as the sensory and motor nerves that connect them 
(DEWS, 2007a). Tear film instability represents a hallmark feature of DES, which 
occurs when the interactions between stabilizing tear constituents are compromised 
by reduced tear secretion, impeded tear clearance, and/or alterations in tear 
compositions.  Tear secretion and clearance from the lid reservoir are thus critical 
physiological processes in ensuring a constant supply of fresh tear components 
essential for maintaining healthy ocular homeostasis and tear film stability. In 
addition, aging is associated with physiological modifications (e.g. reduced tear 
volume and flow, compositional changes in meibomian lipids) that may lead to an 
increased occurrence of DES (DEWS, 2007a). In particular, with advancing age, 
there is increased incidence of ductal pathology that could promote both lacrimal and 
meibomian gland dysfunction via its obstructive effects, thereby adversely affecting 
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the two predominant contributing sources of the human tear fluid. Examples of ductal 
pathological aberrations include periductal fibrosis, interacinar fibrosis, ductal 
hyperkeratinisation and acinar cell atrophy. Very often, ocular inflammation is a 
secondary consequence of tear film instability that signifies a more advanced and 
severe form of DES (DEWS, 2007a). 
 Aqueous-deficient dry eye and evaporative dry eye are currently recognised 
as the two major subclasses of dry eye. Aqueous-deficient dry eye is principally due 
to a failure of lacrimal secretion, and to a smaller extent, a failure of the conjunctiva 
in secreting water. On the other hand, evaporative dry eye can arise from either 
intrinsic (i.e. meibomian gland dysfunction) or extrinsic causes (See Section 1.4). 
These major dry eye subtypes are non-mutually exclusive, and dry eye can be 
initiated by either of these classes. Furthermore, each subtype of dry eye can co-exist 
with or even lead to the other (DEWS, 2007a).  
We applied the analytical approach developed for human tear lipidomics 
reported in Chapter 3 to a clinical cohort of 93 subjects in order to elucidate the 
pathophysiological changes in lipid homeostasis associated with DES. Subjects were 
categorized into patients, risks and controls based on a combination of dry eye 
symptoms (OSDI) and disease signs (TBuT and Schir I). In order to derive lipid 
perturbations that coincide with the principal axes of disease pathogenesis, lipid 
correlates with DES-related physiological processes as abovementioned (i.e. aging, 
tear secretion and drainage) were also reported.  In addition, tear lipid correlates with 
clinical tests currently used for dry eye diagnosis, such as the Baylor’s score for 





4.2 Materials and Methods 
4.2.1 Clinical cohort and study design 
For dry eye biomarker evaluation, a total of 93 subjects were recruited from SNEC 
clinics. Symptomatic patients were recruited from dry eye clinic while age-matched 
control subjects who did not exhibit dry eye symptoms were recruited from glaucoma 
clinic. Detailed demographic information for the study group can be found in the 
appendices (Supplementary Material 4.1).  Written informed consent was obtained 
from all participating subjects and the procedure for the project was specifically 
approved by the SingHealth Centralised Institutional Review Board (CIRB Reference 
No: 2008/611/A). We adhered to the tenets of the declaration of Helsinki for all 
human research conducted in this study. The detailed clinical procedures had been 
reported in Section 2.2.3 (Lam et al, 2011).  
 Patients were defined as subjects having appreciable ocular symptoms of 
DES with OSDI >12.9, which were further sub-divided into aqueous-deficient (AqD) 
and non-aqueous deficient (non-AqD) based on Schir I (cut-off = 5.5 mm). Amongst 
asymptomatic subjects, individuals with tear film instability were identified as at risk 
of developing DES based on TBuT (cut-off = 5 secs).  Individuals at risk of 
developing DES were also categorised into subgroups of AqD and non-AqD. Lastly, 
asymptomatic individuals with no signs of tear film instability were defined as 
healthy controls (Figure 4.1). The cut-offs for individual clinical tests were adopted 
from the report of the diagnostic methodology subcommittee of the International Dry 




Figure 4.1. Clinical classification of study cohort. Schematic diagram illustrating the stratification of  
subjects into various clinical groups. 
 
4.2.2 Statistical Analysis 
Correlation analyses between lipid levels in tears and meibum and common dry eye 
clinical indicators were carried out using the partial correlation. Correlation between 
individual lipid species/classes with the respective DES clinical parameter was 
performed while controlling the effects of all other clinical parameters investigated 
(i.e. Schir I, TBuT, Baylor, OSDI, age, gender). Eclipse demarcates 95% confidence 
region of correlating parameters and lipid species/classes. The levels of various lipid 
classes and species in different clinical subgroups were compared against the control 
subgroup using one-way ANOVA with post hoc Dunnett’s test. False discovery rate 
was controlled for based on q-values calculated using R 3.0.1 (Supplementary 
Material 4.5). Compositional changes in lipid levels amongst subgroups with 
different total lipid amounts were compared using one-way ANOVA with post hoc 
TukeyHSD test. Receiver operating characteristic curves were plotted using the 





4.3.1 Tear lipid correlates with dry eye clinical parameters 
Aging is known to associate with physiological changes that predispose individuals to 
DES, such as lower tear film stability and compositional alterations in meibum 
(DEWS, 2007a). We found the entire class of OAHFA to be positively correlated 
with increasing age (Figure 4.2A). Several individual species of OAHFA in tears 
were also positively correlated with age (Figure 4.3A-B). On the other hand, several 
PUFA-containing phospholipids were decreased with increasing age, including both 
diacyl and ether/plasmalogen species (Figure 4.2A; Figure 4.3C), which might be 
indicative of increased oxidative stress with advancing age, in corroboration with the 
previously reported enhanced oxidation in meibum (based on the ratio of aldehydes to 
hydroperoxides) with age (Borchman et al, 2012c). Remarkably, the levels of oleic 
acid (FA18:1)-based WE were elevated with increasing age, with several individual 
oleic acid-containing species exhibiting similar upward trends (Figure 4.2A; Figure 
4.3D). Since oleic acid-based species represent the major WE species in tears (Figure 
4.7B), increased levels of such species are expected to alter the composition and 
nature of tear lipids considerably. The finding is in agreement with separate studies 
on human meibum using infrared spectroscopy and nuclear magnetic resonance 
spectroscopy, in which the authors reported an increase in double bonds in meibum 
with age (Borchman et al, 2010b; Borchman et al, 2010a), and a resultant decrease in 
hydrocarbon chain order (decreased viscosity) with advancing age (Borchman et al, 
2010a). The increase in lipid disorder probably represents a natural phenomenon of 
aging, facilitating meibum outflow and its subsequent spreading across the ocular 





Figure 4.2. Association between tear lipid levels and dry-eye associated physiological processes. (A) 
Correlations between selected classes/species of tear lipids with age. OAHFA were positively correlated 
with age, while several highly unsaturated PE species were negatively correlated. Oleic acid-based wax 
esters, WE (FA18:1), were positively correlated with age with marginal significance. (B) Positive 
correlations were found between CS, GluCer, GM3 and LPC with the Schirmer’s length (type I) that 
provides a surrogate measure of lacrimal reflex response. (C) Absolute levels of total lipids and molar 
fractions of PA and PG were negatively correlated with Schir I, which might be associated with afflicted 
lipid clearance from the lid reservoirs under an overall aqueous-deficiency. Eclipse demarcates 95% 
confidence region of the correlating parameters.   
 
The Schir I test provides a proximal measure of total tear secretion (basal and 
reflex) (Savini et al, 2008), a physiological process instrumental in determining DES 
onset and progression. The normalized levels of CS, GluCer, GM3 and LPC were 
positively correlated with Schir I (Figure 4.2B), indicating that the release of these 
lipids is elevated with increased tearing. In addition, contrary to other lipid classes 
found in tears, absolute concentrations of CS, GluCer, GM3 and LPC were not 
appreciably increased as tear secretion decreases (Figure 4.4B, Supplementary 
Material 4.2), implying the possible non-Meibomian origin of these lipids. These 
amphiphilic lipids possibly originated from the lacrimal glands and might represent 
suitable indicators of lacrimal function.  
In contrast to the CS, GluCer, GM3 and LPC that exhibited positive trends 
with increasing tear secretion, the absolute concentrations (molml-1) of total lipids 
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displayed a significantly decreasing trend with increasing Schir I (Figure 4.2C). The 
higher lipid level with low Schir I is consistent with earlier work, which noted 
increased casual lipid levels at the lid margin with aqueous deficiency (Yokoi et al, 
1999).  This might be attributed to an afflicted lipid clearance with reduced tear flow, 
as no known reflex control of meibomian gland secretion has been reported thus far 
(Bron et al, 2004). In particular, molar fractions of PA and PG were negatively 
correlated with Schir I (Figure 4.2C), and found in significantly higher levels (p<0.05) 
in aqueous-deficient patients (i.e. Schir I <10mm) than normal subjects. The 
enhanced levels of specific phospholipid classes might be associated with 
modifications by various ocular surface enzymes, such as phospholipases, due to the 
prolonged stagnation of tear lipids at ocular surface and lid reservoir under an overall 
aqueous-deficiency (AqD).  
 
Figure 4.3. Correlation scatter plots illustrating individual lipid species from various classes that 
exhibited statistically significant correlations to age. (A-B) Various species of O-acyl-ω-hydroxy fatty 
(OAHFA) acids displayed significant positive correlations to age; while (C) several poly-unsaturated 
phospholipids showed significant negative correlations to age. (D) Species of wax esters containing 
oleic-acid (FA 18:1) as the fatty acid moieties were positively correlated with age. Only lipid species 
demonstrating statistically significant (p<0.05) correlations with the respective clinical parameters were 




Figure 4.4. Heatmaps illustrating the correlations between lipid levels in tears with dry-eye 
associated clinical parameters including the Schirmer’s length (Schir I), tear breakup time 
(TBUT), modified ocular surface disease index (OSDI) and Baylor’s score for corneal staining. 
Correlation coefficients were plotted with red indicating a positive correlation and blue indicating a 
negative correlation. Statistical significance was denoted by the respective symbols. Correlations 
between (A) normalized levels and (B) molar concentrations of lipid classes with clinical parameters, 
respectively. The correlations between normalized levels of individual lipid species from selected lipid 
classes including (C) cholesteryl esters, (D) phosphatidylcholines, (E) phosphatidic acids and (F) 
phosphatidylglycerols were also presented. Individual species of PC, PA and PG were negatively 
correlated with Schir and TBUT; while positively correlated with OSDI and Baylor. The observed trend 
was consistent across the respective lipid classes, indicating that elevated levels of these species might 
be associated with dry eye disease pathogenesis. # 0.05<p<0.10; *p<0.05; ** p<0.01; *** p<0.001. 
 
4.3.2 Evaluation of pathophysiological changes in clinical subgroups 
4.3.2.1 DES-associated clinical parameters 
The patient, risk and control subjects were clearly segregated in terms of various 
ocular symptoms and signs, including OSDI, Schir I, TBuT, central corneal staining, 
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inferior region corneal staining as well as Baylor score (i.e. summed corneal staining) 
(Figure 4.5).  
 
Figure 4.5. The comparison of dry eye-associated clinical parameters between various clinical 
groups. (A) modified ocular surface disease index (OSDI); (B) Schirmer’s length (Schir I); (C) tear 
breakup time (TBUT); (D) central corneal staining; (E) inferior corneal staining; (F) Baylor’s score for 
corneal staining; (G) age and (H) total molar concentration of lipids detected in tears.  Symptomatic 
score was used primarily to define dry eye as symptoms represent the essence of the disorder for patients. 
As tear film instability manifests as an imitating event in all dry eye subtypes, TBuT was used to identify 
asymptomatic individuals at risks of developing the disease. 
 
Importantly, there was no age difference amongst the patient, risk and control 
groups in the current clinical cohort. In other to elucidate the early pathogenic events 
in DES development, it is essential to incorporate asymptomatic risk groups into our 
clinical design. We had chosen to define these “at-risk” individuals based on TBuT in 
our study design, as tear film instability is often regarded as the initiating event in 
certain forms of dry eye regardless of prior hyperosmolarity, and subtle degrees of 
tear film instability may predispose individuals to the downstream cascade of events 
leading to the development frank symptoms of dry eye (DEWS, 2007a). The “at-risk” 
114 
 
groups thus probably represent asymptomatic subjects with pathophysiological 
background favouring the development of the disease, and lipid aberrations in these 
groups possibly demarcate early and possibly causative events in disease 
development. Notably, no significant reductions in the absolute levels of lipids were 
observed in the tears of risk and patient subjects compared to controls. In fact, patient 
subjects appeared to have elevated levels of total lipids in tears compared to controls, 
albeit not of statistical significance (Figure 4.5). 
 
4.3.2.2 Overall changes in individual lipid classes 
No appreciable changes in individual classes of lipids were observed amongst the 
different clinical subgroups apart from the appreciably lower levels of CS (p<0.10) in 
AqD-patients and AqD-risk subjects (Figure 4.6).  The reductions in CS in AqD-
subjects regardless of DES symptom presentation (i.e. at-risk or patient subjects) is in 
agreement with our observation that CS was found to be positively correlated with 
lacrimal function as measured by Schir I (see Section 4.3.1).  The overall absence of 
appreciable changes in individual lipid classes in DES is not surprising, considering 
that DES is a multifactorial, progressive disease that is often not associated with 
severe phenotypes until the advanced stage of the disease, which is marked by acute 
and severe ocular inflammation (Knop et al, 2011). Furthermore, even species within 
the same lipid class (i.e. comprising similar functional groups) could exert distinct 
biological and biophysical functions due to their differing molecular masses as well 
as degrees of saturation. This is of particular physiological relevance to the tear lipids, 
which could elicit both biochemical and structural functions in maintaining the 




Figure 4.6. Comparison of the levels of lipid classes among various clinical groups. (A) Neutral 
lipids including waxes (WE), cholesteryl esters (CE), triacylglycerides (TAG), diacylglycerides (DAG), 
free cholesterols (Free Cho); (B) O-acyl-ω-hydroxy-fatty acids (OAHFA), cholesteryl sulfate (CS), and 
sphingolipids including sphingomyelins (SM), ceramides (Cer), glucosylceramides (GluCer), and 
monosialo-dihexosyl gangliosides (GM3); (C) phospholipids including phosphatidylcholines (PC), 
phosphatidylethanolamines (PE), phosphatidylserines (PS), phosphatidylinositols (PI), phosphatidic 
acids (PA), phosphatidylglycerols (PG) and lyso-biphosphatidic acids (LBPA); and (D) lyso-
phospholipids including lyso-PC (LPC), lyso-PE (LPE), lyso-plasmalogen PE (LpPE), lyso-PS (LPS), 






Figure 4.7. Structure-specific changes in wax esters with dry eye syndrome.  Wax esters were 
stratified into three categories based on molecular masses: low (490.5-588.6); medium (590.6-672.6); 
high (674.6-716.6). Pie-chart illustrates the relative abundances of wax esters categorized based on (A) 
molecular masses (i.e. low, medium and high) and (B) fatty acyl moieties in their structures. (C) 
Heatmap illustrates changes in the levels of individual wax ester species in various clinical categories 
compared to normal controls. Values were plotted as ratios of levels of individual wax ester species in 
the respective clinical categories to that in normal individuals. Red indicates an increase compared to 
normal while blue indicates decrease. (D) The levels of low molecular mass wax esters and those 
containing saturated acid moieties were negatively correlated with OSDI but positively correlated with 
both TBuT and Schir I. Subclasses of wax esters of (E) low molecular masses or those containing (F-H) 
saturated acid moieties were significantly reduced in symptomatic dry eye patients with or without 
aqueous deficiency (cutoff: Schir I < 5.5mm). R: Individuals at risk; R (AqD): Individuals at risk with 





4.3.2.3 Structure-specific alterations in tear wax esters in DES 
While the category of low molecular mass WE constitutes only a minor fraction 
(approximately 7%) of the total waxes (Figure 4.7A), their levels were found to 
consistently decrease with DES onset, reaching statistical significance in patients 
(AqD and non-AqD) (Figure 4.7E). In agreement with the lower levels observed in 
patients, low molecular mass WE were negatively correlated with OSDI, while 
positively correlated with TBuT and Schir I (Figure 4.7D). These observations 
cumulatively suggest that reductions in low molecular mass WE were associated with 
DES pathogenesis. Individual species displayed similar trends to that observed for the 
entire category of low molecular mass WE (Figure 4.7C; Figure 4.8A).  
On the other hand, species of WE containing saturated fatty acyl moieties 
were considerably lower in proportion compared to their unsaturated counterparts 
(Figure 4.7B). Intriguingly, amongst medium to high molecular masses WE, only 
species with saturated fatty acid chains were specifically and significantly decreased 
in DES patients (AqD and non-AqD), while the levels of species with unsaturated 
fatty acids were increased, albeit not reaching statistical significance (Figure 4.7C). In 
addition, only species with saturated fatty acid chains were specifically and 
significantly correlated with Schir I and TBuT (positive correlations); as well as 
OSDI (negative correlations) (Figure 4.7D), indicating that reductions in WE 
containing saturated fatty acid chains are associated with disease pathology. On the 
other hand, several high molecular mass WE with unsaturated fatty acid chains were 
positively correlated with the Baylor score for corneal staining (Figure 4.8B), 
implying that the saturation status of WE fatty acyl moieties might exert critical roles 
in the manifestations of disease signs and symptoms. The entire subclasses of WE 
containing the respective saturated fatty acid moieties (i.e. FA 16:0, FA 17:0, FA 18:0) 




Figure 4.8. Correlations of individual wax esters with DES clinical signs and symptoms. Heatmaps 
summarizing the correlations between individual wax ester species of (A) low molecular mass (range: 
490.5-588.6) and (B) medium to high molecular mass (range: 590.6-716.6) with clinical parameters for 
DES. Values were plotted as correlation coefficients. Red indicates positive correlation while blue 
indicates negative correlation. R: Individuals at risk; RA: Individuals at risk with aqueous deficiency; P: 






4.3.2.4 Evaluation of diagnostic efficacy of selected tear wax species for DES 
 
Figure 4.9. Evaluation of the diagnostic efficacy of a panel of five tear wax esters for DES. ROC 
curve displaying the classifying performance of the panel of five tear wax esters selected based on their 
significantly different levels in DES patients versus controls (A). The predictive power of the panel of 
five wax esters as illustrated by a diagnostic matrix based on 19 normal controls and 35 DES patients (B).  
 
The diagnostic efficacy of five selected wax species, namely C18:2C16:0, 
C18:1C20:1, C18:1C17:0, C16:0C26:1 and C16:0C30:1, that differed significantly in 
DES patients compared to normal controls (Figure 4.7) were evaluated using receiver 
operating characteristic curves (ROC) and the resulting diagnostic matrix was 
presented (Figure 4.9; Supplementary Material 4.4). While individual wax ester 
species did not produce ideal sensitivity and specificity for DES diagnosis 
(Supplementary Material 4.4), the combined ROC of the five wax ester species 
produced a satisfactory area under curve (0.857), with a reasonable specificity of 89.5% 
and a moderate sensitivity of 68.6% (Figure 4.9).  While the sensitivity and 
specificity of the panel of wax ester markers were short of ideal, the diagnostic 
efficacy was comparable to or even slightly better than current DES clinical 
indicators used either alone or in combination. For instance, Schir I (<5.5 mm/5 min) 
had a reported sensitivity of 85% and specificity of 83%; TBuT (<10 secs) had a 
sensitivity of 72% and specificity of 62%, while the combination of Schir I and TBuT 
(<1 mm/min/<10 secs) had a sensitivity of 78% and specificity of 56% (DEWS, 
2007c). The moderate sensitivity of 68.6% and a high specificity of 89.5% may be 
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suitable for use in DES diagnosis. As DES is seldom a life-threatening condition by 
itself, it may be desirable to select a test with high specificity to prevent 
overburdening the health care delivery system with an excessive number of false-
positives. Furthermore, the respective sensitivity and specificity of the corresponding 
tests or battery of tests in all three studies aforementioned were derived from a study 
population comprising a considerably large proportion of severe DES cases (DEWS, 
2007c), this form of spectrum bias would unavoidably lead to artificially increased 
test sensitivity and specificity. For our current study, only 9.7 % of the study 
population was represented by patients with severe DES as defined by an OSDI > 
41.2 (Sullivan et al, 2010), which represents a study population with a reasonable 
balance of mild, moderate and severe DES cases (Supplementary Material 4.1). In 
addition, as the panel of wax ester markers probably represents a measure of tear film 
instability (See Section 4.4.2), the main pathogenic mechanism resulting from various 
etiological causes that essentially perpetuates the DES pathology, this panel of wax 
markers is expected to be applicable to a range of DES etiological subtypes.  
 Due to the multifactorial nature of DES, variable test efficacy is still likely to 
occur from study to study due to the different combinations of various DES 
etiological subtypes in individual studies. This problem can only be circumvented via 
the recruitment of considerably large study population that can effectively capture a 
range of DES patients with various etiologies. Thus, the diagnostic efficacy of the 
panel of wax ester markers derived in the current study needs to be further validated 






4.3.3 Compositional changes in tear lipids with varying total lipid levels in tears   
Rather surprisingly, we did not observe significant reductions in total tear lipids in 
both DES subtypes (AqD and non-AqD) according to the classification scheme based 
on clinical parameters (see Section 4.3.2.1; Figure 4.5). This is contrary to the 
common perception that evaporative dry eye (i.e. non-AqD) 1  resulted from 
compromised tear film stability due to insufficient delivery of meibomian lipids to the 
lid margin (Bron et al, 2004). As no current clinical tests for DES are sufficiently 
predictive of symptomatology to render them as leading disease indicators, it is 
possible that these clinical signs do not truly reflect physiological processes aligned 
with the principal axes of DES pathogenesis (Sullivan et al, 2012). Meibomian gland 
secretions could undergo enhanced modifications by host- and/or bacterial-derived 
enzymatic activities in the gland ducts if secretions became entrapped and stagnate 
behind partially obstructed glands (Dougherty et al, 1991), leading to reduced 
delivery of meibum (i.e. hyposecretion) with altered compositions into tears. We thus 
hypothesize that non-AqD dry eye might have resulted from an altered composition 
of tear lipids accompanying hyposecretion, instead of an insufficiency in lipids per se.  
In order to derive pathologically-relevant lipid changes in non-AqD DES, we 
attempted to move away from the conventional scheme of classification by 





1 In the current study, the subgroup of non-AqD patients represents a comparatively heterogeneous group 
of DES patients with normal lacrimal function. As no detailed examinations of meibomian gland 
function were carried out in the current study, it cannot be ascertained that this subgroup represents a 
homogenous group of individuals with DES purely due to afflicted meibomian gland function. 
Nonetheless, MGD represents the major cause of DES together with lacrimal dysfunction (see Section 
1.4), and it is expected that a majority of these non-AqD individuals possess at least some degree of 




Figure 4.10. Classification of clinical cohort based on molar concentrations of lipids. Dot plot 
illustrates the distribution of total lipid levels in the study cohort. The study cohort was stratified into 




 percentiles of the cohort based on total lipid 
levels in molar concentration (μmolml-1). 
 
4.3.3.1 Changes in DES-associated clinical parameters 
Significantly higher corneal staining (both inferior and summed score) was observed 
in subjects with low total lipid levels compared to those with moderate or high total 
levels of lipid in tears (p<0.05) (Figure 4.11). Elevated corneal staining translates to 
increased damages to the cornea epithelial tissues under conditions of low lipid levels 
in tears, which could be attributed to increased desiccation stress in the absence of an 
effective lipid barrier at the ocular surface. Also, an increasing trend was observed for 
Schir I with decreasing total lipid levels in tears, which could be attributed to 
compensatory lacrimal secretion in response to an overall lipid deficiency (see section 





Figure 4.11. The comparison of dry eye-associated clinical parameters between the low, medium 
and high groups defined by total lipid levels. (A) modified ocular surface disease index (OSDI); (B) 
Schirmer’s length (Schir); (C) tear breakup time (TBUT); (D) central corneal staining; (E) inferior 
corneal staining; (F) Baylor’s score for corneal staining; (G) age were shown. 
 
4.3.3.2 Changes in tear lipid compositions 
Interestingly, molar fractions of CS increased considerably in the low-lipid category 
(Figure 4.12). Looking into the Schirmer’s lengths for individual subjects with 
appreciable increases in CS revealed that most of these subjects exhibited 
hypersecretion of aqueous tears (i.e. Schir I > 15mm) (Figure 4.13A), consistent with 
our observation that the release of CS increases with tearing (Figure 4.2B). This 
finding is supported by previous work stating elevated tear secretion (based on Schir I) 
in patients with meibomian gland dysfunction (MGD) compared to controls due to 
compensatory secretion from the still healthy lacrimal glands (Shimazaki et al, 1995). 
The increase in GluCer in the low-lipid category, however, could not be attributed 
solely to compensatory tearing, as a number of aqueous-deficient subjects exhibited 




Figure 4.12. Comparison of the levels of lipid classes among low, medium and high groups defined 
by total lipid levels. (A) Neutral lipids including waxes (WE), cholesteryl esters (CE), triacylglycerides 
(TAG), diacylglycerides (DAG), free cholesterols (Free Cho); (B) O-acyl-ω-hydroxy-fatty acids 
(OAHFA), cholesteryl sulfate (CS), and sphingolipids including sphingomyelins (SM), ceramides (Cer), 
glucosylceramides (GluCer), and monosialo-dihexosyl gangliosides (GM3); (C) phospholipids including 
phosphatidylcholines (PC), phosphatidylethanolamines (PE), phosphatidylserines (PS), 
phosphatidylinositols (PI), phosphatidic acids (PA), phosphatidylglycerols (PG) and lyso-biphosphatidic 
acids (LBPA); and (D) lyso-phospholipids including lyso-PC (LPC), lyso-PE (LPE), lyso-plasmalogen 
PE (LpPE), lyso-PS (LPS), lyso-PI (LPI) and lyso-PA (LPA). 
 
The elevated levels of DAG in low-lipid category (Figure 4.12A; Figure 
4.13C) could be attributed to enhanced activities of esterases and lipases from lid 
commensal bacteria in MGD subjects, which may lead to irritation or other DES-
associated symptoms (Shine et al, 1993). Molar fraction of CE was significantly 
lower in the low-lipid group (Figure 4.12A; Figure 4.13D), with corresponding 
increase in the level of free Cho (Figure 4.12A; Figure 4.13E), suggestive of an 
enhanced breakdown of CE to free Cho. The hydrolysis of CE releasing free Cho was 
previously reported to promote the growth of ocular flora in chronic blepharitis 
(Shine et al, 1993).  
Interestingly, molar fractions of PC and PC (Figure 4.13F; Figure 4.12D), 
which are major membrane lipid constituents, were also significantly elevated in the 
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low-lipid category.  Elevated levels of these lipids might have resulted from increased 
cellular debris in entrapped meibum associated with MGD.  
 
Figure 4.13. Compositional alterations in tear lipids with varying amounts of total lipids. Subjects 
were stratified into three groups (i.e. low, medium and high) based on the total absolute concentrations 
of lipids detected using the 25th and 75th percentiles as cutoffs. Changes in the molar fractions of selected 
lipid classes including (A) CS; (B) GluCer; (C) DAG; (D) CE; (E) free Cho and (F) PC amongst the 
three groups were observed.  The Schirmer’s lengths for selected subjects in the low-lipid category with 
elevated CS and GluCer were indicated with dotted lines. Blue: Subjects without aqueous-deficiency; 




4.4.1 Biochemical and biophysical roles of tear lipids possibly of lacrimal origin 
As noted in Section 4.3.1, the positive correlations of CS, GluCer, GM3 and LPC 
were with Schir I suggested that the release of these lipids is elevated with increased 
tearing, and that these lipids possibly originated from the lacrimal glands instead of 
the meibomian glands. Nagyová and Tiffany have suggested that the lacrimal protein 
lipocalin might facilitate to lower surface tension by complexing with specific lipids 
and spreading out as a monolayer at the surface of the tear film (Nagyová et al, 1999). 
Using TLC, separate groups had concluded that glycolipids might be involved in 
126 
 
binding to tear lipocalins (Glasgow et al, 1995; Nagyová et al, 1999).  It was 
suggested that the lacrimal gland might be a probable source of such lipids and that 
the protein lipocalin might be secreted from the gland already fully charged with 
these lipids (Nagyová et al, 1999). Correspondingly, our results showed that GluCer 
and GM3 were strongly positively correlated with increasing Schir I (Figure 4.2B). 
Also, the propensity of GluCer to aggregate forming highly ordered gel domains had 
been shown to increase the order of fluid membranes (Varela et al, 2012). 
In addition, the trapping of ocular pathogens by soluble sialyated and/or 
glycated proteins had been shown to modulate the accessibility of such microbes to 
the epithelial glycocalyx, thereby protecting the cornea from infections (Fleiszig et al, 
2003). Similarly, soluble GluCer and GM3 might help to entrap invading microbes 
thus preventing microbial adherence to epithelial mucins. Thus, apart from possibly 
reducing surface tension of the tear film, the enhanced release of GluCer and GM3 
with tearing might facilitate microbe clearance via drainage through the ocular punta. 
This represents an example of the dual roles (i.e. both biochemical and biophysical) 
exerted by lipids at the ocular surface. 
 
4.4.2 Structural-specific changes in wax esters possibly create a 
microenvironment at the ocular surface favouring the development of DES 
As an evolutionary adaptation to non-aquatic environment, humans developed a 
structurally and biochemically intricate preocular tear film stabilized by 
compositional and hydrodynamic factors (Pflugfelder et al, 1998). A notable finding 
in our study is the structurally-specific reductions in low molecular mass WE; as well 
as medium to high molecular mass species with saturated fatty acyl moieties in DES 
(Figure 4.14). Consistent with our finding, Dougherty and coworkers reported lower 
levels of saturated fatty acids in meibum WE from chronic blepharitis patients, with 
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corresponding increases in species containing monounsaturated fatty acids 
(Dougherty et al, 1991).   
 
Figure 4.14. Schematic diagram summarizing lipid alterations in DES subtypes. Lipids at the ocular 
surface can exert biochemical and/or biophysical functions to maintain ocular health and homeostasis. 
Both “lipid-deficient”* and aqueous-deficient DES exhibited distinct lipid perturbations that might be 
specific to the respective biochemical aberrations associated with each disease subtype. On the other 
hand, lipids eliciting biophysical (i.e. structural) roles in maintaining overall tear film integrity and 
stability might be similarly modified in both disease subtypes. Low molecular mass WE in tears 
containing unsaturated acid moieties were associated with decreased risk of DES. In contrast, medium to 
high molecular mass WE containing unsaturated fatty acyl components were associated with increased 
risk of DES, while the opposite trend was observed for species containing saturated acid moieties in the 
same molecular mass range.  
*Our analyses showed that patients did not have an actual physiological deficiency in absolute lipid 
levels compared to normal controls.  
 
The saturation of the fatty acyl component of WE, instead of the alcohol 
moiety, is shown to be critical in determining the stiffness of WE films (Schuett et al, 
2012). The presence of a saturated fatty acid component generally makes the film 
stiffer, eliciting greater resistance to spreading out again after being compressed 
(Schuett et al, 2012). On the other hand, having a saturated fatty acid component 
translates to a smaller surface area taken up by the WE molecule as a whole, 
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indicating a greater fluidly in sliding over each other to lift from the surface (Schuett 
et al, 2012). WE containing saturated fatty acids might thus facilitate the formation of 
a stable, multilayered lipid film after a blink. By virtue of their saturated fatty acid 
components that confer fluidity in sliding across different planes, such species might 
intercalate between different layers of an expanded, multilayered film, thereby 
providing a specific degree of stiffness and resistance to collapsing after an intact film 
is formed.  
On the other hand, low molecular mass WE would have comparatively higher 
polarity, thus serving as transitional lipids in bridging the interaction between 
amphiphilic lipid sublayer with the bulk of the other non-polar lipids. Hence, a 
reduction in WE with low molecular mass or saturated fatty acids could possibly 
exert an adverse effect on overall tear film stability.  
Furthermore, since the progressive reductions in WE species of low 
molecular masses or that containing saturated fatty acid moieties were consistently 
observed from controls to risk groups and finally patient groups, these structural-
specific reductions in WE indicate that such species might be suitable as leading 
indicators predictive of symptomatology of the disease. Such leading indicators 
would be useful in diagnosing early-stage DES before the development of frank 
symptoms, and could also aid substantially in treatment monitoring, as current 
clinical indicators (i.e. TBuT, Schir I and staining) exhibit a lack of response to anti-
inflammatory or lubricant therapies designated for the disease. 
 
4.4.3 Qualitative instead of quantitative lipid aberrations in disease pathogenesis  
Notably, we did not observe significant reduction in total lipid levels even in non-
AqD DES patients. It was reported that in MGD patients with some but not all of the 
glands blocked, there were adequate lipids (17-53 times of the amounts required) on 
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the lid margin to form a multilayered tear film lipid layer. The quality, instead of 
quantity, of meibum could thus potentially contribute to MGD in such patients 
(Faheem et al, 2012). In agreement with this hypothesis, we found appreciable 
compositional changes in tear lipids as the absolute amounts of lipids in tears varied 
(Figure 4.14). In particular, proportional increases in major phospholipid classes (i.e. 
PC and PE) were observed in low-lipid category. In addition, elevated levels of PA 
and PG were also detected in aqueous-deficient individuals. Due to their polar nature, 
phospholipids can easily transverse the tear film aqueous layer and adhere to the 
ocular epithelial and mucin components, thereby creating “unwettable” regions that 
hinder the supply of nutrients to the avascular cornea, which might lead to reduced 
TBuT and corneal epithelial damage. Indeed, elevated molar fractions of PA and PG 
were significantly correlated with increasing Baylor score, indicative of corneal 
epithelial damages with enhanced levels of these lipids (Figure 4.4).  It had been 
shown that both lipocalin (Glasgow et al, 2010) and phospholipid transfer protein 
(PLTP) (Setälä et al, 2010) in human tears serve to scavenge lipids from corneal 
surfaces to ensure a “wettable” cornea. Specifically, it was stated that PLTP knock-
out mice developed appreciable DES and elevated corneal epithelial permeability 
(Setälä et al, 2010), which is also in agreement with the accumulation of 







Chapter 5. Longitudinal Study: Effectiveness of Eyelid 





MGD is defined as a condition of progressive obstruction due to ductal 
hyperkeratinization or inspissation of secretion (Foulks, 2007). In MGD, pathological 
alterations in the compositions of the meibomian gland secretions result in the 
thickening of the meibum, subsequently leading to the blockage of the glandular 
ducts. The occlusion may also be attributed to excessive colonization by bacterial 
commensals as well as exfoliated skin materials and crusts as a result of 
hyperkeratinization of the glandular ducts. These aberrations cumulatively result in a 
hyposecretion of lipids into the tear reservoir at the lid margins (Blackie et al, 2010). 
 The currently accepted view of MGD states that the disease is fundamentally 
a result of (1) a deficiency in meibum and/or (2) abnormal lipids to constitute the tear 
film lipid layer, either of which will substantially compromise the overall structural 
integrity of the tear film, leading to reduced tear film stability, loss of lubrication, and 
damage to the corneal epithelium due to excessive evaporation and the resultant 
desiccation. As the disease progresses, these pathophysiological alterations eventually 
lead to the emergence of disease symptoms including ocular discomfort and afflicted 
visual quality (Driver et al, 1996).  
 The rheological properties of the human meibomian secretions at the ocular 
surface depend heavily on the temperature. The average temperature of the ocular 
surface is reported to be in the range of 33.8 to 34.3 C, while the temperature in the 
meibomian glands embedded in the inner eyelids is close to the body temperature at 
36.9 C. Thus, the meibomian lipids normally cool upon secretion onto the ocular 
surface, accompanied by an increase in interfacial elasticity of the lipid film.  The 
melting range of the meibomian gland secretions is therefore expected to exert critical 
effects on the essential physiological properties of the meibum, namely (1) the ability 
to be expressed from the glandular ducts onto the ocular surface and (2) the efficiency 
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in spreading out across the ocular surface to form a stable tear film lipid layer (Leiske 
et al, 2012).  
 As a naturally complex secretion comprising a myriad of different lipid 
species, meibum melts over a range of temperature instead of at a single temperature. 
Meibum collected from healthy individuals melts from 25 to 40 C, and this melt 
transition temperature is reported to be influenced by both age and disease 
(Borchman et al, 2011; Borchman et al, 2010a; Borchman et al, 2012a), suggesting 
that changes in lipid compositions can substantially alter the average melt 
temperature of the meibum. As meibum melts, the hydrocarbon chains of lipids 
transition from the trans rotomers to the gauche rotomers (Borchman et al, 2007a) 
(Figure 5.1). Lipids pack less densely as a result of the increase in lipid disorder, with 
an accompanying reduction in viscoelasticity in the less structured meibum (Leiske et 
al, 2012). 
 
Figure 5.1. Illustration of trans and gauche rotomers. Left panel displays phospholipid molecule with 
ordered hydrocarbon chains (trans), and right panel shows phospholipid molecule with disordered 
hydrocarbon chains (gauche). The trans and gauche conformations are also applicable to other classes of 
lipids containing hydrocarbon chains. Modified from Borchman et al, 2007a. 
 
 In the disease state, compositional changes in meibum could lead to elevated 
melt temperature and enhanced viscosity. As pressure exertion onto the eyelids 
during blinking is required for glandular expression (see Section 1.3.2), increased 
meibum viscosity could hinder the flow of lipids out of the glandular ducts. Indeed, it 
has been previously demonstrated that the average lipid order (i.e. stiffness) of 
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meibum at 33.4C for MGD patients is significantly increased compared to that of 
controls (30% increase, p=0.004) (Borchman et al, 2011). Apart from compromised 
meibum secretion, the altered composition of the meibum would also lead to 
considerable changes in viscoelasticity, thus adversely affecting the spreading of the 
lipid layers after a blink. Currently, the ideal mechanical properties essential for 
stabilization of the tear film remain largely unknown (Leiske et al, 2012), although 
our comprehensive elucidation of tear lipid compositions has put forth structure-
specific components in wax esters as major determinant factors in modulating tear 
film stability (see Section 4.4.2).  
It must be noted, however, that an apparent difference exists between the 
melting of meibum in thin layer and in bulk. The T0.5 2  was estimated to be 
approximately 20 C in film, while in bulk it has been found to be around 32 C, 
implying that meibum in bulk exhibits a considerably higher degree of lipid-lipid 
interactions (i.e. cooperativity) than in a thin layer at the air-liquid interface 
(Butovich et al, 2010). The physiological implications of these biophysical 
observations would mean that the delivery of meibum from the glandular orifices 
onto the ocular surface, instead of the spreading of the meibum to form a lipid film, 
will be much more susceptible to the adverse effects of cold temperature (e.g. cold 
weather, wind drafts). In other words, warm compress therapy applied to the eyelids 
is expected to be more beneficial in terms of alleviating meibum occlusion and 
enhancing meibum delivery and secretion, instead of facilitating the spreading of the 
lipid film across the ocular surface per se.  
Warming the eyelid to 45 C represents one of the earliest therapies for 
treating MGD, as it is expected that raising the eyelid temperature would lead to 
                                                            
2 T0.5 is an experimental constant with physical definition of the temperature at which an experimentally 
measured effect is 50% of maximum. The experimentally measured effect in this case represents the 
normalized intensity of the reflected light (i.e. proportional to transparency), which was assumed to be 
directly proportional to the degree of lipid melting. 
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conformational changes in the lipid hydrocarbon chains (i.e. trans to gauche rotomers) 
in the meibum, thus increasing the disorder in the packing of these lipids and 
enhancing delivery and secretion out of the glandular ducts. Indeed, numerous studies 
have demonstrated the temperature-induced elevation in hydrocarbon chain disorder 
in meibomian lipids (Leiske et al, 2012; Borchman et al, 2007a). Warm compresses 
currently represent the most frequently prescribed treatment for patients with MGD or 
glandular obstruction leading to DES symptoms. The primary therapeutic effect lies 
in easing the flow of meibum and reducing glandular obstruction. Eyelid warming 
also serves as secondary adjunct to additional treatment methodologies such as oral 
(systemic) and topical antibiotics, manual expression of glands, artificial tears and 
steroid ointments (Blackie et al, 2010). Despite the expected benefits of warm 
compress treatment, patient compliance has nonetheless remained low, as patients 
were unable to sustain warm compresses (at the desired temperature) for an extended 
duration on a routine basis. This has led to the development of modern treatment 
modalities to replace the traditional use of warm towels. Some of these newly-
developed modalities are portable and omit the need for a permanent source of 
electrical power, allowing frequent travellers to use them with ease. Regardless of the 
methodological details, the fundamental therapeutic aims of heat therapy are (1) to 
heat the meibomian gland secretions thus facilitating their secretion into the tear film, 
(2) to reduce glandular obstruction and (3) to increase vascular flow to the tissues 
surrounding the meibomian glands (Blackie et al, 2008).  
While the biophysical changes in meibum lipids upon warming are well-
documented, the precise molecular changes in tear lipid composition, if any, that 
might accompany routine eyelid warming eventually leading to DES symptom 
alleviation, remain largely unknown. Thus, a primary aim of the current study is to 
elucidate longitudinal changes in the molecular compositions of tear lipids with 
eyelid warming over an extended period of routine treatment. In addition, this study 
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also compares the efficacy of novel eyelid warming devices (i.e. Blephasteam and 
EyeGiene) (see Section 5.2.1) with traditional method of using a warm towel for the 
treatment of MGD via objective clinical scoring, assessment of ocular surface 
parameters and changes in tear lipid profiles in an Asian population.  
 
5.2. Materials and Methods 
5.2.1 Clinical cohort and study design  
A total of 32 patients diagnosed with obstructive MGD in the dry eye clinics at 
Singapore National Eye Center who were keen to test out alternative ways for treating 
the disease were recruited into the study (Supplementary Material 5.1).  
Inclusion criteria: 
1. Presence of at least one visible blocked meibomian gland openings (i.e. plugs) 
in the four eyelids, or discernible alterations in the consistency of meibum 
expressed from meibomian glands residing in the upper or lower eyelids.  
2. Presence of appreciable DES symptoms based on a modified dry eye 
questionnaire (Schein et al, 1997) (i.e. at least one out of the 8 questions 
answered with often or all the time, which equates to a score = 3 or 4). 
3. Absence of other ocular surface pathology that requires treatment more than 
eye lubricant and conventional eyelid hygiene. 
Exclusion criteria: 
1. Known history of thyroid disorders (diagnosed by physicians). 
2. Ocular surgery within the previous six months and LASIK within the 
previous one year. 
3. Intake of central nervous system and hormonal drugs within last 30 days and 
inability to withhold such drugs for at least six weeks. 
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4. Active ocular infection or pterygium. 
5. Anticipated necessity to wear contact lens during the duration of the study. 
6. Living in the same household as another participant of the study. 
7. Any other specified reason as determined by the clinical investigator (e.g. the 
need to use any treatment or eyedrops not permitted by the study).  
Screening visit was performed at the regular dry eye clinic. Informed consent was 
obtained from eligible patients and baseline examination was subsequently carried 
out. Follow up visits were conducted after 12 weeks of treatment. A window period 
of +/-3 days was permitted for this visit.  Eligible patients were randomly assigned 
into three respective treatment arms each utilizing a different treatment modality: 
(1) Traditional method of warm compresses  using a hot towel (n=10) 
(2) Blephasteam (n=10) 
(3) EyeGiene (n=12) 
Blephasteam (Spectrum Théa, France) is an eyelid warming device available in 
Europe that can be conveniently used at home (Figure 5.2A). The goggles provide 
standardized heat of approximately 38 OC to liquefy lipids and humidify the chambers 
with mineral water to ensure optimal moisture levels. EyeGiene (Eyedetec Medical 
Inc., US) is a self-contained, convenient warm compress system for the eyes (Figure 
5.2B). The system is composed of a reusable eye mask and one-time use warmers that 
are inserted into the eye mask during usage. The warming units are activated by 
squeezing just prior to usage and deliver 40 OC heat for up to 5 minutes within 30-60 




Figure 5.2. Illustration of Blephasteam and EyeGiene eyelid warming modalities. 
 
Written informed consent was obtained from all participants in the current 
study. The clinical procedure was specifically approved by the Singhealth Centralised 
Institutional Review Board (CIRB Ref No: 2011/197/A). We adhered to the tenets of 
the declaration of Helsinki for all human research conducted in this study. 
Withdrawal from the study followed the usual Good Clinical Practice in clinical trials. 
For withdrawn subjects, no data would be obtained after the date of the withdrawal. 
Withdrawn subjects were not replaced. 
 
5.2.2 Treatment regimes  
Patients in each treatment arm carried out routine treatment using the assigned eyelid 
warming modality for 10 minutes each time, and for two times a day. All patients 
were allowed to continue their regular management of MGD such as the use of lid 
scrubs or lid hygiene preparations (e.g. Lidcare and Blephagel). The usage of these 
measures was monitored in a daily diary, and other types of MGD treatment such as 
omega-3 tablets, antibiotics or steroid ointments, and the manual expression of 




5.2.3 Outcome parameters evaluated  
5.2.3.1 Primary efficacy outcome 
A visual analogue scale (VAS) was applied to evaluate DES symptoms as previously 
described (Schaumberg et al, 2007). The evaluation of ocular discomfort based on 
VAS was taken as the primary efficacy outcome of the current study (Supplementary 
Material 5.2, Question 1). The scores were recorded separately for frequency and 
severity of dry eye symptoms experienced.  Patients were asked to check on a point 
on a 100-mm line that corresponded to the degree of the symptom. The location of 
the mark checked by the patient for each question was measured and recorded (in mm) 
from the left margin of the line.  
For the follow-up visits, patients were asked to check a mark from a central 
anchor (which represented condition at the last visit) (Supplementary Material 5.3). 
The distance between the mark checked by the patient from the central anchor was 
measured and recorded (in mm). A negative value was recorded if mark was on the 
left of the central anchor and vice-versa. A global score that takes into account both 
the frequency and severity of the symptom evaluated was then calculated using the 
following equation: 
ܩ݈݋ܾ݈ܽ	ܵܿ݋ݎ݁ ൌ 	ඥ݂ݎ݁ݍݑ݁݊ܿݕ	ݏܿ݋ݎ݁	ݔ	ݏ݁ݒ݁ݎ݅ݐݕ	ݏܿ݋ݎ݁ 
 
5.2.3.2 Secondary outcomes 
Other outcome measures include differences in the VAS of visual outcomes (i.e. 
blurred vision and light sensitivity) (Supplementary Materials 5.2-5.3, Questions 2-3), 
TBuT, Schir I test, and corneal fluorescent staining (see Section 2.2.3 for details of 
clinical procedures). The severity of MGD was also graded in this study. Microscopic 
signs of MGD including the presence of misdirected lashes, fragility of lashes, scurf 
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formation, irregularity of meibomian gland orifices, loss of meibomian gland 
expressibility, formation of plaques, and the number of blocked meibomian gland 
orifices (i.e. plugs) were recorded. The Yamaguchi grading scheme was used to 
identify microscopic signs of MGD (Yamaguchi et al, 2006). Briefly, a Yamaguchi 
grade 0 (least severe) indicates a posterior location of the mucocutaneous junction 
(Marx’s line), as determined by the fluorescein dye staining, relative to the 
meibomian gland orifices; and grade 3 (most severe) indicates an anterior position of 
the Marx’s line relative to the meibomian gland orifices. Grades 1 and 2 represent 
intermediate grades. The change in location of the Marx’s line relative to the 
meibomian gland orifices has been previously shown to correlate strongly with 
meibomian gland function (Yamaguchi et al, 2006). Ocular evaporation rate was 
measured based on infrared thermography in a clinical room setting as reported 
previously (Petznick et al, 2013).  
 
5.2.4 Statistical analysis 
While patients in individual treatment arms utilized different treatment modalities, the 
actual treatment received was, in principle, similar amongst the three groups (i.e. 
eyelid warming). Therefore, paired-t comparisons were performed on the tear lipid 
profiles of a combined group of patients from the three individual treatment arms, 
obtained at Week 0 and Week 12 of the study. This would reveal lipid alterations 
under an extended period of routine eyelid warming. On the other hand, one-way 
ANOVA was performed to compare the differences in tear lipid profiles amongst the 
three patient groups at Week 0 (before treatment), Week 12 (after treatment), as well 
as for the differences before and after treatment amongst the three groups (i.e. Week 
12-Week 0). These comparisons amongst the three groups could potentially reveal the 
different efficacies of the respective treatment modalities. False discovery rate was 
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controlled for based on q-values calculated using R 3.0.1 (Supplementary Material 
5.4). Correlation analyses between the changes in individual lipid species/classes with 
changes in clinical signs following 12-week treatment was performed using 
Spearman’s correlation. Eclipse demarcates 95% confidence region of correlating 




5.3.1 Changes in dry eye clinical parameters before and after heat treatment 
Heat treatment for 12 weeks resulted in appreciable alleviation of symptoms of ocular 
discomfort (p<0.01), the primary efficacy outcome as defined in the current study 
(Table 5.1). In addition, light sensitivity and global symptom score (sum of individual 
scores for ocular discomfort, light sensitivity and blurred vision) were also reduced 
with marginal significance (p<0.10) after heat treatment. Rather counter-intuitively, 
routine heat treatment resulted in a considerable increase (p<0.01) in the total 
Yamaguchi’s score, suggestive of a deterioration in meibomian gland function after 
treatment. Nevertheless, the number of plugged orifices were significantly reduced 
(p<0.1) and there was a noticeable improvement in TBuT (p<0.10), which is in 
agreement with an earlier study demonstrating that the application of heat to the inner 
surface of the eyelids on a routine basis led to steady increases in both TBuT and the 
number of meibomian gland yielding liquid secretion over a 12-week treatment 
period (Korb et al, 2010). On the other hand, no significant changes were observed in 
Schir I after treatment, which was not surprising since the current MGD cohort did 
not have discernible lacrimal dysfunction to begin with, even at Week 0 (i.e. mean 
Schir I > 5.5 mm). Heat treatment also did not bring about appreciable improvement 
in the scores for corneal staining; implying that the relief of meibomian plugs either 
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has minimal effect on restoring the integrity of the corneal epithelial tissues, or that 
the duration of treatment was not sufficiently long to achieve the desired clinical 
outcomes. On another note, eyelid warming treatment resulted in a reduction in 
ocular evaporation rate with marginal significance (p<0.10). Indeed, the reductions in 
ocular evaporation rate, corneal evaporation rate and scleral (conjunctival) 
evaporation rate were all statistically significant (p<0.05) with the use of one-tailed 
paired t-test. 
Table 5.1 Changes in ocular symptoms and signs after routine eyelid warming treatment for 12 
weeks. Values were presented as means + standard errors. A total of 32 MGD patients successfully 
completed the entire course of treatment. TBuT: Tear Breakup Time; Schir I: Schirmer’s I test. 
#<0.05p<0.10; *p<0.05; **p<0.01; ***p<0.001, NS: non-significant.  
 Symptoms Signs 
 




35.7+3.9 30.7+3.9 ** TBuT 
 
 
2.5+0.3 4.0+0.8 # 
Light 
sensitivity 
23.1+5.3 18.7+4.9 # Schir I 
 
 
9.8+1.5 9.6+1.4 NS 
Blurred 
vision 
25.9+5.2 25.5+5.6 NS Total corneal 
staining 
 




84.7+10.7 74.9+10.7 # Total 
Yamaguchi’s 
score 
5.1+0.6 6.5+0.4 ** 





    Ocular 
evaporation 
rate 
80.6+3.2 71.6+3.6 # 
 
5.3.2 Changes in tear lipids before and after heat treatment 
Routine eyelid warming did not result in a discernible increase in the absolute amount 
of total lipids in the tear fluid (Figure 5.3A), which is rather surprising considering 
the reductions in the number of plugged meibomian glands (Section 5.3.1) following 
heat treatment. This could imply that the relief of meibomian plugs resulted in a 
restoration of normal lipid turnover, instead of an enhanced amount of lipids at the 
eyelid margin. In fact, the MGD cohort under study did not exhibit an absolute 
deficiency in total lipids to begin with, considering that the mean molar concentration 
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of total lipids in tears for this cohort before treatment (ca. 0.58 µmolml-1) was 
comparable to that of a healthy cohort asymptomatic for DES (ca. 0.50 µmolml-1) 
(see Section 4.3.2.1). This observation is in good agreement with our earlier 
discussion that the quality of meibomian lipids, instead of the quantity, might be the 
actual cause of MGD-associated signs and symptoms of ocular discomfort (Section 
4.4.3). Indeed, stark changes in the compositions of tear lipids were observed after 
routine eyelid warming for 12 weeks. 
 
Figure 5.3. Changes in tear lipid levels with routine eyelid warming treatment. Barplots illustrate 
the changes in (A) absolute concentration of total lipids (µmolml-1), and molar fractions of (B) 
lysophospholipids classes, (C) phospholipid classes, (D) non-polar lipid classes as well as (E) OAHFA, 
CS and sphingolipid classes in tears of MGD patients (n=32) after routine eyelid warming treatment for 
a total therapeutic window of 12 weeks. Values were plotted as mean + standard errors. #0.05<p<0.10, 
*p<0.05, **p<0.01, ***p<0.001. 
 
The most striking changes were observed in lyso-phospholipids (Figure 5.3B). 
Molar fractions of major lyso-phospholipid classes, including lyso-plasmalogen PE 
(LpPE), lyso-PC (LPC) and lyso-PI (LPI) were reduced by almost half (p<0.001) 
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after treatment, while total lyso-PE (LPE) also displayed a significant decrease 
(p<0.05) (Figure 5.4). Remarkably, several individual species of LpPE, LPE, LPI and 
LPC were also significantly reduced after treatment (Figure 5.5A-D), consistent with 
the overall trends observed for the respective lipid classes.  Interestingly, the drastic 
reduction in total LpPE was paralleled by concomitant increases in several 
plasmalogen PE species that possessed a high degree of unsaturation (containing 6 or 
more double bonds) (Figure 5.6A). In addition, numerous diacyl PE, diacyl PC and 
diacyl PI species were also significantly increased after the 12-week treatment period 
(Figure 5.6), which corresponded well with the observed reductions in their 
respective lyso-phospholipid counterparts. Reductions in the various lyso-
phospholipids accompanied by increases in the corresponding diacyl-phospholipids 
after the 12-week treatment period implied a diminished level of ocular 
phospholipase activity following routine eyelid warming. 
Figure 5.4. Changes in lysophospholipids classes in tears with eyelid warming treatment. Dot plots 
illustrate the molar fractions of total (A) LpPE, (B) LPE, (C) LPC and (D) LPI in individual MGD 




In addition, while total DAG did not change significantly after the treatment 
period, levels of individual DAG species containing PUFA in their structures, namely 
DAG 18:0/20:4 (p<0.01) and DAG 18:0/22:6 (p<0.05), were almost halved following 
eyelid warming treatment. On another note, molar fractions of major tear film lipid 
amphiphiles, namely CS (p<0.10) and OAHFA (p<0.001), were noticeably increased 
following heat treatment (Figure 5.7A-B). Also, the increases in total OAHFA and 
numerous OAHFA species, including OAHFA 18:1/26:1, OAHFA 18:1/30:2 and 
OAHFA 18:1/34:1, were significantly correlated with the reductions in ocular 
discomfort (Figure 5.7C), suggesting that the alleviation of ocular discomfort with 
treatment was associated with enhanced levels of these lipid species in the tear fluid.  
 
Figure 5.5. Changes in individual lysophospholipid species with eyelid warming treatment. 
Heatmaps illustrate molar fractions of individual species of (A) LpPE, (B) LPE, (C) LPI and (D) LPC at 




Figure 5.6. Changes in individual phospholipid species with eyelid warming treatment. Bar plots 
illustrate the molar fractions of individual species of (A) PE, (B) PC, (C) PS and (D) PI in the tear 
samples of MGD patients (n=32) at Week 0 and Week 12 of the study. Values were plotted as mean + 





Figure 5.7. Alterations in the levels of amphiphilic lipid classes (CS and OAHFA) in tears with 
eyelid warming treatment. Dot plots illustrate the molar fractions of total (A) CS and (B) OAHFA in 
individual MGD patients (n=32) before and after the 12-week eyelid warming treatment. (C) The 
increases in the levels of total OAHFA and numerous individual OAHFA species were significantly and 
negatively correlated with the alleviation of ocular discomfort following the 12-week treatment. Eclipse 
indicates region within 95% confidence interval of the correlating parameters. #0.05<p<0.10, *p<0.05, 
**p<0.01, ***p<0.001. 
 
5.3.3 Correlation between changes in the levels of tear lipid amphiphiles with 
reduction in ocular evaporation rate following heat treatment 
The increase in total OAHFA, as well as several other OAHFA species including 
OAHFA 18:1/25:0, OAHFA 18:1/28:1, OAHFA 16:1/32:1, OAHFA 18:1/30:1, 
OAHFA 18:1/31:0, OAHFA 18:2/32:1, OAHFA 18:1/32:2 and OAHFA 18:1/34:2, 
were significantly (p<0.05) correlated with the reduction in ocular evaporation rate 
following 12-week treatment (Figure 5.8 and data not shown). On the other hand, the 
reduction in total LpPE, as well as several other LpPE species including LpPE 16:0p, 
LpPE 18:1p, LpPE 18:0p and LpPE 20:1p, was significantly correlated (p<0.05) with 
the reduction in ocular evaporation rate  (Figure 5.8 and data not shown). Similar 
trends were observed between changes in molar fractions of OAHFA and LpPE with 
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improvement in corneal evaporation rate and scleral (conjunctival) evaporation rates 
(data not shown). These observations implied that while OAHFA might have a 
stabilizing effect on tear film structural integrity, elevated levels of LpPE might 
compromise tear film stability, leading to an increase in evaporation rate (and thus 
clinical manifestations of evaporative dry eye).  
Figure 5.8. Correlation between changes in OAHFA and LpPE with ocular evaporation rates 
following 12-week eyelid warming treatment. The increases in the levels of total OAHFA and 
numerous individual OAHFA species were significantly and negatively correlated with the improvement 
in ocular evaporation rates following the 12-week treatment. On the other hand, the reductions in LpPE 
and numerous individual LpPE species were significantly and positively correlated with the 
improvement in ocular evaporation rates following the 12-week treatment. Eclipse indicates region 
within 95% confidence interval of the correlating parameters. #0.05<p<0.10, *p<0.05, **p<0.01, 
***p<0.001. 
 
5.3.4 Comparing the efficacies of different eyelid warming modalities in the 
alleviation of dry eye syndrome 
No significant difference was observed in the treatment outcomes amongst the three 
treatment arms. The evaluation was based on changes in DES-associated clinical 
parameters as well as levels of more than 500 individual species of tear lipids before 
and after routine eyelid warming using the respective modality, for a total duration of 
12 weeks. The foregoing results thus did not indicate superior treatment efficacies of 





5.4.1 Ocular phospholipases might be implicated in MGD pathogenesis 
Group IIA phospholipases A2 (GIIAPLA2) are the most potent mammalian-secreted 
PLA2 in terms of antibacterial efficiency against Gram-positive bacteria, and 
constitute part of the body’s innate immunity as the first-line antimicrobial defence 
against invading microbes and pathogens (Nevalainen et al, 2008). The bactericidal 
properties of GIIAPLA2 reside in the (1) high positive surface charge of the molecule 
and (2) its phospholipolytic enzymatic activity (Beers et al, 2002). In addition, 
GIIAPLA2 possess higher binding affinity to anionic phospholipids such as PE 
compared to zwitterionic PC, which represents the predominant phospholipid 
constituent of mammalian cell membranes (Bayburt et al, 1993), therefore ensuring 
the preferential elimination of bacterial membranes over eukaryotic host tissues 
(Nevalainen et al, 2008). 
As a consequence of their bactericidal properties, high levels of GIIAPLA2 
expression could be found at the various potential routes of pathogenic entry 
throughout the body, such as the corneal and intestinal mucosal epithelia. The 
presence of GIIAPLA2 has been previously reported in the human main lacrimal 
glands and tear fluid (Nevalainen et al, 1994). In particular, the human tear fluid has 
been shown to contain one of the highest amounts of GIIAPLA2 amongst other 
human secretions, with an estimated concentration of 54.5+33.9 µgml-1 (Saari et al, 
2001). The human lacrimal tissues have been found to contain two distinct acinar cell 
types each specialized for the production and secretion of lysozyme and GIIAPLA2, 
respectively (Aho et al, 1996). The cells expressing GIIAPLA2 have been found in 
comparatively smaller numbers, and localized mainly in central regions of the lobules 
in main and accessory lacrimal glands (Aho et al, 1996). 
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Aho and colleagues (2002) have demonstrated an almost twofold increase in 
GIIAPLA2 levels in the tears of dry eye patients compared to age-matched healthy 
controls. The increase in GIIAPLA2 might serve to compensate for the compromised 
antibacterial activity in the tear fluid, as a result of concomitant decreases in tear 
lysozyme and lactoferrin with DES, the major bactericidal proteins normally found in 
tear fluid (Seal et al, 1986). It has thus been suggested that the subtype of acinar cells 
designated for lysozyme and water production could be selectively destroyed in DES, 
while that responsible for GIIAPLA2 synthesis were retained (Aho et al, 2002). This 
postulation has been supported by separate clinical findings that dry eye was not 
associated with increased incidence of bacterial infections, and that no enhanced 
conjunctival infections by Staphylococcus aureus or Staphylococcus epidermis was 
observed in DES, albeit decreases in major bactericidal proteins with the disease 
(Seal et al, 1986). In addition, it has been found that the levels of tear GIIAPLA2 were 
almost doubled in the tear fluid of chronic blepharitis patients compared to controls, 
and the authors have verified that the elevated GIIAPLA2 in tears displayed 
preferential hydrolysis of PE over PC by an approximated ratio of 3:1 (Song et al, 
1999). 
In corroboration with earlier works on ocular phospholipases (Song et al, 
1999; Aho et al, 2002), we observed that the levels of major lysophospholipids in 
tears were reduced by almost half after the treatment period, suggesting that ocular 
PLA2 activity was diminished following routine eyelid warming. The notable 
reductions in various lysophospholipids following eyelid warming treatment, without 
the application of other medications such as steroids or antibiotics, were reported for 
the first time. We surmise that the diminished PLA2 activity might be attributed to the 
relief of intraglandular pressure within meibomian ductal systems via facilitating the 
melting and outflow of meibum from the obstructed orifices with heating. In 
obstructive MGD, the elevation in intraglandular pressure imposes considerable 
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mechanical stress on the ductal and acinar epithelia of gland tissues, which could 
possibly activate mitogen-activated protein (MAP) kinase activity leading to the 
downstream release of chemokines and cytokines, therefore eliciting the ocular 
inflammatory cascade, as it has been previously demonstrated in conjunctival and 
corneal epithelial tissues (Luo et al, 2004). On another note, it has been reported that 
pathophysiological signal transduction, including inflammatory responses, could be 
mediated by mechanical stress on vascular smooth muscle cells (Li et al, 2007). In 
addition, the induction of extracellular PLA2 secretion from various cell types under 
an inflammatory milieu has also been extensively documented (Gronich et al, 1988; 
Pfeilschifter et al, 1989; Oka et al, 1991; Pfeilschifter et al, 1993; Zallen et al, 2000). 
Therefore, the release of PLA2 from meibomian gland acinar and ductal epithelia as a 
result of elevated intraglandular pressure might represent a plausible mechanistic 
pathway for the enhanced levels of lysophospholipids observed in the tears of MGD 
patients. Consequentially, the relief of plugged orifices with eyelid warming could 
remove the stimulus for the increased PLA2 activity, leading to normalization of 
lysophospholipids levels. Nonetheless, it remains to be determined whether the 
meibomian gland tissues could secrete PLA2 in response to mechanical induction. 
Alternatively, the mechanical stress could be communicated from the 
meibomian gland acinar epithelia to the corneal and conjunctival epithelial tissues, as 
well as the lacrimal gland epithelia, that collectively lead to an enhanced release of 
PLA2. The expression and production of PLA2 in the cornea (Landreville et al, 2004), 
conjunctiva and lacrimal glands (Wang et al, 2010) has been well-documented. In 
fact, the ocular epithelial tissues could be regarded as a continuum, and the lacrimal 
gland and meibomian gland simply denote invaginations of this continuous 
epithelium (Obata, 2002).  Swartza and colleagues (2001) have previously shown that 
mechanical stress could be communicated between different cell types to bring about 
comprehensive matrix remodelling in the airway system. It remains to be elucidated, 
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however, if the mechanical stress imposed on meibomian epithelial tissues in 
obstructive MGD could be conveyed to lacrimal epithelia that subsequently leads to 
the production of  aqueous tears with elevated levels of PLA2, as has observed in tear 
samples from dry eye (Aho et al, 2002) and chronic blepharitis  patients (Song et al, 
1999). 
Regardless of the precise mechanistic details, the increased release of PLA2 
enzymatic products (i.e. lysophospholipids and free fatty acids) to the ocular surface 
could substantially compromise tear film stability, in view of the detergent-like 
properties of  the highly polar lysophospholipids (Makide et al, 2009). Indeed, we 
observed significant correlation between reductions in the levels of LpPE with 
improvement in ocular (both corneal and scleral) evaporation rate, indicative of the 
detrimental effects that LpPE might exert on tear film structural integrity. In addition, 
the specific increases in highly unsaturated plasmalogen PE after treatment period 
implied that such species might be preferentially targeted during MGD pathogenesis. 
Such highly unsaturated plasmalogen PE species possibly contain polyunsaturated 
fatty acids, such as arachidonic acid (FA20:4) and docosahexaenoic acid (FA22:6) at 
their sn-2 positions. Furthermore, our data also indicated that phospholipase C (PLC) 
might exhibit the same trend as PLA2 in selectively targeting PUFA-containing 
phospholipids during MGD pathogenesis, as shown by the appreciable decreases in 
DAG 18:0/20:4 and DAG 18:0/22:6 following heat treatment. Upon release, 
arachidonic acids could be converted to downstream inflammatory mediators 
including prostaglandins and leukotrienes that further fuel the sustained inflammatory 
cycle commonly observed in DES (Song et al, 1999). Also, the presence of 
leukotriene B4 and platelet-activating factor has been reported in human tears (Thakur 
et al, 1998). Accordingly, the reductions in these proinflammatory metabolite 




Nonetheless, the consistent decreases in LPE, LpPE, LPC and LPI with heat 
treatment suggest that PLA2 other than GIIAPLA2, which has a specific preference 
for PE over PC, might participate in MGD pathogenesis. Indeed, cytosolic PLA2 with 
high selectivity for phospholipids that possess an sn-2 arachidonic fatty acyl group, 
which hydrolyse PE and PC with equal efficiency (Song et al, 1999), have also been 
found to be expressed in the corneal and conjunctival tissues (Wang et al, 2010). 
Moreover, the contribution of disease phenotypes (i.e. elevated lysophospholipids) by 
bacterial phospholipases at the ocular surface should also be considered. The 
clearance of stagnant meibum would remove potential sources of nutrients for ocular 
commensals. Furthermore, increased lipid turnover would also promote the 
elimination of commensal bacteria, which are known to proliferate in obstructed 
gland ducts (McCulley et al, 1986), via drainage through lacrimal puncta or onto 
peripheral lid skin. Therefore, a diminished level of commensal bacteria (and 
bacterial phospholipase activity) might also partially account for the observed 
reductions in lysophospholipids following eyelid warming treatment in relieving 
meibomian plugs. 
 
5.4.2 Meibum-derived amphiphilic lipids in maintaining tear film stability 
The relief of obstructed meibomian orifices would release the stagnated meibomian 
oils onto the eyelid margin, thereby facilitating lipid removal by bulk flow and 
increasing lipid turnover at the eyelid margins. Earlier on, we have postulated that the 
lipid anomalies associated with MGD and DES might have resulted primarily from 
diminished lipid turnover, instead of an absolute deficiency in lipids per se (see 
Section 4.4.3), which is in accordance with our observation that eyelid warming and 
disease symptom alleviation were not associated with enhanced amounts of lipids in 
tears. The increased lipid turnover would facilitate delivery of fresh meibomian and 
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lacrimal secretions onto the ocular surface, while removing toxic contaminants and 
other metabolized products. Thus, the appreciable increases in amphiphilic lipids, 
such as CS and OAHFA, in the tears of MGD patients might be associated with 
increased delivery of fresh meibomian and lacrimal secretions onto lid margins 
following eyelid warming. 
 The higher levels of lipid amphiphiles brought about by routine lid warming 
would exert positive effects on tear film structural integrity and stability, as indicated 
by the increase in TBuT following treatment. Interestingly, significant correlations 
were found between the increases in total OAHFA, as well as numerous OAHFA 
species, with alleviation in the degree of ocular discomfort after treatment. In addition, 
increases in the levels of several OAHFA species were also appreciably associated 
with improvement in ocular evaporation rates after treatment. These implied that 
OAHFA could serve as suitable indicators of treatment response and ocular symptom 
improvement. This finding is in good agreement with our previous observation that 
OAHFA displayed consistent decreases with increasing DES severity (Lam et al, 
2011) (see Section 2.4.2.3), and further strengthens the validity of OAHFA as 
appropriate indicators of DES/MGD pathogenesis and severity.   
 
5.4.3 Limitations of the current study design 
The lack of observable differences between the treatment efficacies of modern eyelid 
warming modalities (i.e. Blephasteam and EyeGiene) and conventional usage of 
warm towels was somewhat surprising, as these modern devices were expected to be 
able to maintain a constant elevated temperature over prolonged treatment period 
compared to warm towels, thereby facilitating the melting of stagnant meibum in 
obstructed gland ducts with greater efficiency. The full temperature range for the 
complete melting of obstructed meibomian oils has been shown to be from 32 to 45 
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C (Bron et al, 2004). Thus, in order to relieve severely obstructed glands, it could be 
assumed that a constant inner eyelid temperature of > 40 C would probably be 
required (Blackie et al, 2008). In addition, it has been previously shown that 
approximately 20 to 30 minutes were required for the inner eyelid surface to attain its 
maximum temperature during eyelid warming, and hence a treatment time of at least 
15 to 20 minutes might actually be needed to alleviate severe meibomian gland 
obstruction (Blackie et al, 2008). Thus, the temperature maintained by Blephasteam 
at 38 C was probably inadequate in effectively melting the meibomian gland 
inspissation. On the other hand, while EyeGiene confers a higher temperature of 40 
C for 5 minutes, this limited duration of constant heat might be insufficient to raise 
the inner eyelid temperature to > 40 C for effectively relieving severely obstructed 
glands.  On another note, the statistical powers of the current study could possibly be 
circumvented by the relatively small sample size within each treatment arm. In 
addition, a treatment period of 12 weeks was possibly not long enough to produce 












In the preceding chapters, we have described the development of comprehensive 
lipidomic platforms, largely built upon the principles of liquid-chromatography mass 
spectrometry, for extensive characterization of the lipid profiles of human meibomian 
gland secretions and tear fluid. Using three different clinical cohorts in separate cross-
sectional studies and a longitudinal study, we have derived lipid species associated 
with various aspects of the multifaceted dry eye syndrome, including disease 
progression (Chapter 2), disease onset and pathogenesis (Chapter 4), as well as 
treatment response (Chapter 5). In addition, we have systematically compared 
between different tear lipid sampling techniques and put forth the most 
comprehensive human tear lipidome to date (Chapter 3). The detailed evaluations of 
various sampling techniques could help standardize collection protocols, thereby 
facilitating future biomarker studies on tears. Furthermore, we have demonstrated the 
translational feasibility of using Schirmer’s strip for tear collection designated for 
lipid analyses (our method of choice), which confers high reproducibility in terms of 
lipid profiles across samples with a wide range of wetted lengths; and is thus 
applicable even to patients with severe DES.  
 
6.1 Dissecting the roles of lipids at the ocular surface 
Our in-depth analysis of the human tear lipidome has provided new insights 
pertaining to ocular surface biochemistry and tear film biophysics, especially with 
regard to the composition of the tear film amphiphilic lipid sublayer critical for 
maintaining its overall structural integrity. We have shown that the tear fluid is 
appreciably enriched in phospholipids and sphingolipids relative to the meibum, and 
demonstrated that a surplus of phospholipids and sphingolipids is available in tears to 
constitute the amphiphilic lipid sublayer. We have also put forth CS as a novel 
candidate for this interfacial lipid sublayer. In addition, we reported associations 
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between specific tear lipids with physiological processes such as aging and lacrimal 
reflex. Nonetheless, the exact biological significance of these observations awaits 
future experimental evidence. For instance, while some physiological changes such as 
the proportional increases in oleic-acid-containing WE might constitute a natural part 
of aging to facilitate meibomian lipid outflow thus compensating for the weakened 
muscular contractions in the eyelids, the reductions in highly unsaturated PE probably 
denote an unavoidable secondary consequence of elevated oxidative stress at the 
ocular surface with aging.  
 The roles of lipids at the ocular surface are further complicated by the unique 
location of these lipids at the boundary between the body’s interior and the external 
environment. Lipids can elicit structural roles in maintaining the biophysical integrity 
of the tear film for enhancing vision, function physiologically in cellular signalling 
events, or participate in immunological inflammation and its resolution to facilitate 
the clearance of invading pathogens. On the other hand, as the ocular surface also 
represents a site of excretion, some lipids might simply be metabolic or pathological 
by-products that do not serve any specific biological functions. In addition, being 
directly exposed to the external environment, the ocular surface lipids could be 
subjected to lipid peroxidation induced by environmental factors such as ultraviolet 
radiation. Elucidation of the precise functions of the myriad of lipid species at the 
ocular surface is therefore a formidable task, which is further confounded by the 
diverse contributing sources of ocular surface lipids including the meibomian glands, 
lacrimal glands, cornea and conjunctival tissues, as well as resident lid commensals. 
While our work have put forth novel insights pertaining to the lipid biology at the 
ocular surface, particularly with regards to tear film physiology, confirmation of the 
speculated lipid functions would necessitate further validation via future biophysical 




6.2 Lipid anomalies in dry eye syndrome 
This work has unmasked extensive lipid perturbations associated with various aspects 
of the multifactorial DES (Figure 6.1). In particular, it was found that reducing levels 
of meibum OAHFA were associated with increasing DES severity, and that routine 
lid warming treatment, proven to alleviate ocular discomfort, led to elevated levels of 
tear OAHFA. The consistent trends demonstrated by meibum and tear OAHFA also 
implied that meibomian secretions probably denote the predominant source of 
OAHFA in tears.  
 
Figure 6.1. Overall summary of lipid anomalies in association with the various contributing 
elements of dry eye syndrome.  
 
We also investigated lipid aberrations in the tears of symptomatic DES 
patients compared to age-matched healthy controls and at-risk individuals.  Notably, 
we found that low molecular mass wax esters, as well as medium to high molecular 
mass wax esters containing saturated fatty acyl moieties, were specifically reduced in 
DES patients. Importantly, these wax ester species were also significantly correlated 
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with both DES signs and symptoms, and such “unifying” indicators represent an 
exciting finding for DES diagnostics, given the current lack of correlations between 
the signs and symptoms of dry eye (Sullivan et al, 2012). The consistent decreasing 
trends observed for the specific WE species from normal controls through risk groups 
to patients also suggested that these lipids could serve as potential predictors of DES 
onset before the actual occurrence of clinical symptoms. Corresponding trends for 
these specific tear WE species, however, were not observed in the longitudinal study 
targeted at MGD patients. This might mean that the aforementioned structure-specific 
reductions in WE was not primarily due to the inspissation of meibomian oils, and 
therefore could not be normalized even with lid warming treatment.  
On the other hand, the drastic reductions in lysophospholipids accompanying 
lid warming indicated that elevated PLA2 activity might significantly contribute to 
DES-associated ocular discomfort. Increases in lysophospholipids, however, were not 
observed in DES patients in the cross-sectional studies. The discrepancy might be 
attributed to the different nature of the clinical cohorts. The clinical cohort in the 
eyelid warming study has an appreciably lower starting modified OSDI (20.8+2.1) 
compared to the patient groups (28.1+2.8; 36.6+3.4) in the cross-sectional study 
(ANOVA: p<0.001), implying that the perturbations in lysophospholipids might only 
be observable in milder cases at the incipient stage of DES, or it might represent a 
specific feature of non-AqD subtype (i.e. evaporative dry eye due to obstruction of 
the meibomian glands). Indeed, for the cross-sectional study reported in Chapter 4, 
the non-AqD risk group displayed the highest amounts of lysophospholipids with the 
exception for LPE, albeit not reaching statistical significance (Figure 4.6D).  
Lastly, but perhaps most surprisingly, our comprehensive analysis of tear 
lipid aberrations in DES did not reveal an actual “lipid-deficiency” on the lid margins 
in both DES subtypes; but suggested instead that compositional alterations possibly 
leading to impeded spreading and/or compromised stability of the tear film might be 
the actual key to disease pathogenesis. This clinical conceptual advance challenges 
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the current doctrine that non-aqueous (i.e. evaporative) dry eye occurs primarily due 
to lipid hyposecretion. Results from the longitudinal eyelid warming study also 
supported this hypothesis, as symptom improvement was not accompanied by 
concomitant increases in the absolute lipid amounts in the tear fluid, but appreciable 
compositional changes in tear lipids instead.  
 
6.3 Limitations and future work 
As a matter of fact, the examination of meibum and tear lipid profiles could only lead 
to conjectures about the precise mechanisms of disease pathogenesis. Indeed, it is still 
a world-wide challenge to study the pathology of DES due to the difficulties in 
culturing primary meibomian gland cell for mechanistic studies, coupled with the 
multifactorial nature of the disease per se. While numerous models for DES such as 
the mouse, rabbit, canine and monkey are available, none of these models can fully 
recapitulate the disease symptoms and pathology in humans nor confers a complete 
picture of the multifactorial nature of the disease (Schrader et al, 2008). For instance, 
while the rabbits have a considerably larger ocular surface area than the mice that 
allows for similar clinical tests such the Schir I to be performed with relative ease 
compared to the latter, the average TBuT of rabbits has been estimated to be 
approximately 30 secs (Wei et al, 2013), which is vastly different from that of 
humans, implying appreciable differences in tear film composition and henceforth 
structure. Indeed, Butovich and colleagues (2012) have previously compared the 
meibum lipidomes of the mouse, canine and rabbit with that of humans, and 
concluded that rabbit meibum lipidome bears little resemblance to that of humans. On 
the other hand, the mouse and canine meibum lipidomes are highly similar to humans, 
suggesting comparable tear film structure. Nevertheless, most of the current DES 
models in the mouse cover only the aqueous-deficient aspect of DES, which 
essentially involves the infiltration (and hence destruction) of the lacrimal glands by 
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immune cells (Barabino et al, 2004). Models that capture the pathological aspects of 
evaporative dry eye, which are expected to be biologically more related to 
disturbances in ocular surface lipid homeostasis, are currently lacking. On the other 
hand, while the primary cell culture (and subsequent immortalization) of the human 
meibomian gland epithelial cells offers a seemingly good opportunity for 
investigating the roles of meibomian glands in maintaining ocular surface 
homeostasis in terms of their lipid-secreting properties, stable cell lines are not yet 
commercially available. Thus far, only one study has reported on the primary culture 
and immortalization of human meibomian gland cells (Liu et al, 2010). The 
characterization of the reported cells, however, was based largely on the presence of 
Nile Red staining that indicates the accumulation of lipids. While the authors claimed 
that their cultured cells express major lipids similar to that of the human meibomian 
gland secretions, no detailed lipidomic results were presented, and neither is follow-
up report available. I have attempted the primary culture of human meibomian gland 
epithelial cells and characterized the lipid biology of these cells via staining with the 
lipophilic dye LD 540, as well as using HPLC/MS. Unfortunately, while these cells 
were stained heavily with LD 540 and exhibited appreciable accumulation of lipid 
droplets, MS profiles indicated that these lipids were predominantly TAG, and lipids 
characteristic of the human meibum such as OAHFA were not found in appreciable 
levels. Thus, the human primary cell culture may not be an apt in vitro system to 
study meibomian gland lipid biology as well. Hence, the lack of appropriate animal 
models and in vitro system for DES make the further pursuit and validation of 
mechanistic details extremely challenging.  
Despite these difficulties, mouse models of MGD may be suitable to 
investigate if treatment with inhibitors of PLA2 activity (e.g. arachidonic acid analogs 
such as 7,7-dimethyleicosadienoic acids) or topical application of artificially-
synthesized OAHFA can alleviate ocular symptoms of DES. This may be conducted 
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via cauterization of individual meibomian gland orifices to create a model of MGD, 
similar to what has been previously performed in rabbits (Gilbard et al, 1989). Due to 
the considerably smaller ocular area of the mice, however, this procedure may be 
technically very challenging and tedious in the mouse. 
 On the other hand, further biophysical experiments may offer a good way to 
confirm the proposed biophysical roles of various lipid species in maintaining tear 
film structural integrity, particularly for the novel lipid amphiphile (CS), first reported 
in tears and meibum in the current study. On another note, the possibility of the 
lacrimal origin of CS as well as glycosylated lipids such as GluCer and GM3 based 
on their correlation with Schir I (Chapter 3) can only be verified by obtaining pure 
lacrimal secretion via micropuncture and catheterization techniques, which are 
ethically impossible in humans. Considering the close resemblance of the mouse 
meibum lipidome to that of humans, the mouse may represent a reasonable alternative.  
 In addition, future validations of the observed lipid changes in larger clinical 
cohorts are required to confirm the observed DES-related markers in the current study. 
As mentioned in Chapter 4, the multifactorial nature of DES would require a multi-
stage study of sufficiently large sample size to fully capture the range of disease 
pathologies normally observed in the populations. This may require joint 
collaborations between different centers dedicated to DES research in order to 
achieve a sufficiently large and unbiased population, and may involve patient 
recruitment over a considerably longer duration.  
 
6.4 Implications of the human tear lipidome beyond ophthalmology  
The ocular tissues and fluids could be potential reporters of integrated metabolic 
stress over prolonged periods, otherwise obscured by complex homeostatic 
mechanisms on a systemic scale (Sapieha et al, 2011).  The tear fluid, being the most 
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accessible of all ocular fluids, therefore also represents a novel source of biomarkers 
for systemic diseases marked by long prodromal periods, extending the translational 
significance of the comprehensive human tear lipidome and the technological 
platform reported herein from the ocular field to other realms of clinical medicine. In 
my opinion, the tear fluid might represent a novel biological fluid for unravelling 
complex interactions on a systemic scale due to the presence of less “background 
interferences” compared to conventionally used body fluids such as the blood or 
plasma. 
Hence, the systematic lipidomic analysis of tears would be of broad 
translational relevance for investigation of various human diseases including ocular 
diseases, neurological disorders and even for metabolic diseases. In fact, the 
association between tear fluid constituents and neurological disorders could possibly 
be intriguing, since both the eye and brain represent vital organs for survival from an 
evolutionary perspective. Furthermore, the eye is considered an anatomical extension 
of the brain, and shares critical commonalities with elements of the brain in its limited 
regenerative potential as well as immuno-privilege (Niederkorn, 2006). Indeed, 
sporadic studies on proteomic analyses of human tears have already identified 
numerous potential protein markers/patterns that could serve as putative reporters of 
diabetic retinopathy (Kawai et al, 2002), Type 1 diabetes (Moll et al, 2011), Type 2 
diabetes (Grus et al, 2002; Herber et al, 2002), breast cancer (Lebrecht et al, 2009), as 
well as various other forms of cancer (Evans et al, 2001).  
 
6.5 Conclusion  
Our findings would be of substantial translational utility in facilitating the clinical 
evaluation of tear film condition and ocular health status for the field of 
ophthalmology. We also expect this study to incite further work pertaining to the 
biophysics of tear film spreading and future pharmaceutical developments of artificial 
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tears for managing dry eye and other ocular conditions. Furthermore, the current lack 
of precise diagnostic indicators with sufficient specificity and sensitivity for DES 
makes our study timely. Overall, our work has underscored the importance of lipid 
homeostasis in ocular health and dry eye disease, and put forth several hypothesis-
generating insights with regard to the observed lipid anomalies associated with 
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1 Light sensitivity 
 
0 1 2 3 4 
2 Gritty or scratchy sensation 
 
0 1 2 3 4 
3 Burning or stinging 
 
0 1 2 3 4 
4 Blurred vision 
 
0 1 2 3 4 
5 Vision that fluctuates with blinking 
 
0 1 2 3 4 
6 Vision that improves with artificial tears 
 
0 1 2 3 4 
7 Tearing 
 
0 1 2 3 4 
8 Pain or burning in the middle of the night or 
upon awakening in the morning 
0 1 2 3 4 
9 Irritation while reading or driving car for 1 
hour 
0 1 2 3 4 
10 Irritation while watching TV or working on a 
computer for 1 hour 
0 1 2 3 4 
11 Discomfort during winds or drafts 
 
0 1 2 3 4 
12 Discomfort in places with low humidity such 
as air-conditioned buildings 
0 1 2 3 4 
 
Calculation of OSDI = 
ሺ܁ܝܕ	ܗ܎	܂ܗܜ܉ܔ	܁܋ܗܚ܍ሻܠ૛૞





Supplementary Material 2.2 
Demographic and clinical data of DES patients (n=27) and normal subjects (n=10).  
No. Sex Age Ethnicity Schir I (mm) TBuT (secs) OSDI Score 
P1 F 72 Chinese 0 3.0 22.9 
P2 F 68 Chinese 35.0 5.0 22.9 
P3 F 74 Chinese 16.0 5.0 25.0 
P4 M 54 Chinese 10.0 2.0 25.0 
P5 F 62 Chinese 4.0 3.0 29.2 
P6 M 28 Chinese 6.0 3.0 29.2 
P7 F 59 Bangladeshi 8.0 3.0 31.3 
P8 F 71 Chinese 20.0 3.0 33.3 
P9 F 63 Chinese 2.0 2.0 37.5 
P10 F 75 Chinese 20.0 3.0 39.6 
P11 F 41 Chinese 16.0 2.0 39.6 
P12 F 50 Chinese 6.0 2.0 41.7 
P13 F 73 Chinese 1.0 2.0 41.7 
P14 F 51 Chinese 5.0 2.0 43.8 
P15 F 57 Chinese 4.0 4.0 47.9 
P16 F 53 Chinese 12.0 3.0 50.0 
P17 F 68 Chinese 6.0 3.0 56.3 
P18 F 69 Chinese 14.0 3.0 58.3 
P19 F 49 Chinese 4.0 3.0 58.3 
P20 F 43 Chinese 1.0 5.0 60.4 
P21 F 51 Chinese 2.0 4.0 60.4 
P22 F 58 Chinese 7.0 1.0 62.5 
P23 F 65 Chinese 1.0 1.0 64.6 
P24 M 59 Chinese 1.0 2.0 64.6 
P25 F 72 Indian 5.0 5.0 70.8 
P26 F 67 Chinese 8.0 3.0 85.4 
P27 F 52 Chinese 11.0 2.0 87.5 
N1 F 22 Chinese 8.0 3.0 0 
N2 F 24 Chinese 25.0 3.0 0 
N3 F 31 Sinhalese 17.0 9.0 0 
N4 F 45 Indian 10.0 7.0 0 
N5 F 26 Chinese 19.0 5.0 2.1 
N6 F 26 Chinese 36.0 3.0 4.2 
N7 M 28 Chinese 29.0 4.0 4.2 
N8 M 38 Indian 30.0 16.0 6.3 
N9 M 28 Chinese 15.0 4.0 8.3 
N10 F 26 Chinese 21.0 3.0 10.4 




Supplementary Material 2.3 
 
Demographic and clinical data of DES patients in the mild (n=12), moderate (n=12) and severe 
(n=11) categories.  
Severity* Sex Age Race Schir I (mm) TBuT (secs) OSDI Score 
    
Mild 1 M 43 Malay 16.0 2.0 2.1 
Mild 2 F 52 Japanese 3.0 3.0 4.2 
Mild 3 F 51 Chinese 7.0 10.0 4.2 
Mild 4 F 59 Chinese 4.0 2.0 8.3 
Mild 5 F 67 Chinese 6.0 2.0 8.3 
Mild 6 F 52 Chinese 3.0 3.0 12.5 
Mild 7 M 74 Chinese 5.0 4.0 12.5 
Mild 8 M 74 Indian 15.0 2.0 16.7 
Mild 9 F 62 Chinese 3.0 7.0 16.7 
Mild 10 F 67 Chinese 5.0 7.0 18.8 
Mild 11 F 57 Chinese 24.0 2.0 20.8 
Mild 12 M 69 Chinese 8.0 3.0 20.8 
Moderate 1 F 72 Chinese 0.0 3.0 22.9 
Moderate 2 F 68 Chinese 35.0 5.0 22.9 
Moderate 3 F 74 Chinese 16.0 5.0 25.0 
Moderate 4 M 54 Chinese 10.0 2.0 25.0 
Moderate 5 F 62 Chinese 4.0 3.0 29.2 
Moderate 6 F 59 Bangladeshi 8.0 3.0 31.3 
Moderate 7 F 71 Chinese 20.0 3.0 33.3 
Moderate 8 F 63 Chinese 2.0 2.0 37.5 
Moderate 9 F 75 Chinese 20.0 3.0 39.6 
Moderate 10 F 41 Chinese 16.0 4.0 39.6 
Moderate 11 F 50 Chinese 6.0 2.0 41.7 
Moderate 12 F 73 Chinese 1.0 2.0 41.7 
Severe 1 F 51 Chinese 5.0 2.0 43.8 
Severe 2 F 53 Chinese 12.0 3.0 50.0 
Severe 3 F 68 Chinese 6.0 3.0 56.3 
Severe 4 F 69 Chinese 14.0 3.0 58.3 
Severe 5 F 49 Chinese 4.0 3.0 58.3 
Severe 6 F 43 Chinese 1.0 5.0 60.4 
Severe 7 F 51 Chinese 2.0 4.0 60.4 
Severe 8 F 65 Chinese 1.0 1.0 64.6 
Severe 9 M 59 Chinese 1.0 2.0 64.6 
Severe 10 F 67 Chinese 8.0 3.0 85.4 
Severe 11 F 52 Chinese 11.0 2.0 87.5 
Schir I: Schirmer’s I score; TBuT: Tear Breakup Time; OSDI: Ocular Surface Disease Index 






Supplementary Material 3.1 
Validation of Schirmer’s strip method of tear collection. Demographic information of four volunteers 
who provided Schirmer’s tear samples for the method validation.  Replicate samples were obtained from 




Sex Ethnicity Eye sampled Schir I (mm) 
Subject 1 Male Chinese R 22.0 
      R 19.0 
Subject 2 Female German R 24.0 
      R 27.0 
Subject 3 Female Chinese R 24.0 
      R 19.5 
Subject 4 Female Chinese R 5.5 







































Comparison of tear collection techniques. Demographic and clinical information of five volunteers 
recruited to contribute Schirmer’s and capillary-collected tear samples. The volunteers had normal 
lacrimal function based on the cutoff value given by the report from the Diagnostic Methodology 




























1 M 40 Chinese R 8.0 2 20 
L 6.0 
2 F 25 Chinese R 24.0 1* 30 
L 30.0 
3 F 24 Chinese R 24.0 1.5 60 
L 25.0 
4 F 22 Chinese R 7.0 5 60 
L 6.0 
5 F 32 Chinese R 19.0 5 10 
L 14.0 



































Supplementary Material 3.3 
 
Demographic and clinical information of the dry eye cohort used for validation of analytical 
methods. A total of 28 patients were included from which both Schirmer’s tear and meibum samples 
were analyzed. Entry criteria include TBuT < 5 secs; Schir I < 5.5mm; OSDI > 12.9; Baylor score > 0.  
Patients were considered to suffer from certain aspects of dry eye as long as two of the four criteria 
aforementioned were fulfilled. The entry criteria were not considered stringent as this cohort was only 
used for validating the translational feasibility of analytical methods developed.  
No. Sex Age Race Eye TBuT (secs) Schir I (mm) OSDI Baylor score 
         
18 F 55 Chinese R 3.0 3.0 33.3 3 
19 F 50 Chinese R 2.0 7.0 16.7 1 
20 F 61 Chinese L 2.0 10.0 0 7 
21 F 55 Chinese L 4.0 25.0 43.8 5 
22 F 77 Chinese L 1.0 3.0 58.3 4 
23 M 58 Chinese L 3.0 0.0 16.7 7 
24 M 50 Chinese L 2.0 5.0 20.8 2 
26 F 49 Chinese R 3.0 9.0 35.4 3 
27 F 63 Chinese R 3.0 4.0 12.5 3 
28 F 58 Chinese R 4.0 11.0 27.1 10 
29 F 56 Chinese R 15.0 23.0 35.4 1 
30 F 55 Chinese R 2.0 1.0 12.5 19 
31 M 58 Malay L 1.0 18.0 12.5 2 
32 F 52 Chinese L 2.0 11.0 25.0 10 
34 F 54 Chinese R 3.0 7.0 12.5 3 
36 M 63 Malay R 2.0 21.0 45.8 11 
38 M 66 Chinese R 2.0 9.0 10.4 9 
41 F 60 Chinese L 3.0 9.0 20.8 2 
43 F 60 Chinese R 6.0 7.0 20.8 2 
44 F 52 Chinese L 2.0 7.0 43.8 9 
45 F 48 Chinese L 1.0 15.0 0.0 7 
46 F 62 Chinese L 2.0 7.0 58.3 11 
47 F 74 Chinese R 4.0 16.0 43.8 20 
49 F 72 Chinese R 1.0 4.0 31.3 1 
50 F 54 Chinese L 2.0 5.0 39.6 8 
52 F 52 Chinese R 5.0 6.0 31.3 3 
54 M 59 Chinese R 4.0 1.0 45.8 0 
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Supplementary Material 4.2 
 
Partial correlation plots between molar concentration (µmol ml-1) of CS, total GluCer, total GM3 
and total LPC with Schir 1. Other confounding parameters including age, gender, TBuT, Baylor 
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ROC curves displaying the classifying performance of individual wax ester species, expressed by 
its true positive rate (sensitivity) and false positive rate (1-specificity), with C18:2C16:0 providing 






Supplementary Material 4.5 
P-values and q-values for ANOVA of wax ester species. 
 
Wax species p value q value Wax species p value q value 
C16:1C17:1 0.16 0.09 C15:2C27:0 0.57 0.21 
C18:1C15:1 0.13 0.08 C16:2C26:0 0.68 0.22 
C16:1C17:0 0.59 0.21 C16:1C26:1 0.43 0.18 
C17:1C16:0 0.14 0.08 C17:1C25:1 0.64 0.21 
C18:1C15:0 0.00 0.01 C18:2C24:0 0.25 0.12 
C16:2C18:0 0.01 0.01 C18:1C24:1 0.72 0.22 
C16:1C18:1 0.16 0.09 C16:1C26:0 0.82 0.23 
C18:2C16:0 0.00 0.00 C17:1C25:0 0.41 0.18 
C18:1C16:1 0.10 0.07 C16:0C26:1 0.00 0.00 
C16:1C18:0 0.64 0.21 C18:0C24:1 0.00 0.01 
C17:1C17:0 0.22 0.11 C14:2C29:0 0.17 0.09 
C18:1C16:0 0.00 0.01 C16:2C27:0 0.03 0.03 
C15:2C20:0 0.05 0.04 C17:1C26:1 0.75 0.22 
C17:1C18:1 0.07 0.05 C18:2C25:0 0.43 0.18 
C18:2C17:0 0.02 0.02 C18:1C25:1 0.74 0.22 
C16:1C19:0 0.70 0.22 C16:1C27:0 0.35 0.16 
C17:1C18:0 0.11 0.07 C17:1C26:0 0.21 0.11 
C18:1C17:0 0.00 0.00 C18:1C25:0 0.71 0.22 
C16:2C20:0 0.25 0.12 C17:0C26:1 0.00 0.01 
C16:1C20:1 0.78 0.23 C18:0C25:1 0.02 0.02 
C17:1C19:1 0.20 0.10 C16:2C28:0 0.84 0.24 
C18:2C18:0 0.00 0.01 C16:1C28:1 0.91 0.25 
C18:1C18:1 0.00 0.01 C17:1C27:1 0.85 0.24 
C16:1C20:0 0.78 0.23 C18:2C26:0 0.17 0.09 
C17:1C19:0 0.19 0.10 C18:1C26:1 0.72 0.22 
C18:1C18:0 0.02 0.02 C16:1C28:0 0.50 0.19 
C15:2C22:0 0.24 0.12 C17:1C27:0 0.17 0.09 
C16:2C21:0 0.12 0.08 C16:0C28:1 0.01 0.01 
C16:1C21:1 0.41 0.18 C18:1C26:0 0.38 0.17 
C17:1C20:1 0.56 0.20 C18:0C26:1 0.00 0.00 
C18:2C19:0 0.01 0.01 C20:1C24:0 0.45 0.18 
C16:1C21:0 0.44 0.18 C15:2C30:0 0.03 0.03 
C17:1C20:0 0.13 0.08 C16:2C29:0 0.06 0.04 
C18:1C19:0 0.05 0.04 C17:1C28:1 0.96 0.26 
C14:2C24:0 0.04 0.03 C18:1C27:1 0.46 0.18 
C16:1C22:1 0.64 0.21 C16:1C29:0 0.43 0.18 
C18:2C20:0 0.16 0.09 C15:0C30:1 0.03 0.03 
C18:1C20:1 0.00 0.01 C18:1C27:0 0.70 0.22 
C16:1C22:0 0.06 0.04 C17:0C28:1 0.01 0.02 
C17:1C21:0 0.04 0.03 C20:1C25:0 0.24 0.12 
C18:1C20:0 0.01 0.01 C16:1C30:1 0.88 0.25 
C16:1C23:1 0.04 0.04 C18:2C28:0 0.10 0.07 
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C17:1C22:1 0.12 0.08 C18:1C28:1 0.56 0.20 
C18:2C21:0 0.02 0.03 C16:1C30:0 0.76 0.22 
C18:1C21:1 0.06 0.05 C16:0C30:1 0.00 0.01 
C16:1C23:0 0.03 0.03 C18:1C28:0 0.23 0.11 
C17:1C22:0 0.05 0.04 C20:1C26:0 0.35 0.16 
C18:1C21:0 0.00 0.01 C17:1C30:1 0.61 0.21 
C16:2C24:0 0.01 0.01 C18:2C29:0 0.35 0.16 
C16:1C24:1 0.02 0.02 C16:1C31:0 0.70 0.22 
C18:2C22:0 0.01 0.02 C17:1C30:0 0.51 0.20 
C18:1C22:1 0.00 0.00 C16:0C31:1 0.09 0.07 
C16:1C24:0 0.56 0.20 C18:1C29:0 0.53 0.20 
C17:1C23:0 0.39 0.17 C17:0C30:1 0.00 0.01 
C16:0C24:1 0.00 0.01 C20:1C27:0 0.63 0.21 
C18:1C22:0 0.75 0.22 C16:1C32:1 0.73 0.22 
C18:0C22:1 0.02 0.02 C18:2C30:0 0.61 0.21 
C16:1C25:0 0.55 0.20 C18:1C30:1 0.83 0.24 
C15:0C26:1 0.02 0.02 C16:1C32:0 0.58 0.21 
C17:1C24:0 0.43 0.18 C16:0C32:1 0.00 0.01 
C18:1C23:0 0.94 0.26 C18:1C30:0 0.72 0.22 
C17:0C24:1 0.00 0.01 C18:0C30:1 0.01 0.02 
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Visual Analogue Scale for recording ocular symptoms at Week 12. 
 
Please place an 'X' on the line to indicate how often, on average, your eyes feel the following 






Supplementary Material 5.4 
 
P-values and q-values for paired t-tests. 
 
Lipid  p-value q-value Lipid  p-value q-value 
Total WE 0.05 0.04 PC34:1e,34:0p 0.32 0.16 
Total CE 0.27 0.14 PC34:0e 0.44 0.18 
CHO 0.54 0.22 PC34:4 0.38 0.17 
CS 0.07 0.06 PC34:3 0.04 0.05 
Total TAG 0.95 0.35 PC34:2 0.04 0.05 
Total DAG 0.10 0.07 PC34:1 0.18 0.11 
Total OAHFA 0.00 0.00 PC34:0 0.23 0.13 
Total SM 0.31 0.14 PC36:5e,36:4p 0.87 0.30 
Total Cer 0.19 0.11 PC36:4e,36:3p 0.47 0.19 
Total GluCer 0.79 0.31 PC36:3e,36:2p 0.37 0.17 
Total GM3 0.21 0.11 PC36:2e,36:1p 0.49 0.20 
Total PC 0.09 0.07 PC36:1e,36:0p 0.54 0.20 
Total PE 0.03 0.03 PC36:0e 0.52 0.20 
Total PS 0.03 0.03 PC36:5 0.08 0.06 
Total PI 0.17 0.10 PC36:4 0.02 0.03 
Total LPC 0.00 0.00 PC36:3 0.01 0.03 
Total LPE 0.01 0.02 PC36:2 0.03 0.04 
Total LpPE 0.00 0.00 PC36:1 0.13 0.09 
Total LPS 0.29 0.14 PC36:0 0.04 0.05 
Total LPI 0.00 0.00 PC38:6e,38:5p 0.30 0.16 
LPE16:1 0.29 0.10 PC38:5e,38:4p 0.86 0.30 
LPE16:0 0.00 0.00 PC38:4e,38:3p 0.51 0.20 
LPE18:2 0.23 0.08 PC38:3e,38:2p 0.52 0.20 
LPE18:1 0.96 0.30 PC38:2e,38:1p 0.43 0.18 
LPE18:0  0.00 0.00 PC38:7 0.78 0.28 
LPC16:0e 0.00 0.00 PC38:6 0.01 0.03 
LPC16:1 0.00 0.00 PC38:5 0.02 0.04 
LPC16:0 0.00 0.00 PC38:4 0.01 0.03 
LPC18:0e 0.00 0.00 PC38:3 0.01 0.03 
LPC18:2 0.00 0.00 PC38:2 0.08 0.06 
LPC18:1 0.00 0.00 PC38:1 0.16 0.11 
LPC18:0 0.00 0.00 PC38:0 0.34 0.16 
LPC20:4 0.00 0.00 PC40:6e,40:5p 0.91 0.31 
LPC22:6 0.45 0.15 PC40:5e,40:4p 0.26 0.14 
LPI16:0 0.00 0.00 PC40:7 0.06 0.06 
LPI18:0 0.00 0.00 PC40:6 0.01 0.03 
LPI20:4 0.00 0.00 PC40:5 0.02 0.03 
LPE16:0p 0.00 0.00 PC40:4 0.03 0.04 
LPE18:1p 0.00 0.00 PC40:3 0.16 0.11 
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LPE18:0p 0.00 0.00 PC40:2 0.44 0.18 
LPE20:1p 0.00 0.00 PC40:1 0.82 0.29 
LPE20:0p 0.00 0.00 PC40:0 0.83 0.29 
PI 32:1 0.20 0.12 PE32:2 0.43 0.18 
PI 34:2 0.26 0.14 PE34:2p, 34:3e 0.35 0.16 
PI 34:1 0.21 0.12 PE34:1p, 34:2e 0.15 0.11 
PI 36:4 0.34 0.16 PE34:2 0.01 0.03 
PI 36:3 0.02 0.04 PE34:1 0.01 0.03 
PI 36:2 0.17 0.11 PE36:4p, 36:5e 0.09 0.07 
PI 36:1 0.34 0.16 PE36:3p, 36:4e 0.03 0.04 
PI 36:0 0.15 0.11 PE36:2p, 36:3e 0.89 0.30 
PI 38:6 0.06 0.06 PE36:1p, 36:2e 0.79 0.28 
PI 38:5 0.06 0.06 PE36:4 0.04 0.05 
PI 38:4 0.35 0.16 PE36:3 0.01 0.03 
PI 38:3 0.05 0.05 PE36:2 0.00 0.00 
PI 40:6 0.03 0.04 PE36:1 0.06 0.06 
PI 40:5 0.16 0.11 PE38:6p, 38:7e 0.00 0.01 
PI 40:4 0.91 0.31 PE38:5p, 38:6e 0.02 0.04 
PS 34:2 0.02 0.04 PE38:4p, 38:5e 0.34 0.16 
PS 34:1 0.02 0.04 PE38:6 0.08 0.06 
PS 36:2 0.00 0.02 PE38:5 0.01 0.03 
PS 36:1 0.20 0.12 PE38:4 0.02 0.04 
PS 38:4 0.03 0.04 PE38:3 0.09 0.07 
PS 38:3 0.00 0.01 PE38:1 0.05 0.05 
PS 40:6 0.00 0.03 PE40:6p,40:7e 0.07 0.06 
PS 40:5 0.32 0.16 PE40:5p,40:6e 0.07 0.06 
PS 40:4 0.21 0.12 PE40:4p,40:5e 0.60 0.22 
PC32:2e,32:1p 0.96 0.32 PE40:3p,40:4e 0.56 0.21 
PC32:1e,32:0p 0.41 0.18 PE40:2p,40:3e 0.78 0.28 
PC32:2 0.04 0.05 PE40:6 0.32 0.16 
PC32:1 0.08 0.06 PE40:5 0.25 0.14 
PC32:0 0.36 0.16 PE42:6p,42:7e 0.28 0.15 





Supplementary Material 6.1 
 
Lipid biology of primary human meibomian gland epithelial cell culture. Primary human meibomian 
gland epithelial cells were stained heavily with the lipophilic dye LD 540 (A), indicating the presence of 
appreciable amounts of lipid droplets, as compared to human corneal epithelial cells as a control (B). Lipid 
profiles (n=3 for each type) of primary human meibomian gland epithelial cells lacked the characteristic 
lipids such as CE and OAHFA of the human meibmomian gland tissues (and thus meibum), but displayed a 
predominating amount of TAG instead (C).  
 
 
 
